data_2enn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2enn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.7 m80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.812 0.339 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -103.88 99.48 9.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.4 t -121.72 112.64 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 2.5 mptp? 58.66 41.1 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 5.9 t 65.63 37.69 5.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -134.6 125.96 28.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -92.29 81.73 4.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.505 ' CZ ' HD11 ' A' ' 197' ' ' ILE . 33.2 m-85 -72.28 121.63 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.8 p -126.64 123.44 37.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.115 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.36 104.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.1 t -130.45 149.06 52.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.167 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -105.69 108.71 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.35 111.46 20.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.66 0.743 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -7.03 20.02 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -129.19 154.29 80.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 87.6 m -116.7 135.38 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -78.11 136.22 37.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.31 159.47 17.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.5 m -94.72 -23.64 17.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.48 -75.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.137 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.9 p -67.7 -22.2 65.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 40.3 m80 62.34 50.91 3.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -122.59 145.32 48.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -55.25 119.47 5.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.547 HG23 ' CE1' ' A' ' 198' ' ' HIS . 25.4 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.474 ' CE2' HD12 ' A' ' 202' ' ' ILE . 11.4 m-85 -140.92 132.82 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 110.883 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -132.47 119.73 20.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.55 162.07 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -95.43 -24.37 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.34 -75.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.9 p -71.34 -24.0 62.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.37 51.95 2.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.49 129.99 36.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 197' ' ' ILE . . . -95.83 126.15 40.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.505 HD11 ' CZ ' ' A' ' 162' ' ' PHE . 29.9 pt -149.86 153.62 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.174 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.547 ' CE1' HG23 ' A' ' 180' ' ' VAL . 69.3 m80 -67.02 159.94 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -59.2 -35.86 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -76.04 -23.28 55.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 66.2 m -87.91 24.5 1.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.474 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.1 tt -87.61 -30.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.82 -19.54 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -89.23 25.02 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.41 117.68 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 25.6 mm -116.17 -47.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.31 141.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -89.55 156.97 18.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 3.5 t -83.48 133.51 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -82.21 110.43 17.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 160' ' ' HIS . 70.9 t -134.12 126.29 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.607 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.0 mptt 36.41 46.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 66.2 m 63.14 42.35 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 94.9 m-70 -136.99 131.77 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -96.36 79.18 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -69.45 133.84 48.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.3 p -136.7 125.53 24.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.09 113.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.3 t -133.02 158.41 42.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.172 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.03 100.88 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 196' ' ' ALA . 84.1 m-85 -75.29 118.96 74.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.606 0.717 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -9.03 25.1 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.656 2.237 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.63 158.01 54.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 110.1 2.48 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.7 2.267 . . . . 0.0 112.334 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.431 HG21 ' CB ' ' A' ' 196' ' ' ALA . 9.8 t -98.14 150.71 21.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 177' ' ' HIS . 2.1 t80 -76.97 107.66 9.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 t -57.25 127.16 30.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.1 p -82.92 25.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.437 HG22 ' CG2' ' A' ' 197' ' ' ILE . 88.8 t -131.91 -53.63 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -106.85 -17.91 14.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 4.8 m170 72.8 49.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -136.96 140.13 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -46.16 120.4 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.566 HG21 ' CE1' ' A' ' 198' ' ' HIS . 60.0 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.432 ' CE2' HD12 ' A' ' 202' ' ' ILE . 17.8 m-85 -148.83 132.77 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.922 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -132.34 127.39 35.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.9 t -69.49 162.06 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -92.31 -18.64 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -103.72 -73.87 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.453 ' C ' ' CG ' ' A' ' 194' ' ' ASN . 27.8 p -72.48 -14.46 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.453 ' CG ' ' C ' ' A' ' 193' ' ' CYS . 1.0 OUTLIER 48.47 53.44 12.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.93 126.14 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 167' ' ' PHE . . . -96.38 121.14 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.437 ' CG2' HG22 ' A' ' 175' ' ' VAL . 40.2 pt -143.61 163.21 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.566 ' CE1' HG21 ' A' ' 180' ' ' VAL . 69.7 m80 -67.87 152.13 46.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -57.32 -27.32 62.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -84.7 -25.36 28.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 77.4 m -85.13 26.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.432 HD12 ' CE2' ' A' ' 188' ' ' TYR . 20.7 tt -87.1 -33.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.79 -23.98 31.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -89.24 28.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.49 119.7 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.088 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 87.5 mt -114.28 -54.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.44 118.0 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -73.59 158.59 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.452 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.9 t -86.77 131.05 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 -179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -104.05 102.15 11.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -127.78 108.02 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.11 43.24 21.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 66.04 35.87 6.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CB ' ' CE2' ' A' ' 162' ' ' PHE . 97.7 m-70 -129.27 117.86 21.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -76.75 50.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 160' ' ' HIS . 37.2 m-85 -60.2 105.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -122.16 136.27 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.12 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.56 124.86 3.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.441 HG23 ' CB ' ' A' ' 189' ' ' GLN . 15.2 t -143.2 153.49 42.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -102.65 128.82 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.05 109.33 58.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.707 2.272 . . . . 0.0 112.309 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -144.76 157.51 54.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 127.19 14.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 172' ' ' PHE . 88.4 m -128.96 138.72 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.406 ' N ' HG22 ' A' ' 171' ' ' THR . 19.7 m-85 -75.39 129.73 37.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.0 t -60.7 157.4 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 t -98.63 -29.2 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.16 -74.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.1 p -71.09 -23.87 62.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 63.54 53.88 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 179' ' ' PHE . 20.8 mt-10 -134.44 130.86 37.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 178' ' ' GLU . 8.5 p90 -34.73 123.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.439 HG21 ' CE1' ' A' ' 198' ' ' HIS . 84.1 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -154.08 140.55 18.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.441 ' CB ' HG23 ' A' ' 165' ' ' THR . 66.5 tt0 -140.81 109.69 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -58.78 161.42 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -95.13 -19.84 19.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.458 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 20.6 mt-30 -98.84 -74.57 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.425 ' C ' ' CG ' ' A' ' 194' ' ' ASN . 30.7 p -71.3 -12.63 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 192' ' ' GLN . 0.6 OUTLIER 47.16 52.01 12.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.92 122.68 32.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.426 ' C ' HG23 ' A' ' 197' ' ' ILE . . . -95.79 115.31 27.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.09 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.426 HG23 ' C ' ' A' ' 196' ' ' ALA . 27.3 pt -140.64 173.91 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.439 ' CE1' HG21 ' A' ' 180' ' ' VAL . 58.8 m80 -63.59 172.61 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -78.1 -15.43 58.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.8 pptp? -106.03 -32.21 8.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 3.4 m -55.43 -16.68 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.59 -26.83 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.85 -31.72 61.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.67 32.87 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.69 89.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.8 mt -91.25 -44.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.62 135.19 1.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -79.1 153.74 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.484 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 8.1 t -79.57 113.26 17.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 45.4 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.824 0.345 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -112.34 123.78 51.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.6 t -140.01 107.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.508 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.5 mttm 62.36 47.91 5.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.61 37.92 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 99.6 m-70 -131.04 113.55 14.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -84.13 76.3 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -71.9 138.79 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 73.3 p -140.72 128.71 22.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.56 116.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 15.3 t -138.67 142.07 39.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.88 110.62 22.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 13.3 m-85 -88.13 111.37 42.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.749 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -16.16 37.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.301 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -114.23 154.29 46.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 109.57 2.35 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.661 2.24 . . . . 0.0 112.317 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 57.1 m -113.69 135.01 54.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 7.3 p90 -77.14 115.67 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -44.93 159.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.2 m -99.29 -26.12 14.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.1 t -88.69 -71.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.8 p -75.23 -23.78 57.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.833 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.5 m80 64.21 51.87 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 179' ' ' PHE . 62.2 mt-10 -133.18 131.53 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 178' ' ' GLU . 27.3 p90 -32.91 113.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.549 HG23 ' CE1' ' A' ' 198' ' ' HIS . 68.1 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -150.4 129.82 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 110.946 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -123.72 131.62 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 11.4 t -76.22 161.81 28.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -93.23 -20.38 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.24 -75.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.6 p -69.92 -15.18 63.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 51.6 52.61 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.19 123.39 33.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -98.29 120.99 39.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 38.2 pt -141.36 171.97 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.549 ' CE1' HG23 ' A' ' 180' ' ' VAL . 49.7 m80 -63.01 -177.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -79.21 -37.15 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -87.32 -37.18 17.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 4.6 m -49.07 -18.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 tt -54.97 -32.5 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.81 -35.56 64.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -84.68 35.05 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.29 118.7 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 207' ' ' ALA . 3.8 mp -119.65 -56.86 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -35.02 112.4 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -64.38 150.25 46.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.8 t -73.07 137.19 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 77.6 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.838 0.352 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -76.22 113.4 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.78 106.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.495 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.0 mptp? 60.62 42.59 13.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 63.3 m 64.41 37.85 8.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.3 m-70 -131.47 119.02 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -83.07 79.45 9.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CZ ' HD11 ' A' ' 197' ' ' ILE . 25.3 m-85 -72.76 135.75 45.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 p -140.01 123.32 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -51.14 112.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -141.02 148.54 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -94.3 134.19 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -107.71 105.02 55.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.637 0.732 . . . . 0.0 110.901 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -3.53 12.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -128.92 153.54 80.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.709 2.273 . . . . 0.0 112.333 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.5 m -126.87 136.04 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -83.57 123.03 29.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 3.0 t -54.23 156.39 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 33.9 p -100.79 -17.41 16.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.3 t -97.77 -68.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -80.03 -14.86 58.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.5 m170 57.49 49.09 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 179' ' ' PHE . 70.9 mt-10 -128.29 130.94 48.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.7 p90 -35.46 134.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 198' ' ' HIS . 63.6 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.52 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 16.0 m-85 -136.33 140.33 43.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -135.92 115.22 12.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 14.4 t -63.09 138.34 58.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -85.67 20.48 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -132.32 -64.52 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.8 p -86.94 -15.52 38.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 59.48 54.06 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.39 128.06 52.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 129.9 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.47 HD11 ' CZ ' ' A' ' 162' ' ' PHE . 33.2 pt -151.03 153.68 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.557 ' CE1' HG21 ' A' ' 180' ' ' VAL . 60.8 m80 -64.57 161.65 17.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.52 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 7.6 mtpm? -64.04 -27.2 68.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -22.56 24.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.2 m -83.98 14.57 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.1 tt -79.47 -41.87 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -73.84 -26.81 60.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -88.07 38.16 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.5 t -111.02 112.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.411 ' O ' ' C ' ' A' ' 207' ' ' ALA . 77.4 mt -106.76 -50.78 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.14 143.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.076 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -97.23 137.57 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.545 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.5 t -65.47 140.52 58.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.168 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -88.87 109.13 19.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.9 t -132.12 136.92 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.606 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 21.6 mmtm 38.96 43.07 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 m 64.75 41.7 4.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 87.2 m-70 -136.27 142.17 43.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.73 75.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.479 ' CZ ' HD11 ' A' ' 197' ' ' ILE . 36.9 m-85 -66.43 105.13 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 p -109.95 121.25 44.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.99 105.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -127.9 149.9 50.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -107.18 105.08 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.62 114.58 33.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -6.96 19.81 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.751 2.3 . . . . 0.0 112.383 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -140.1 159.5 63.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.599 0.714 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 179' ' ' PHE . 53.7 Cg_endo -69.78 116.5 4.59 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.666 2.244 . . . . 0.0 112.327 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.463 HG22 ' CB ' ' A' ' 196' ' ' ALA . 11.9 t -114.38 156.87 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.75 146.98 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.9 t -79.53 160.05 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 46.6 t -101.84 -30.38 11.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.46 -73.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -75.02 -25.12 58.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 63.18 50.13 3.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -123.2 135.59 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 170' ' ' PRO . 4.2 t80 -39.63 122.18 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.513 HG23 ' CE1' ' A' ' 198' ' ' HIS . 22.5 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -122.35 135.65 54.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -124.83 121.82 35.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 25.9 t -64.21 163.01 13.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -90.4 -21.82 21.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -103.25 -73.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.5 p -71.36 -12.15 61.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 194' ' ' ASN . 5.1 p-10 43.05 52.87 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -91.24 130.32 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.463 ' CB ' HG22 ' A' ' 171' ' ' THR . . . -93.19 122.4 35.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.479 HD11 ' CZ ' ' A' ' 162' ' ' PHE . 28.6 pt -142.81 147.82 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.513 ' CE1' HG23 ' A' ' 180' ' ' VAL . 69.2 m80 -57.69 151.46 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.84 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -57.27 -19.7 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -90.99 -27.41 18.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.9 m -82.62 20.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.21 -37.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -82.84 -24.22 33.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -85.28 31.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.7 t -101.52 127.0 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.43 -44.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -53.75 125.07 17.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.79 167.29 11.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.479 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 7.8 t -88.31 113.13 23.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.141 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.781 0.324 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -96.29 112.0 23.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 158' ' ' LYS . 97.3 t -140.65 135.53 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mptt 36.31 45.19 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 99.0 m 63.31 46.08 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.1 m-70 -136.3 178.37 7.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -130.66 50.23 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.54 ' CD2' HG13 ' A' ' 202' ' ' ILE . 23.2 m-85 -51.43 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.414 ' CG2' ' NH2' ' A' ' 191' ' ' ARG . 7.3 t -117.95 136.67 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.182 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.55 124.16 3.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.495 HG23 ' CZ ' ' A' ' 167' ' ' PHE . 13.6 t -145.75 159.89 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -124.94 109.89 13.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.495 ' CZ ' HG23 ' A' ' 165' ' ' THR . 3.4 m-85 -85.26 119.27 72.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.276 . . . . 0.0 112.309 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -147.74 158.28 42.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.614 0.721 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 124.48 11.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.401 HG21 ' CB ' ' A' ' 196' ' ' ALA . 12.2 t -117.68 157.47 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -84.78 115.75 22.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.47 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 49.1 t -64.81 126.56 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.0 t -87.12 26.96 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.423 HG23 ' CG2' ' A' ' 197' ' ' ILE . 53.5 t -129.76 -55.34 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.89 -16.03 14.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.9 m170 63.59 51.87 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -134.99 132.63 38.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -40.25 109.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.47 ' CG2' ' HB2' ' A' ' 173' ' ' CYS . 82.6 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.168 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.94 143.87 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.835 0.35 . . . . 0.0 110.926 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.423 ' CB ' HG22 ' A' ' 165' ' ' THR . 46.0 tt0 -143.52 119.71 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 28.2 t -63.46 163.08 11.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.414 ' NH2' ' CG2' ' A' ' 163' ' ' THR . 21.3 mmt-85 -98.03 -22.79 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -92.28 -68.4 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.99 -25.36 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 63.53 50.15 2.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -89.44 119.39 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.076 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.43 ' C ' HG21 ' A' ' 197' ' ' ILE . . . -92.58 121.04 33.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.43 HG21 ' C ' ' A' ' 196' ' ' ALA . 43.1 pt -144.18 174.91 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -68.42 178.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -73.84 -53.88 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 202' ' ' ILE . 10.7 pttm -70.97 -43.7 67.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 18.7 m -43.16 -22.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.54 HG13 ' CD2' ' A' ' 162' ' ' PHE . 19.3 tt -50.37 -38.26 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -34.95 71.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.409 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 36.8 mmtt -82.72 36.82 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.55 126.17 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.65 -55.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -37.98 139.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.103 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -90.07 159.36 16.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.489 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 5.2 t -79.54 110.18 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.346 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.46 ' CE1' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m-70 -125.22 105.49 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 88.7 t -137.83 120.68 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 52.91 39.44 29.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.3 t 65.99 40.01 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -132.01 119.94 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.46 ' OE1' ' CE1' ' A' ' 156' ' ' HIS . 6.6 mm-40 -78.35 70.58 4.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -71.48 97.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.1 t -112.12 134.44 53.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.25 120.32 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.455 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 5.1 t -139.29 149.74 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -105.82 117.46 34.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.455 ' CE1' ' CG2' ' A' ' 165' ' ' THR . 18.8 m-85 -91.13 109.73 37.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.728 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -7.56 21.37 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.701 2.267 . . . . 0.0 112.348 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -136.04 160.72 66.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 121.9 8.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.751 2.301 . . . . 0.0 112.326 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.8 m -115.66 150.18 37.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.412 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 32.8 p90 -96.74 111.43 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 12.7 t -47.56 157.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 p -97.56 -22.67 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.5 t -92.81 -74.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.138 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -73.27 -23.62 60.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 63.56 46.27 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.98 148.66 43.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -45.01 130.57 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 69.1 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.516 ' CZ ' ' HG2' ' A' ' 199' ' ' LYS . 14.5 m-85 -104.0 131.98 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -129.78 118.71 22.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 8.9 t -62.68 161.68 11.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -96.49 -20.71 18.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -97.21 -71.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 21.5 p -74.18 -20.55 60.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 57.83 53.51 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.38 128.7 41.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.416 ' C ' HG22 ' A' ' 197' ' ' ILE . . . -94.84 125.79 39.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.416 HG22 ' C ' ' A' ' 196' ' ' ALA . 23.7 pt -152.09 147.27 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.076 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -60.01 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 188' ' ' TYR . 41.7 mttt -58.67 -22.83 58.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -22.85 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 79.2 m -86.77 27.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 tt -88.27 -30.39 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -80.58 -25.45 38.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -88.77 31.48 0.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.58 110.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' ALA . 46.7 mm -109.27 -54.3 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.38 145.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.131 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -91.92 167.11 12.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.6 t -98.64 124.97 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.812 0.339 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -110.57 107.12 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.833 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 160' ' ' HIS . 58.2 t -129.65 131.46 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.078 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 14.2 mptt 37.41 45.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 59.1 m 63.47 41.22 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.545 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -133.25 120.88 21.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.6 70.39 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -75.69 103.68 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.1 t -119.9 138.94 53.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.52 119.82 2.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.5 t -141.25 141.39 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -97.21 118.85 34.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -90.63 108.84 30.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -5.68 16.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.725 2.284 . . . . 0.0 112.289 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -133.88 153.95 80.15 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 m -108.62 156.35 19.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 172' ' ' PHE . 19.0 p90 -103.74 131.95 50.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.06 155.28 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 m -100.49 -24.29 14.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.23 -72.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -74.43 -21.29 59.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 8.2 m170 63.2 47.67 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -124.52 143.85 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -48.23 128.17 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 199' ' ' LYS . 20.8 m-85 -124.78 135.51 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.46 112.92 9.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.9 t -57.72 159.17 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -96.98 -16.99 20.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -97.85 -68.43 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.68 -23.45 53.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.98 53.33 3.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.75 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.51 118.75 31.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 29.8 pt -140.02 158.12 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -62.64 161.35 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 188' ' ' TYR . 50.9 tttt -68.75 -11.17 60.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -105.19 -20.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.69 15.66 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.6 tt -79.27 -40.09 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.452 ' OD2' ' NZ ' ' A' ' 204' ' ' LYS . 6.8 p-10 -71.55 -25.52 62.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.452 ' NZ ' ' OD2' ' A' ' 203' ' ' ASP . 0.6 OUTLIER -90.54 37.25 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.44 96.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.68 -44.82 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -41.75 154.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.08 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -99.31 159.96 14.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -85.51 145.14 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.821 0.343 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -101.69 99.62 9.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 160' ' ' HIS . 90.1 t -117.87 134.67 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.568 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 1.5 mmmp? 33.79 47.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.864 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 64.3 m 64.61 45.08 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.5 m-70 -135.09 118.75 17.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.83 75.56 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -72.34 144.53 48.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.7 p -134.01 127.33 32.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.82 119.17 3.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -143.99 153.26 42.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -116.5 112.77 21.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 196' ' ' ALA . 65.7 m-85 -87.74 111.18 40.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.668 0.747 . . . . 0.0 110.863 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -6.39 18.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.328 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -128.83 152.53 79.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.61 0.719 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.67 2.247 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.0 m -113.9 138.47 50.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -66.93 129.72 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.1 t -72.04 159.26 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.1 t -98.09 -29.21 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.9 t -87.55 -75.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.098 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.3 p -72.17 -22.11 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 60.91 45.45 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.35 169.67 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -62.84 122.86 17.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.564 HG21 ' CE1' ' A' ' 198' ' ' HIS . 48.4 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -154.43 134.59 13.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -132.58 127.85 35.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.4 t -71.76 162.02 30.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -88.72 -20.02 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -105.61 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 25.7 p -66.56 -10.61 47.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 42.57 49.92 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.75 28.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . . . -94.94 122.05 37.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 36.4 pt -145.54 173.75 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.564 ' CE1' HG21 ' A' ' 180' ' ' VAL . 74.2 m80 -66.9 176.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -24.13 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -96.57 -38.11 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.48 -25.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.2 tt -49.02 -39.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.153 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -70.25 -32.72 70.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -86.04 38.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.4 125.51 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 80.7 mt -120.64 -40.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.14 136.09 42.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.422 ' HG3' ' NZ ' ' A' ' 158' ' ' LYS . 7.0 mtpm? -83.1 167.05 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.409 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.3 t -84.6 122.18 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 39.3 m80 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.802 0.334 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -78.06 111.4 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 54.7 t -130.99 115.36 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 10.9 mptt 53.16 40.93 32.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 42.0 m 67.04 40.27 2.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -134.79 118.1 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -79.25 80.41 5.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -80.69 107.23 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 77.0 p -111.53 126.8 55.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.83 108.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.6 t -132.8 146.34 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.159 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.36 143.15 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.97 124.96 28.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.615 0.722 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -23.97 29.77 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.654 2.236 . . . . 0.0 112.311 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -127.45 152.47 76.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 127.93 15.33 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.467 ' O ' ' CG2' ' A' ' 180' ' ' VAL . 4.7 t -120.21 149.82 41.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -79.14 128.76 33.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.73 159.63 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.6 m -95.93 -19.16 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.457 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 90.2 t -100.31 -72.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.5 p -71.62 -22.48 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.457 ' CE1' ' O ' ' A' ' 175' ' ' VAL . 9.9 m80 62.83 44.38 6.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.83 151.27 37.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -52.43 130.61 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 171' ' ' THR . 66.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.518 ' CE2' ' HG2' ' A' ' 199' ' ' LYS . 26.9 m-85 -128.69 147.55 50.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.0 110.887 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -143.7 110.58 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 5.3 t -57.94 157.81 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -96.34 -14.76 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -99.28 -67.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.42 -22.26 54.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 59.78 47.89 9.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.69 133.33 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -99.55 124.24 44.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 42.7 pt -145.15 175.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -85.99 163.87 17.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.518 ' HG2' ' CE2' ' A' ' 188' ' ' TYR . 34.2 mttm -67.29 -20.22 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -92.51 -27.16 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 76.3 m -82.56 11.04 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.1 tt -73.16 -34.98 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.85 -27.08 49.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -88.75 32.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.8 t -111.12 88.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.184 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.1 mp -85.13 -55.74 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.81 116.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -73.86 144.43 45.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.75 134.11 53.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -100.96 107.62 19.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 85.2 t -131.66 125.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 45.33 36.52 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 67.92 44.4 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.517 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.9 m-70 -134.66 118.31 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.448 ' OE2' ' NH2' ' A' ' 191' ' ' ARG . 21.0 mt-10 -91.92 78.17 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -67.84 150.07 49.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 43.6 p -142.0 117.82 10.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.5 106.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -133.6 157.65 45.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.141 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -112.75 107.66 16.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.849 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -81.55 112.11 31.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.435 ' HG2' ' CD ' ' A' ' 169' ' ' GLN . 53.5 Cg_endo -69.78 -7.01 19.97 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.313 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.435 ' CD ' ' HG2' ' A' ' 168' ' ' PRO . 19.6 mp0 -125.46 152.71 71.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.608 0.718 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 110.53 2.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 180' ' ' VAL . 1.3 m -109.26 157.42 18.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.157 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -96.48 129.7 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.6 t -69.29 128.63 37.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 72.2 m -85.62 19.52 2.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.07 -57.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.69 -13.91 17.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 4.7 m170 63.93 52.26 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 179' ' ' PHE . 25.9 mt-10 -132.67 136.71 46.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.458 ' C ' ' O ' ' A' ' 178' ' ' GLU . 29.9 m-85 -33.35 137.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 171' ' ' THR . 88.0 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -149.1 137.15 20.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -130.24 120.03 23.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 4.7 t -66.93 162.02 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.448 ' NH2' ' OE2' ' A' ' 161' ' ' GLU . 18.9 mtm105 -92.93 -24.91 18.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -99.78 -74.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.4 p -72.51 -9.74 58.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 42.99 54.17 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.46 131.96 34.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.105 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.419 ' C ' HG21 ' A' ' 197' ' ' ILE . . . -97.7 115.66 28.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.419 HG21 ' C ' ' A' ' 196' ' ' ALA . 12.5 pt -143.11 159.49 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.41 ' NE2' HG22 ' A' ' 180' ' ' VAL . 46.2 m80 -65.23 159.61 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -65.02 -35.09 80.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -26.62 48.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 86.0 m -84.21 22.53 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.45 -36.03 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -83.16 -25.27 32.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -86.11 31.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.7 t -104.94 116.52 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.19 -47.47 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -38.59 137.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 19.7 ttpt -88.38 156.0 19.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -91.88 113.39 25.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.2 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -97.49 98.57 10.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 65.3 t -120.15 116.58 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.608 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.9 mptt 43.39 45.94 5.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 65.2 m 62.88 40.05 9.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 91.9 m-70 -135.64 123.67 22.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -87.91 88.95 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.549 ' CZ ' HD11 ' A' ' 197' ' ' ILE . 29.6 m-85 -82.51 122.88 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -129.67 123.3 30.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.08 101.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.8 t -126.23 155.42 41.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -112.09 112.99 25.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -84.94 126.48 67.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -11.05 30.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.706 2.271 . . . . 0.0 112.382 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.16 152.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 117.62 5.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.3 t -114.67 136.41 53.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.134 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.24 128.83 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.04 159.64 9.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 12.6 m -97.36 -26.45 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.92 -75.15 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 12.7 p -70.55 -20.79 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 5.7 m170 60.87 49.45 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 179' ' ' PHE . 5.9 mm-40 -126.95 133.49 50.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 178' ' ' GLU . 12.1 p90 -36.05 111.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -140.47 137.08 33.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -132.44 118.26 19.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 10.6 t -58.56 162.67 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -94.14 -13.56 26.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -112.36 -62.59 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 194' ' ' ASN . 17.3 p -87.92 4.95 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 193' ' ' CYS . 2.0 p30 34.08 45.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.48 119.41 16.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.096 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.31 115.05 27.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.085 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.549 HD11 ' CZ ' ' A' ' 162' ' ' PHE . 29.9 pt -141.88 158.32 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -63.22 161.2 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -65.03 -18.88 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.59 -23.72 16.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 81.3 m -83.35 22.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.1 tt -84.3 -39.57 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -75.33 -30.74 60.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -84.39 36.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -108.74 108.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 39.7 mm -105.42 -50.2 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.49 146.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -92.89 165.12 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.7 t -95.39 118.16 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.929 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -94.08 106.41 18.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 160' ' ' HIS . 87.5 t -124.83 126.67 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . 28.7 mmmt 34.76 39.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 t 74.98 43.92 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.566 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 92.1 m-70 -137.76 115.4 11.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -80.77 74.25 7.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 33.1 m-85 -70.3 128.75 37.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 80.9 p -136.01 126.43 26.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.3 115.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.8 t -134.45 154.14 51.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.17 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -105.36 103.7 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -77.9 111.91 21.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.64 19.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.644 2.229 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -140.48 156.68 69.37 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.712 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 109.0 2.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.676 2.25 . . . . 0.0 112.355 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.439 HG23 ' CB ' ' A' ' 196' ' ' ALA . 12.8 t -99.16 157.91 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.113 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 1.4 p90 -87.6 129.01 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 40.0 t -79.37 119.01 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.1 t -82.31 26.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.27 -59.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -101.81 -13.37 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.4 m170 62.16 53.37 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.95 131.13 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -40.91 114.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.464 -0.255 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.556 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 14.8 m-85 -150.54 134.99 17.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -132.3 117.99 18.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 41.7 t -63.36 163.72 10.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -99.71 -27.06 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -87.98 -68.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.3 p -81.49 -24.64 36.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 190' ' ' CYS . 4.0 m-80 62.71 51.06 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.23 125.69 34.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.059 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.439 ' CB ' HG23 ' A' ' 171' ' ' THR . . . -94.09 130.24 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.409 HG21 ' C ' ' A' ' 196' ' ' ALA . 28.4 pt -154.16 170.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -71.37 159.86 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.556 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 2.2 ttpm? -66.33 -29.19 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 -27.21 24.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.3 m -81.69 21.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 188' ' ' TYR . 19.8 tt -79.55 -39.22 20.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -77.73 -28.4 50.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -84.64 32.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 62.3 t -107.48 114.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.4 mp -103.09 -54.74 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.68 122.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -82.84 158.36 22.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.566 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.8 t -88.06 137.5 32.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.1 m170 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.79 0.329 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -96.95 110.75 23.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.0 t -134.68 126.46 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . 22.7 mmtt 37.2 38.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 3.4 t 70.23 42.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.558 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.1 m-70 -132.9 128.6 36.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -92.65 74.78 5.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 38.4 m-85 -65.12 140.49 58.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 26.4 p -139.76 121.87 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.162 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.09 114.48 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.512 HG22 ' CZ ' ' A' ' 167' ' ' PHE . 14.4 t -142.46 149.0 38.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -110.43 125.12 52.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.512 ' CZ ' HG22 ' A' ' 165' ' ' THR . 18.1 m-85 -100.92 106.65 45.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -5.1 15.37 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.694 2.263 . . . . 0.0 112.36 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -126.93 158.92 67.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 116.26 4.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.634 2.222 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 88.9 m -121.16 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.23 138.32 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.92 159.24 30.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.6 m -105.82 -26.85 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' A' ' 204' ' ' LYS . 75.2 t -80.24 -62.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.9 p -86.79 -27.0 23.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 10.6 m80 72.84 40.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 179' ' ' PHE . 37.9 mt-10 -125.27 128.89 48.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 178' ' ' GLU . 1.5 p90 -36.61 119.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 198' ' ' HIS . 47.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.431 ' HB3' ' CD1' ' A' ' 162' ' ' PHE . 42.0 m-85 -134.55 137.74 44.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -123.84 124.77 43.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 52.2 t -73.15 143.3 47.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -89.97 18.41 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.855 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -128.54 -61.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 26.5 p -91.85 -16.21 27.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 60.4 48.12 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.33 124.22 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 128.86 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 43.9 pt -145.39 173.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.567 ' CE1' HG21 ' A' ' 180' ' ' VAL . 46.4 m80 -67.73 175.42 2.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -75.35 -31.88 60.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -91.1 -41.36 11.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.7 m -43.77 -25.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 203' ' ' ASP . 16.7 tt -45.8 -36.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.467 ' N ' HG21 ' A' ' 202' ' ' ILE . 8.4 t70 -73.53 -37.45 65.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.404 ' O ' ' CG1' ' A' ' 175' ' ' VAL . 9.7 mmmm -82.57 40.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.27 116.18 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.11 -41.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -42.29 154.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -107.76 138.82 43.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.558 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -72.5 140.37 48.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.864 0.364 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.47 112.64 24.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.94 125.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm 47.98 36.42 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 11.0 t 72.51 39.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.7 m-70 -132.29 122.45 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -90.7 76.55 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.517 ' CD2' HG13 ' A' ' 202' ' ' ILE . 42.7 m-85 -75.03 107.69 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.9 p -113.26 130.94 56.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.5 101.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.531 HG23 ' CE1' ' A' ' 167' ' ' PHE . 14.9 t -121.67 152.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -113.0 114.54 27.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.531 ' CE1' HG23 ' A' ' 165' ' ' THR . 30.2 m-85 -88.48 128.47 52.83 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.674 0.749 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.92 154.51 67.64 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.535 0.683 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 115.94 4.33 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.4 t -105.62 153.41 21.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.36 116.28 28.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.3 t -44.9 160.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.416 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 1.6 m -103.99 -34.29 8.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 80.6 t -76.61 -68.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.4 p -80.29 -24.51 39.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.416 ' NE2' ' O ' ' A' ' 174' ' ' SER . 39.2 m80 64.27 47.94 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -120.61 152.02 38.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -50.68 116.52 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.567 HG22 ' CE1' ' A' ' 198' ' ' HIS . 81.2 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.456 ' CD2' ' HA ' ' A' ' 199' ' ' LYS . 12.4 m-85 -127.28 150.14 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.92 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.433 ' CB ' HG22 ' A' ' 165' ' ' THR . 33.5 tt0 -138.52 119.46 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 42.5 t -74.43 132.27 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -83.3 24.24 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -131.37 -55.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -98.53 -24.81 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.8 t30 73.73 45.34 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.77 120.85 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.89 121.06 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 46.0 pt -143.97 171.35 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.567 ' CE1' HG22 ' A' ' 180' ' ' VAL . 58.2 m80 -65.16 175.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.456 ' HA ' ' CD2' ' A' ' 188' ' ' TYR . 24.0 mtpt -77.39 -28.66 52.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 202' ' ' ILE . 18.9 pttm -93.46 -38.8 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.27 -20.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.517 HG13 ' CD2' ' A' ' 162' ' ' PHE . 19.2 tt -51.54 -26.03 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 202' ' ' ILE . 14.5 t0 -80.48 -32.95 36.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -83.4 33.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.2 t -112.82 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.11 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 89.8 mt -120.65 -38.09 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -47.72 138.39 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -84.6 140.67 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 6.5 t -71.48 141.01 50.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 62.5 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.847 0.356 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -90.2 114.64 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.83 127.8 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mmtp 39.85 43.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 87.1 m 63.57 44.96 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -137.23 131.74 32.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.77 77.17 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 39.0 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 42.4 p -140.85 123.33 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.47 109.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.1 t -134.42 150.29 50.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.59 115.55 30.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 41.0 m-85 -91.44 107.49 22.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.61 0.719 . . . . 0.0 110.86 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.455 ' HG2' ' NE2' ' A' ' 169' ' ' GLN . 54.2 Cg_endo -69.74 -6.37 18.42 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.311 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.455 ' NE2' ' HG2' ' A' ' 168' ' ' PRO . 14.7 mp0 -129.38 153.65 80.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 109.5 2.35 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.653 2.235 . . . . 0.0 112.331 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.8 m -104.58 157.33 17.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 37.7 p90 -92.86 112.89 25.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.853 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.5 t -61.86 127.82 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.0 t -83.75 19.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 90.0 t -127.38 -59.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -98.95 -16.17 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.2 m170 62.47 49.43 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -125.85 139.62 53.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -40.14 132.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.529 HG23 ' CE1' ' A' ' 198' ' ' HIS . 75.2 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.57 ' CE2' ' HG2' ' A' ' 199' ' ' LYS . 11.4 m-85 -138.31 130.06 28.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -121.99 119.52 31.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.8 t -65.6 162.66 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -94.83 -24.22 17.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 15.7 mt-30 -94.52 -75.09 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 31.6 p -72.67 -22.17 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 192' ' ' GLN . 7.6 m-80 59.22 52.99 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -92.12 130.02 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.401 ' C ' HG23 ' A' ' 197' ' ' ILE . . . -95.69 120.97 36.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.401 HG23 ' C ' ' A' ' 196' ' ' ALA . 23.1 pt -145.47 165.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.529 ' CE1' HG23 ' A' ' 180' ' ' VAL . 53.2 m80 -73.96 154.55 39.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.57 ' HG2' ' CE2' ' A' ' 188' ' ' TYR . 45.0 mtmt -57.74 -36.47 72.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -74.72 -30.35 61.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 57.1 m -83.99 28.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.441 HG21 ' N ' ' A' ' 203' ' ' ASP . 20.8 tt -85.72 -38.96 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.441 ' N ' HG21 ' A' ' 202' ' ' ILE . 5.2 m-20 -80.35 -23.35 40.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -84.3 29.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -104.16 121.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.415 HD12 ' NZ ' ' A' ' 158' ' ' LYS . 49.1 mm -116.43 -47.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.18 125.72 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.05 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -75.53 153.39 37.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.549 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.9 t -78.98 126.19 30.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 -179.93 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.67 110.13 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 160' ' ' HIS . 85.2 t -137.94 130.33 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.6 mmtm 36.95 45.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.1 m 64.56 46.13 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.573 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.1 m-70 -136.99 128.76 28.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -87.27 76.6 9.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -78.03 126.46 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.545 ' CG2' ' CZ ' ' A' ' 191' ' ' ARG . 6.1 t -147.16 135.52 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.159 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.71 115.29 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.56 HG21 ' CE1' ' A' ' 167' ' ' PHE . 10.2 t -135.43 158.57 44.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.03 118.13 33.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.56 ' CE1' HG21 ' A' ' 165' ' ' THR . 24.9 m-85 -94.63 127.66 42.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.2 32.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.718 2.279 . . . . 0.0 112.375 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -127.11 158.84 67.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.58 0.705 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.19 2.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.718 2.279 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.442 HG21 ' CB ' ' A' ' 196' ' ' ALA . 12.9 t -96.95 157.74 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -97.22 140.36 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.466 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 48.7 t -80.09 124.49 28.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 t -86.17 22.11 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.6 t -121.87 -48.32 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.65 -11.36 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 17.5 m170 63.2 52.24 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 179' ' ' PHE . 13.6 mm-40 -131.85 136.02 47.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 178' ' ' GLU . 5.5 m-85 -36.97 126.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.485 HG22 ' CE1' ' A' ' 198' ' ' HIS . 46.4 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 11.8 m-85 -126.47 131.14 51.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 110.895 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -126.75 124.38 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 49.3 t -77.13 130.12 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.545 ' CZ ' ' CG2' ' A' ' 163' ' ' THR . 0.2 OUTLIER -81.2 19.08 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -124.95 -61.55 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.4 p -93.11 -24.56 18.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 73.54 46.64 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.8 121.55 38.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.442 ' CB ' HG21 ' A' ' 171' ' ' THR . . . -95.85 123.06 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.416 HG23 ' C ' ' A' ' 196' ' ' ALA . 41.8 pt -141.97 167.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.485 ' CE1' HG22 ' A' ' 180' ' ' VAL . 44.8 m80 -70.73 151.13 45.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.87 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.57 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 23.8 tttt -57.94 -34.98 70.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -80.95 -26.07 36.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 87.2 m -83.04 27.45 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.5 tt -86.06 -39.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -74.17 -29.82 61.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 36.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.09 128.9 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 207' ' ' ALA . 88.4 mt -126.08 -52.94 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.84 116.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.094 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 160.41 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 9.1 t -87.81 144.53 26.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 -179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.808 0.337 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.77 100.05 12.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.21 107.79 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 16.6 mmtm 62.63 41.3 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 m 63.94 39.16 8.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.897 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 97.4 m-70 -132.54 124.92 29.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -92.74 77.84 4.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.01 121.19 21.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 62.5 p -123.91 127.27 47.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.157 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.9 115.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.459 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 10.1 t -134.63 143.29 47.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -99.89 108.09 20.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.459 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 45.6 m-85 -81.19 127.41 74.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.661 0.743 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -26.69 27.46 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.244 . . . . 0.0 112.373 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -129.94 153.38 80.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 110.15 2.48 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.2 t -97.73 153.64 18.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 1.3 p90 -81.7 118.77 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -54.04 160.49 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.1 t -103.16 -29.05 11.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.57 -66.82 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 16.7 p -81.19 -22.31 38.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 5.4 m170 63.48 45.17 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 179' ' ' PHE . 54.3 mt-10 -127.42 133.79 49.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.8 p90 -35.38 105.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 23.1 m-85 -133.41 143.12 48.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -139.61 132.67 29.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.7 t -73.83 162.71 28.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -90.82 -20.08 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.83 -70.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 15.4 p -72.07 -16.24 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 50.3 48.21 22.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -82.25 118.76 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.31 121.55 33.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 40.0 pt -145.74 175.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -70.97 175.24 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.557 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 5.9 mtpm? -70.51 -43.67 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.4 pptp? -80.15 -36.08 35.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 1.8 m -51.02 -22.5 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.41 ' CG2' ' O ' ' A' ' 199' ' ' LYS . 16.6 tt -52.79 -38.33 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.6 -32.73 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -83.27 37.16 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.8 t -114.23 115.35 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.9 mt -110.65 -43.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.64 163.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 3.8 ttmp? -110.92 162.85 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.452 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -86.8 109.42 19.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.954 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.812 0.339 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -74.57 118.11 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.8 t -139.8 122.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.4 mptt 42.04 44.9 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.939 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 4.2 m 63.31 42.47 6.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.4 m-70 -137.16 119.15 15.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -84.32 79.35 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -73.62 139.14 45.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.6 p -141.5 125.86 17.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.2 106.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.1 t -125.1 160.97 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.159 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -112.56 115.79 29.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.562 ' CE2' ' HB3' ' A' ' 196' ' ' ALA . 21.0 m-85 -89.56 110.64 40.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.628 0.728 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -15.09 36.69 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 0.0 112.355 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -129.97 160.91 62.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.923 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.32 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 m -102.09 147.36 26.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -89.58 109.43 20.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.87 159.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 p -99.36 -28.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.6 -73.48 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.7 p -75.31 -22.64 57.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 63.13 44.42 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.54 142.79 49.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -42.67 123.07 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.57 HG23 ' CE1' ' A' ' 198' ' ' HIS . 92.8 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 199' ' ' LYS . 23.3 m-85 -149.17 146.22 27.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -145.62 114.75 7.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.76 161.11 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -96.12 -20.47 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -96.81 -70.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.943 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -72.55 -20.63 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 56.67 51.58 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.24 126.23 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.562 ' HB3' ' CE2' ' A' ' 167' ' ' PHE . . . -92.48 131.71 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.41 HG22 ' C ' ' A' ' 196' ' ' ALA . 29.7 pt -151.39 151.51 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' HIS . . . . . 0.57 ' CE1' HG23 ' A' ' 180' ' ' VAL . 73.0 m80 -61.03 157.66 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.42 ' HD2' ' CZ ' ' A' ' 188' ' ' TYR . 0.2 OUTLIER -63.28 -14.31 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -98.51 -23.03 15.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 88.0 m -83.0 16.56 2.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.13 -38.98 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.162 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.12 -28.79 60.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -87.68 32.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.0 t -110.01 111.48 36.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.167 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 97.5 mt -111.23 -46.89 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -37.39 155.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -101.37 164.0 11.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.473 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -91.39 138.62 31.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.1 t -163.72 170.56 16.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.854 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.1 p -166.77 150.97 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -143.7 173.16 24.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.452 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 m -121.14 129.81 53.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.846 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.8 t -47.2 -46.7 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.34 140.07 4.52 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.525 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -117.36 125.92 51.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -133.61 146.6 51.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.28 170.16 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 140.09 57.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.64 42.31 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.74 0.305 . . . . 0.0 111.118 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.7 tt -128.81 117.57 44.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.186 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -95.66 -58.85 2.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 152' ' ' ALA . 34.9 tp60 -166.79 147.51 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.459 ' N ' ' HG3' ' A' ' 151' ' ' GLN . . . -142.45 126.79 17.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.086 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.51 160.15 8.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 155' ' ' HIS . 95.6 t -137.92 141.86 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.141 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.452 ' N ' HG11 ' A' ' 154' ' ' VAL . 14.7 m80 -93.53 125.85 38.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -103.88 99.48 9.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.4 t -121.72 112.64 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 2.5 mptp? 58.66 41.1 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 5.9 t 65.63 37.69 5.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -134.6 125.96 28.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -92.29 81.73 4.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.505 ' CZ ' HD11 ' A' ' 197' ' ' ILE . 33.2 m-85 -72.28 121.63 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.8 p -126.64 123.44 37.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.115 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.36 104.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.454 ' C ' ' NE2' ' A' ' 186' ' ' GLN . 12.1 t -130.45 149.06 52.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.167 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.422 ' CE2' ' OE1' ' A' ' 186' ' ' GLN . 15.2 m-85 -105.69 108.71 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.35 111.46 20.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.66 0.743 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -7.03 20.02 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -129.19 154.29 80.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 87.6 m -116.7 135.38 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -78.11 136.22 37.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.31 159.47 17.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.5 m -94.72 -23.64 17.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.48 -75.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.137 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.9 p -67.7 -22.2 65.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 40.3 m80 62.34 50.91 3.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -122.59 145.32 48.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -55.25 119.47 5.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.547 HG23 ' CE1' ' A' ' 198' ' ' HIS . 25.4 t -98.81 65.21 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.541 ' CG ' ' O ' ' A' ' 181' ' ' TRP . 4.7 p-90 -124.38 37.29 4.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.47 139.39 20.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.521 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.7 128.23 35.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.886 0.374 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 61.44 45.56 8.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -124.91 99.89 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.454 ' NE2' ' C ' ' A' ' 165' ' ' THR . 38.7 tp60 -70.08 131.81 44.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -114.41 -156.28 11.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.459 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.474 ' CE2' HD12 ' A' ' 202' ' ' ILE . 11.4 m-85 -140.92 132.82 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 110.883 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -132.47 119.73 20.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.55 162.07 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -95.43 -24.37 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.34 -75.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.9 p -71.34 -24.0 62.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.37 51.95 2.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.49 129.99 36.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 197' ' ' ILE . . . -95.83 126.15 40.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.505 HD11 ' CZ ' ' A' ' 162' ' ' PHE . 29.9 pt -149.86 153.62 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.174 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.547 ' CE1' HG23 ' A' ' 180' ' ' VAL . 69.3 m80 -67.02 159.94 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -59.2 -35.86 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -76.04 -23.28 55.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 66.2 m -87.91 24.5 1.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.474 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.1 tt -87.61 -30.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.82 -19.54 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -89.23 25.02 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.41 117.68 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 25.6 mm -116.17 -47.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.31 141.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -89.55 156.97 18.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 3.5 t -83.48 133.51 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 211' ' ' GLY . 10.0 t -86.91 -47.21 9.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 210' ' ' THR . . . 103.57 154.04 23.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.8 t -123.2 140.41 53.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 110.834 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 179.922 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -151.73 137.4 17.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.873 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.6 m -129.66 162.46 28.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.4 174.4 39.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.7 m -146.41 162.54 38.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.934 0.397 . . . . 0.0 110.792 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.4 m -103.8 -62.1 1.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.04 141.47 0.63 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -148.17 134.43 19.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -139.58 133.61 30.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -151.7 128.39 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.33 132.98 6.45 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -133.71 165.96 23.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 0.0 111.104 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.7 tt -140.43 151.35 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -79.48 122.56 26.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -66.53 151.13 47.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -165.39 147.38 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.089 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -150.2 168.23 24.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.6 t -114.51 129.54 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -109.01 116.56 32.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -82.21 110.43 17.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 160' ' ' HIS . 70.9 t -134.12 126.29 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.607 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.0 mptt 36.41 46.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 66.2 m 63.14 42.35 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 94.9 m-70 -136.99 131.77 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -96.36 79.18 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -69.45 133.84 48.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.3 p -136.7 125.53 24.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.09 113.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.3 t -133.02 158.41 42.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.172 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.03 100.88 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 196' ' ' ALA . 84.1 m-85 -75.29 118.96 74.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.606 0.717 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -9.03 25.1 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.656 2.237 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.63 158.01 54.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 110.1 2.48 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.7 2.267 . . . . 0.0 112.334 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.431 HG21 ' CB ' ' A' ' 196' ' ' ALA . 9.8 t -98.14 150.71 21.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 177' ' ' HIS . 2.1 t80 -76.97 107.66 9.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 t -57.25 127.16 30.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.1 p -82.92 25.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.437 HG22 ' CG2' ' A' ' 197' ' ' ILE . 88.8 t -131.91 -53.63 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -106.85 -17.91 14.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 4.8 m170 72.8 49.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -136.96 140.13 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -46.16 120.4 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.566 HG21 ' CE1' ' A' ' 198' ' ' HIS . 60.0 t -99.78 84.25 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -133.68 -34.49 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -67.32 -159.74 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 25.0 mt 62.5 44.14 7.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.355 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.57 43.4 12.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt 42.58 43.56 3.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -127.37 137.0 52.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -156.65 -140.6 2.99 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.501 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.432 ' CE2' HD12 ' A' ' 202' ' ' ILE . 17.8 m-85 -148.83 132.77 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.922 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -132.34 127.39 35.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.9 t -69.49 162.06 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -92.31 -18.64 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -103.72 -73.87 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.453 ' C ' ' CG ' ' A' ' 194' ' ' ASN . 27.8 p -72.48 -14.46 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.453 ' CG ' ' C ' ' A' ' 193' ' ' CYS . 1.0 OUTLIER 48.47 53.44 12.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.93 126.14 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 167' ' ' PHE . . . -96.38 121.14 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.437 ' CG2' HG22 ' A' ' 175' ' ' VAL . 40.2 pt -143.61 163.21 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.566 ' CE1' HG21 ' A' ' 180' ' ' VAL . 69.7 m80 -67.87 152.13 46.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -57.32 -27.32 62.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -84.7 -25.36 28.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 77.4 m -85.13 26.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.432 HD12 ' CE2' ' A' ' 188' ' ' TYR . 20.7 tt -87.1 -33.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.79 -23.98 31.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -89.24 28.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.49 119.7 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.088 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 87.5 mt -114.28 -54.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.44 118.0 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -73.59 158.59 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.452 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.9 t -86.77 131.05 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t -104.78 -21.54 13.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 139.92 -134.57 6.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.5 m -91.91 129.28 37.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.85 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.079 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -100.69 139.04 36.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.85 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.4 m -160.87 151.04 17.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.82 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.79 -179.92 26.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.551 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.4 t -161.83 123.98 2.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.85 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 t -132.25 159.6 38.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.848 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.18 105.43 0.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.492 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -165.57 151.49 9.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.792 0.33 . . . . 0.0 110.936 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -134.28 171.45 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.18 147.2 30.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.922 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.42 150.5 21.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.07 106.45 5.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.735 0.302 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.8 tt -149.96 138.7 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -103.78 173.73 6.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -137.92 175.9 9.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.36 159.15 42.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.73 118.28 5.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 155' ' ' HIS . 84.6 t -100.57 148.58 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.436 ' N ' HG13 ' A' ' 154' ' ' VAL . 41.1 m-70 -110.46 138.92 46.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -104.05 102.15 11.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -127.78 108.02 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.11 43.24 21.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 66.04 35.87 6.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CB ' ' CE2' ' A' ' 162' ' ' PHE . 97.7 m-70 -129.27 117.86 21.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -76.75 50.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 160' ' ' HIS . 37.2 m-85 -60.2 105.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -122.16 136.27 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.12 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.56 124.86 3.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.441 HG23 ' CB ' ' A' ' 189' ' ' GLN . 15.2 t -143.2 153.49 42.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -102.65 128.82 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.05 109.33 58.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.707 2.272 . . . . 0.0 112.309 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -144.76 157.51 54.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 127.19 14.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 172' ' ' PHE . 88.4 m -128.96 138.72 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.406 ' N ' HG22 ' A' ' 171' ' ' THR . 19.7 m-85 -75.39 129.73 37.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.0 t -60.7 157.4 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 t -98.63 -29.2 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.16 -74.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.1 p -71.09 -23.87 62.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 63.54 53.88 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 179' ' ' PHE . 20.8 mt-10 -134.44 130.86 37.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 178' ' ' GLU . 8.5 p90 -34.73 123.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.439 HG21 ' CE1' ' A' ' 198' ' ' HIS . 84.1 t -103.72 87.78 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -172.78 110.91 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 151.37 -132.45 3.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.7 tt -44.92 -43.93 9.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.06 85.57 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.444 ' HG3' ' N ' ' A' ' 186' ' ' GLN . 16.5 pttm -76.89 -42.22 40.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.444 ' N ' ' HG3' ' A' ' 185' ' ' LYS . 35.8 mt-30 -78.88 136.94 37.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -140.95 -136.98 3.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.48 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -154.08 140.55 18.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.441 ' CB ' HG23 ' A' ' 165' ' ' THR . 66.5 tt0 -140.81 109.69 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -58.78 161.42 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -95.13 -19.84 19.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.458 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 20.6 mt-30 -98.84 -74.57 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.425 ' C ' ' CG ' ' A' ' 194' ' ' ASN . 30.7 p -71.3 -12.63 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 192' ' ' GLN . 0.6 OUTLIER 47.16 52.01 12.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.92 122.68 32.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.426 ' C ' HG23 ' A' ' 197' ' ' ILE . . . -95.79 115.31 27.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.09 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.426 HG23 ' C ' ' A' ' 196' ' ' ALA . 27.3 pt -140.64 173.91 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.439 ' CE1' HG21 ' A' ' 180' ' ' VAL . 58.8 m80 -63.59 172.61 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -78.1 -15.43 58.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.8 pptp? -106.03 -32.21 8.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 3.4 m -55.43 -16.68 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.59 -26.83 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.85 -31.72 61.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.67 32.87 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.69 89.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.8 mt -91.25 -44.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.62 135.19 1.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -79.1 153.74 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.484 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 8.1 t -79.57 113.26 17.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 45.4 p -104.82 39.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -44.86 -40.71 6.94 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.471 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.1 t -54.18 138.85 37.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 110.866 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.121 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 81.7 p -153.24 123.6 7.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.865 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.1 m -139.01 153.3 48.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -134.45 174.21 21.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.1 t -165.2 163.1 20.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.5 p -169.24 143.54 2.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.847 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -149.55 92.35 0.14 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.49 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -118.23 169.13 9.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.904 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -128.08 158.14 38.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -134.56 162.21 32.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.5 161.13 22.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.44 158.51 16.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.332 . . . . 0.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.2 tp -78.15 121.7 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -68.0 104.03 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -101.24 141.04 34.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.07 173.41 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.096 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -143.96 151.39 39.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.5 t -119.27 133.52 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -106.86 136.53 46.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.832 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -112.34 123.78 51.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.6 t -140.01 107.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.508 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.5 mttm 62.36 47.91 5.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.61 37.92 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 99.6 m-70 -131.04 113.55 14.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -84.13 76.3 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -71.9 138.79 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 73.3 p -140.72 128.71 22.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.56 116.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 15.3 t -138.67 142.07 39.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 186' ' ' GLN . 20.7 m-85 -106.88 110.62 22.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 13.3 m-85 -88.13 111.37 42.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.749 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -16.16 37.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.301 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -114.23 154.29 46.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 109.57 2.35 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.661 2.24 . . . . 0.0 112.317 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 57.1 m -113.69 135.01 54.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 7.3 p90 -77.14 115.67 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -44.93 159.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.2 m -99.29 -26.12 14.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.1 t -88.69 -71.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.8 p -75.23 -23.78 57.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.833 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.5 m80 64.21 51.87 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 179' ' ' PHE . 62.2 mt-10 -133.18 131.53 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 178' ' ' GLU . 27.3 p90 -32.91 113.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.549 HG23 ' CE1' ' A' ' 198' ' ' HIS . 68.1 t -93.74 93.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -174.63 107.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -126.52 -119.7 2.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.542 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.9 tt -120.04 108.51 14.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 44.86 40.48 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -101.63 149.24 24.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 12.2 pt20 -121.4 155.22 35.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -118.67 -137.8 5.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -150.4 129.82 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 110.946 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -123.72 131.62 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 11.4 t -76.22 161.81 28.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -93.23 -20.38 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.24 -75.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.6 p -69.92 -15.18 63.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 51.6 52.61 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.19 123.39 33.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -98.29 120.99 39.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 38.2 pt -141.36 171.97 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.549 ' CE1' HG23 ' A' ' 180' ' ' VAL . 49.7 m80 -63.01 -177.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -79.21 -37.15 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -87.32 -37.18 17.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 4.6 m -49.07 -18.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 tt -54.97 -32.5 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.81 -35.56 64.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -84.68 35.05 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.29 118.7 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 207' ' ' ALA . 3.8 mp -119.65 -56.86 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -35.02 112.4 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -64.38 150.25 46.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.8 t -73.07 137.19 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 77.6 p -113.81 -42.57 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 113.92 -41.95 2.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.482 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.0 t -115.46 163.73 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 110.862 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.094 179.894 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 t -154.27 152.27 30.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 0.0 110.854 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.8 p -132.47 154.28 50.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -141.29 -170.99 12.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.471 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.8 t -115.52 165.32 13.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 0.0 110.825 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.3 m -152.1 160.94 43.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -169.6 157.43 29.13 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -123.49 173.64 7.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -155.07 162.56 41.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -145.06 166.39 25.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -111.31 112.96 3.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.454 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.36 42.23 1.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.806 0.336 . . . . 0.0 111.08 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.9 tt -126.46 126.51 69.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -146.14 151.38 37.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -143.76 131.92 21.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.951 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.43 175.85 9.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.075 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 135.89 47.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 155' ' ' HIS . 59.0 t -116.7 141.16 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.094 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.426 ' N ' HG12 ' A' ' 154' ' ' VAL . 47.9 m-70 -116.16 107.92 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -76.22 113.4 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.78 106.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.495 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.0 mptp? 60.62 42.59 13.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 63.3 m 64.41 37.85 8.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.3 m-70 -131.47 119.02 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -83.07 79.45 9.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CZ ' HD11 ' A' ' 197' ' ' ILE . 25.3 m-85 -72.76 135.75 45.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 p -140.01 123.32 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -51.14 112.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -141.02 148.54 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -94.3 134.19 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -107.71 105.02 55.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.637 0.732 . . . . 0.0 110.901 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -3.53 12.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -128.92 153.54 80.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.709 2.273 . . . . 0.0 112.333 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.5 m -126.87 136.04 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -83.57 123.03 29.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 3.0 t -54.23 156.39 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 33.9 p -100.79 -17.41 16.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.3 t -97.77 -68.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -80.03 -14.86 58.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.5 m170 57.49 49.09 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 179' ' ' PHE . 70.9 mt-10 -128.29 130.94 48.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.7 p90 -35.46 134.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 198' ' ' HIS . 63.6 t -111.6 79.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -174.42 153.89 2.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 83.36 -71.62 2.97 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 183' ' ' LEU . 10.7 mp -80.57 -43.4 20.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -113.51 89.34 3.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -74.75 -48.5 25.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -80.98 127.89 33.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -136.15 -157.35 7.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.52 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 16.0 m-85 -136.33 140.33 43.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -135.92 115.22 12.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 14.4 t -63.09 138.34 58.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -85.67 20.48 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -132.32 -64.52 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.8 p -86.94 -15.52 38.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 59.48 54.06 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.39 128.06 52.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 129.9 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.47 HD11 ' CZ ' ' A' ' 162' ' ' PHE . 33.2 pt -151.03 153.68 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.557 ' CE1' HG21 ' A' ' 180' ' ' VAL . 60.8 m80 -64.57 161.65 17.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.52 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 7.6 mtpm? -64.04 -27.2 68.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -22.56 24.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.2 m -83.98 14.57 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.1 tt -79.47 -41.87 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -73.84 -26.81 60.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -88.07 38.16 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.5 t -111.02 112.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.411 ' O ' ' C ' ' A' ' 207' ' ' ALA . 77.4 mt -106.76 -50.78 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.14 143.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.076 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -97.23 137.57 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.545 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.5 t -65.47 140.52 58.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.6 p -129.11 36.52 4.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.168 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.1 -96.26 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.452 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 60.5 p -56.7 113.68 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.87 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.3 m -147.6 170.38 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.894 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 t -162.15 144.77 11.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -129.54 153.6 20.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 87.3 p -168.04 136.65 2.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.842 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.7 m -144.33 119.27 9.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -105.76 138.1 14.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.437 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -166.63 134.32 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.28 167.37 9.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -124.54 -58.89 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 163.76 106.67 0.2 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.54 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.06 -8.34 57.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 0.0 111.038 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.7 tp -57.16 131.35 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -102.94 129.9 49.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -86.06 125.14 33.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.9 165.82 26.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -166.37 118.78 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.48 135.82 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -98.94 104.39 16.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -88.87 109.13 19.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.9 t -132.12 136.92 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.606 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 21.6 mmtm 38.96 43.07 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 m 64.75 41.7 4.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 87.2 m-70 -136.27 142.17 43.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.73 75.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.479 ' CZ ' HD11 ' A' ' 197' ' ' ILE . 36.9 m-85 -66.43 105.13 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 p -109.95 121.25 44.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.99 105.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -127.9 149.9 50.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -107.18 105.08 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.62 114.58 33.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -6.96 19.81 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.751 2.3 . . . . 0.0 112.383 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -140.1 159.5 63.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.599 0.714 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 179' ' ' PHE . 53.7 Cg_endo -69.78 116.5 4.59 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.666 2.244 . . . . 0.0 112.327 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.463 HG22 ' CB ' ' A' ' 196' ' ' ALA . 11.9 t -114.38 156.87 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.75 146.98 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.9 t -79.53 160.05 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 46.6 t -101.84 -30.38 11.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.46 -73.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -75.02 -25.12 58.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 63.18 50.13 3.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -123.2 135.59 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 170' ' ' PRO . 4.2 t80 -39.63 122.18 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.513 HG23 ' CE1' ' A' ' 198' ' ' HIS . 22.5 t -98.88 83.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -173.88 148.21 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.954 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 98.06 -100.91 2.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.449 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.2 mt -52.57 -55.65 20.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.917 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -98.51 117.11 32.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -108.23 44.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -164.94 144.58 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.53 -176.04 27.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -122.35 135.65 54.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -124.83 121.82 35.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 25.9 t -64.21 163.01 13.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -90.4 -21.82 21.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -103.25 -73.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.5 p -71.36 -12.15 61.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 194' ' ' ASN . 5.1 p-10 43.05 52.87 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -91.24 130.32 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.463 ' CB ' HG22 ' A' ' 171' ' ' THR . . . -93.19 122.4 35.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.479 HD11 ' CZ ' ' A' ' 162' ' ' PHE . 28.6 pt -142.81 147.82 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.513 ' CE1' HG23 ' A' ' 180' ' ' VAL . 69.2 m80 -57.69 151.46 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.84 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -57.27 -19.7 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -90.99 -27.41 18.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.9 m -82.62 20.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.21 -37.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -82.84 -24.22 33.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -85.28 31.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.7 t -101.52 127.0 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.43 -44.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -53.75 125.07 17.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.79 167.29 11.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.479 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 7.8 t -88.31 113.13 23.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.8 p -84.14 34.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.141 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -81.77 -41.65 9.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 43.4 t -57.27 164.09 1.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 110.821 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 179.877 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.2 m -129.09 87.23 2.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.368 . . . . 0.0 110.885 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.9 m -75.94 -58.55 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.813 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.66 164.06 36.74 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.54 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.1 m -129.71 106.29 8.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.0 110.853 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.5 p -153.66 172.55 17.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.86 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 147.06 -171.16 27.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.505 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -150.05 166.73 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -102.1 167.16 10.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.82 162.02 26.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.04 154.39 12.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.557 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -173.39 173.38 3.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.313 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.4 tt -141.02 135.27 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -111.12 150.57 29.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -152.01 150.14 29.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.24 165.28 23.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.433 ' HD3' ' C ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -143.94 164.11 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 161' ' ' GLU . 90.4 t -86.27 129.14 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.428 ' CD2' ' HD2' ' A' ' 153' ' ' LYS . 52.6 m-70 -107.33 144.05 34.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -96.29 112.0 23.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 158' ' ' LYS . 97.3 t -140.65 135.53 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mptt 36.31 45.19 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 99.0 m 63.31 46.08 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.1 m-70 -136.3 178.37 7.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.425 ' HB3' ' CG1' ' A' ' 154' ' ' VAL . 33.7 mt-10 -130.66 50.23 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.54 ' CD2' HG13 ' A' ' 202' ' ' ILE . 23.2 m-85 -51.43 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.414 ' CG2' ' NH2' ' A' ' 191' ' ' ARG . 7.3 t -117.95 136.67 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.182 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.55 124.16 3.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.495 HG23 ' CZ ' ' A' ' 167' ' ' PHE . 13.6 t -145.75 159.89 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -124.94 109.89 13.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.495 ' CZ ' HG23 ' A' ' 165' ' ' THR . 3.4 m-85 -85.26 119.27 72.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.276 . . . . 0.0 112.309 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -147.74 158.28 42.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.614 0.721 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 124.48 11.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.401 HG21 ' CB ' ' A' ' 196' ' ' ALA . 12.2 t -117.68 157.47 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -84.78 115.75 22.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.47 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 49.1 t -64.81 126.56 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.0 t -87.12 26.96 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.423 HG23 ' CG2' ' A' ' 197' ' ' ILE . 53.5 t -129.76 -55.34 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.89 -16.03 14.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.9 m170 63.59 51.87 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -134.99 132.63 38.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -40.25 109.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.47 ' CG2' ' HB2' ' A' ' 173' ' ' CYS . 82.6 t -82.51 79.62 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -175.33 115.77 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 174.68 -109.26 0.29 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.7 tp -86.74 -44.51 11.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.98 151.91 28.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -151.5 -179.73 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 65.64 54.36 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.24 -156.03 1.09 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.94 143.87 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.835 0.35 . . . . 0.0 110.926 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.423 ' CB ' HG22 ' A' ' 165' ' ' THR . 46.0 tt0 -143.52 119.71 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 28.2 t -63.46 163.08 11.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.414 ' NH2' ' CG2' ' A' ' 163' ' ' THR . 21.3 mmt-85 -98.03 -22.79 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -92.28 -68.4 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.99 -25.36 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 63.53 50.15 2.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -89.44 119.39 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.076 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.43 ' C ' HG21 ' A' ' 197' ' ' ILE . . . -92.58 121.04 33.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.43 HG21 ' C ' ' A' ' 196' ' ' ALA . 43.1 pt -144.18 174.91 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -68.42 178.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -73.84 -53.88 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 202' ' ' ILE . 10.7 pttm -70.97 -43.7 67.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 18.7 m -43.16 -22.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.54 HG13 ' CD2' ' A' ' 162' ' ' PHE . 19.3 tt -50.37 -38.26 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -34.95 71.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.409 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 36.8 mmtt -82.72 36.82 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.55 126.17 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.65 -55.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -37.98 139.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.103 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -90.07 159.36 16.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.489 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 5.2 t -79.54 110.18 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.8 t -68.54 -27.87 66.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 69.24 -84.24 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 82.3 p -68.52 140.0 55.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.893 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 179.973 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 t -151.58 137.39 18.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.934 0.397 . . . . 0.0 110.84 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.6 p -170.82 122.45 0.6 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.96 -81.06 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.9 t 67.97 42.22 1.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.875 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -56.28 155.39 6.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.1 157.56 25.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -144.3 109.23 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.749 0.309 . . . . 0.0 110.931 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -154.6 139.98 17.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -170.75 124.64 0.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.08 -112.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.23 160.38 18.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 5.1 tp -74.74 138.06 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.126 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -117.01 127.63 54.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -145.51 119.21 9.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.45 176.09 8.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.6 95.24 4.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.931 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.58 127.97 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -97.73 157.98 15.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.46 ' CE1' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m-70 -125.22 105.49 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 88.7 t -137.83 120.68 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 52.91 39.44 29.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.3 t 65.99 40.01 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -132.01 119.94 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.46 ' OE1' ' CE1' ' A' ' 156' ' ' HIS . 6.6 mm-40 -78.35 70.58 4.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -71.48 97.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.1 t -112.12 134.44 53.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.25 120.32 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.455 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 5.1 t -139.29 149.74 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -105.82 117.46 34.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.455 ' CE1' ' CG2' ' A' ' 165' ' ' THR . 18.8 m-85 -91.13 109.73 37.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.728 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -7.56 21.37 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.701 2.267 . . . . 0.0 112.348 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -136.04 160.72 66.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 121.9 8.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.751 2.301 . . . . 0.0 112.326 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.8 m -115.66 150.18 37.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.412 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 32.8 p90 -96.74 111.43 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 12.7 t -47.56 157.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 p -97.56 -22.67 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.5 t -92.81 -74.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.138 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -73.27 -23.62 60.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 63.56 46.27 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.98 148.66 43.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -45.01 130.57 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 69.1 t -108.79 75.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 3.0 p-90 -173.9 150.94 1.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 109.47 -65.02 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.521 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.08 142.44 25.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -57.13 -30.32 64.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.844 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -67.08 143.6 56.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -91.48 176.21 6.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.939 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -112.09 166.75 12.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.52 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.516 ' CZ ' ' HG2' ' A' ' 199' ' ' LYS . 14.5 m-85 -104.0 131.98 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -129.78 118.71 22.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 8.9 t -62.68 161.68 11.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -96.49 -20.71 18.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -97.21 -71.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 21.5 p -74.18 -20.55 60.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 57.83 53.51 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.38 128.7 41.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.416 ' C ' HG22 ' A' ' 197' ' ' ILE . . . -94.84 125.79 39.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.416 HG22 ' C ' ' A' ' 196' ' ' ALA . 23.7 pt -152.09 147.27 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.076 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -60.01 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 188' ' ' TYR . 41.7 mttt -58.67 -22.83 58.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -22.85 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 79.2 m -86.77 27.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 tt -88.27 -30.39 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -80.58 -25.45 38.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -88.77 31.48 0.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.58 110.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' ALA . 46.7 mm -109.27 -54.3 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.38 145.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.131 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -91.92 167.11 12.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.6 t -98.64 124.97 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p -78.2 -45.69 22.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 42.92 -97.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.505 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 73.8 m -78.52 120.77 23.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.378 . . . . 0.0 110.886 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.919 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 93.2 p -174.59 176.66 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.851 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.1 t -154.49 174.91 14.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.71 163.4 14.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 m -149.65 173.55 13.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.378 . . . . 0.0 110.862 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.8 t -134.71 174.33 10.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.15 121.27 2.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.481 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -143.4 176.38 9.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.778 0.323 . . . . 0.0 110.893 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -148.34 160.77 42.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -133.38 124.68 27.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.07 -153.95 15.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -172.63 160.22 4.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 111.08 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.7 tp -63.06 140.64 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -151.68 143.48 23.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.02 150.89 24.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.89 146.33 14.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -159.63 145.68 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.4 t -104.66 108.99 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -74.38 144.73 44.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -110.57 107.12 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.833 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 160' ' ' HIS . 58.2 t -129.65 131.46 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.078 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 14.2 mptt 37.41 45.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 59.1 m 63.47 41.22 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.545 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -133.25 120.88 21.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.6 70.39 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -75.69 103.68 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.1 t -119.9 138.94 53.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.52 119.82 2.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.5 t -141.25 141.39 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -97.21 118.85 34.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -90.63 108.84 30.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -5.68 16.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.725 2.284 . . . . 0.0 112.289 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -133.88 153.95 80.15 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 m -108.62 156.35 19.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 172' ' ' PHE . 19.0 p90 -103.74 131.95 50.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.06 155.28 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 m -100.49 -24.29 14.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.23 -72.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -74.43 -21.29 59.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 8.2 m170 63.2 47.67 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -124.52 143.85 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -48.23 128.17 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.93 79.89 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -172.44 109.47 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 149.05 -94.53 0.16 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -62.48 1.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 0.0 110.925 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -96.27 79.98 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -47.18 -40.84 16.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.922 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.446 ' N ' ' HG3' ' A' ' 185' ' ' LYS . 7.6 pt20 -95.74 175.29 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -164.95 -155.87 8.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 199' ' ' LYS . 20.8 m-85 -124.78 135.51 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.46 112.92 9.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.9 t -57.72 159.17 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -96.98 -16.99 20.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -97.85 -68.43 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.68 -23.45 53.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.98 53.33 3.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.75 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.51 118.75 31.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 29.8 pt -140.02 158.12 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -62.64 161.35 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 188' ' ' TYR . 50.9 tttt -68.75 -11.17 60.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -105.19 -20.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.69 15.66 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.6 tt -79.27 -40.09 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.452 ' OD2' ' NZ ' ' A' ' 204' ' ' LYS . 6.8 p-10 -71.55 -25.52 62.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.452 ' NZ ' ' OD2' ' A' ' 203' ' ' ASP . 0.6 OUTLIER -90.54 37.25 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.44 96.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.68 -44.82 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -41.75 154.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.08 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -99.31 159.96 14.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -85.51 145.14 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t -106.51 -40.81 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 72.2 46.28 35.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.1 t -97.64 128.48 44.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.854 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.1 t -171.71 173.37 4.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.8 m -149.31 173.24 13.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -149.99 178.69 27.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.8 t -150.75 166.97 28.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -132.84 168.56 18.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -101.46 -175.04 28.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.2 166.78 29.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -135.32 165.65 24.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -164.94 152.14 11.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.09 111.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.465 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.5 170.13 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.084 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 tt -109.95 121.88 63.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 151' ' ' GLN . 30.0 tptt -70.85 124.28 23.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 150' ' ' LYS . 17.8 mp0 -35.89 130.74 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.91 128.22 18.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -137.07 153.76 50.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 68.4 t -99.88 131.69 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -93.87 128.43 40.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -101.69 99.62 9.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 160' ' ' HIS . 90.1 t -117.87 134.67 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.568 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 1.5 mmmp? 33.79 47.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.864 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 64.3 m 64.61 45.08 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.5 m-70 -135.09 118.75 17.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.83 75.56 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -72.34 144.53 48.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.7 p -134.01 127.33 32.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.82 119.17 3.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -143.99 153.26 42.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -116.5 112.77 21.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 196' ' ' ALA . 65.7 m-85 -87.74 111.18 40.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.668 0.747 . . . . 0.0 110.863 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -6.39 18.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.328 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -128.83 152.53 79.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.61 0.719 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.67 2.247 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.0 m -113.9 138.47 50.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -66.93 129.72 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.1 t -72.04 159.26 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.1 t -98.09 -29.21 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.9 t -87.55 -75.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.098 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.3 p -72.17 -22.11 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 60.91 45.45 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.35 169.67 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -62.84 122.86 17.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.564 HG21 ' CE1' ' A' ' 198' ' ' HIS . 48.4 t -110.24 88.14 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.12 157.86 43.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.967 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 147.89 143.78 3.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.71 -44.62 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 0.0 110.949 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -111.77 51.79 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -127.67 87.16 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.451 ' HG2' ' N ' ' A' ' 187' ' ' GLY . 14.5 tt0 -71.0 146.89 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 186' ' ' GLN . . . -127.0 -151.5 7.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.439 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -154.43 134.59 13.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -132.58 127.85 35.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.4 t -71.76 162.02 30.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -88.72 -20.02 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -105.61 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 25.7 p -66.56 -10.61 47.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 42.57 49.92 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.75 28.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . . . -94.94 122.05 37.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 36.4 pt -145.54 173.75 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.564 ' CE1' HG21 ' A' ' 180' ' ' VAL . 74.2 m80 -66.9 176.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -24.13 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -96.57 -38.11 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.48 -25.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.2 tt -49.02 -39.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.153 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -70.25 -32.72 70.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -86.04 38.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.4 125.51 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 80.7 mt -120.64 -40.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.14 136.09 42.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.422 ' HG3' ' NZ ' ' A' ' 158' ' ' LYS . 7.0 mtpm? -83.1 167.05 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.409 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.3 t -84.6 122.18 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 31.4 p -86.58 -46.53 10.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 80.32 103.46 0.29 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.5 p -58.22 152.37 17.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.863 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.145 179.862 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.1 t -117.23 135.15 54.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.88 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.4 m -124.14 142.04 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.91 118.11 0.85 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.455 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.3 t -163.53 122.99 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.884 0.373 . . . . 0.0 110.869 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 95.4 p -157.67 109.55 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.62 123.26 1.46 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.19 165.48 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.935 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -112.96 90.61 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -133.61 85.37 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.67 55.79 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.503 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -117.38 42.32 2.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.73 0.3 . . . . 0.0 111.059 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.5 tt -123.19 135.88 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -127.24 153.7 45.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -104.16 121.38 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.45 139.55 53.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.54 133.94 17.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.86 124.39 37.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -103.34 105.1 15.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -78.06 111.4 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 54.7 t -130.99 115.36 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 10.9 mptt 53.16 40.93 32.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 42.0 m 67.04 40.27 2.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -134.79 118.1 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -79.25 80.41 5.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -80.69 107.23 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 77.0 p -111.53 126.8 55.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.83 108.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.6 t -132.8 146.34 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.159 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.36 143.15 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.97 124.96 28.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.615 0.722 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -23.97 29.77 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.654 2.236 . . . . 0.0 112.311 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -127.45 152.47 76.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.513 ' HB3' ' CG ' ' A' ' 181' ' ' TRP . 53.8 Cg_endo -69.71 127.93 15.33 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.467 ' O ' ' CG2' ' A' ' 180' ' ' VAL . 4.7 t -120.21 149.82 41.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -79.14 128.76 33.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.73 159.63 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.6 m -95.93 -19.16 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.457 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 90.2 t -100.31 -72.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.5 p -71.62 -22.48 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.457 ' CE1' ' O ' ' A' ' 175' ' ' VAL . 9.9 m80 62.83 44.38 6.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.83 151.27 37.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -52.43 130.61 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 171' ' ' THR . 66.4 t -103.5 67.36 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.513 ' CG ' ' HB3' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -106.85 46.96 0.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -73.88 87.88 0.66 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.3 tt -42.8 -52.96 4.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -99.13 -40.18 8.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 140.95 57.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -105.83 161.64 14.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -123.31 -168.3 13.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.518 ' CE2' ' HG2' ' A' ' 199' ' ' LYS . 26.9 m-85 -128.69 147.55 50.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.0 110.887 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -143.7 110.58 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 5.3 t -57.94 157.81 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -96.34 -14.76 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -99.28 -67.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.42 -22.26 54.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 59.78 47.89 9.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.69 133.33 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -99.55 124.24 44.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 42.7 pt -145.15 175.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -85.99 163.87 17.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.518 ' HG2' ' CE2' ' A' ' 188' ' ' TYR . 34.2 mttm -67.29 -20.22 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -92.51 -27.16 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 76.3 m -82.56 11.04 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.1 tt -73.16 -34.98 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.85 -27.08 49.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -88.75 32.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.8 t -111.12 88.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.184 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.1 mp -85.13 -55.74 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.81 116.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -73.86 144.43 45.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.75 134.11 53.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 67.8 p -107.34 -37.96 6.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 137.47 158.05 7.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 74.3 p -57.12 149.14 20.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.099 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.1 p -114.3 120.8 41.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 110.869 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.1 m -92.94 -51.61 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 68.64 137.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.472 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -148.25 128.34 13.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 99.9 p -89.03 112.11 22.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -143.03 56.9 0.56 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.518 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -66.65 137.07 56.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -85.26 157.8 20.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -147.75 165.51 30.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.05 162.79 9.23 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.04 177.57 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.03 -179.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.7 tptm 70.06 41.23 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -117.37 93.09 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.948 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -173.69 152.04 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 106.32 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.8 t -139.2 135.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -97.37 134.42 40.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -100.96 107.62 19.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 85.2 t -131.66 125.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 45.33 36.52 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 67.92 44.4 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.517 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.9 m-70 -134.66 118.31 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.448 ' OE2' ' NH2' ' A' ' 191' ' ' ARG . 21.0 mt-10 -91.92 78.17 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -67.84 150.07 49.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 43.6 p -142.0 117.82 10.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.5 106.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -133.6 157.65 45.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.141 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -112.75 107.66 16.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.849 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -81.55 112.11 31.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.435 ' HG2' ' CD ' ' A' ' 169' ' ' GLN . 53.5 Cg_endo -69.78 -7.01 19.97 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.313 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.435 ' CD ' ' HG2' ' A' ' 168' ' ' PRO . 19.6 mp0 -125.46 152.71 71.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.608 0.718 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 110.53 2.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 180' ' ' VAL . 1.3 m -109.26 157.42 18.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.157 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -96.48 129.7 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.6 t -69.29 128.63 37.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 72.2 m -85.62 19.52 2.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.07 -57.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.69 -13.91 17.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 4.7 m170 63.93 52.26 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 179' ' ' PHE . 25.9 mt-10 -132.67 136.71 46.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.458 ' C ' ' O ' ' A' ' 178' ' ' GLU . 29.9 m-85 -33.35 137.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 171' ' ' THR . 88.0 t -123.39 102.1 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -172.85 174.75 3.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 136.33 133.85 3.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.21 -61.01 2.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.79 0.329 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -85.72 42.41 0.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -131.66 168.44 17.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -148.35 157.09 43.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -135.38 -149.73 5.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.508 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -149.1 137.15 20.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -130.24 120.03 23.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 4.7 t -66.93 162.02 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.448 ' NH2' ' OE2' ' A' ' 161' ' ' GLU . 18.9 mtm105 -92.93 -24.91 18.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -99.78 -74.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.4 p -72.51 -9.74 58.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 42.99 54.17 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.46 131.96 34.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.105 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.419 ' C ' HG21 ' A' ' 197' ' ' ILE . . . -97.7 115.66 28.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.419 HG21 ' C ' ' A' ' 196' ' ' ALA . 12.5 pt -143.11 159.49 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.41 ' NE2' HG22 ' A' ' 180' ' ' VAL . 46.2 m80 -65.23 159.61 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -65.02 -35.09 80.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -26.62 48.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 86.0 m -84.21 22.53 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.45 -36.03 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -83.16 -25.27 32.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -86.11 31.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.7 t -104.94 116.52 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.19 -47.47 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -38.59 137.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 19.7 ttpt -88.38 156.0 19.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -91.88 113.39 25.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.2 p -95.21 -46.62 6.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 87.86 98.66 0.91 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.53 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 213' ' ' ALA . 14.3 t -134.54 166.79 22.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 0.0 110.855 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 212' ' ' SER . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.1 p -170.49 136.51 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.842 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.1 t -167.46 159.47 12.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.845 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.82 176.25 45.69 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.4 t -167.11 159.95 13.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.9 t -162.98 157.54 21.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -159.62 150.35 20.65 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.47 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -145.34 120.68 10.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -130.15 137.15 49.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -156.03 153.13 28.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -102.96 -154.83 24.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -130.3 167.51 18.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.741 0.305 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.84 143.38 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -161.13 107.48 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -150.28 163.33 38.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.67 172.07 7.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.099 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.89 172.63 10.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 155' ' ' HIS . 88.4 t -137.84 144.44 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.467 ' N ' HG12 ' A' ' 154' ' ' VAL . 86.2 m-70 -105.31 137.53 42.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -97.49 98.57 10.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 65.3 t -120.15 116.58 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.608 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.9 mptt 43.39 45.94 5.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 65.2 m 62.88 40.05 9.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 91.9 m-70 -135.64 123.67 22.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -87.91 88.95 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.549 ' CZ ' HD11 ' A' ' 197' ' ' ILE . 29.6 m-85 -82.51 122.88 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -129.67 123.3 30.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.08 101.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.8 t -126.23 155.42 41.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -112.09 112.99 25.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -84.94 126.48 67.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -11.05 30.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.706 2.271 . . . . 0.0 112.382 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.16 152.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 117.62 5.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.3 t -114.67 136.41 53.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.134 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.24 128.83 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.04 159.64 9.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 12.6 m -97.36 -26.45 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.92 -75.15 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 12.7 p -70.55 -20.79 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 5.7 m170 60.87 49.45 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 179' ' ' PHE . 5.9 mm-40 -126.95 133.49 50.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 178' ' ' GLU . 12.1 p90 -36.05 111.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.5 t -87.92 86.26 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -175.95 124.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -151.62 -113.03 0.56 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.6 mt -147.12 117.74 7.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 57.5 42.24 24.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -128.75 92.57 3.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -74.17 140.04 44.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -105.44 -150.4 19.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -140.47 137.08 33.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -132.44 118.26 19.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 10.6 t -58.56 162.67 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -94.14 -13.56 26.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -112.36 -62.59 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 194' ' ' ASN . 17.3 p -87.92 4.95 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 193' ' ' CYS . 2.0 p30 34.08 45.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.48 119.41 16.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.096 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.31 115.05 27.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.085 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.549 HD11 ' CZ ' ' A' ' 162' ' ' PHE . 29.9 pt -141.88 158.32 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -63.22 161.2 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -65.03 -18.88 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.59 -23.72 16.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 81.3 m -83.35 22.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.1 tt -84.3 -39.57 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -75.33 -30.74 60.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -84.39 36.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -108.74 108.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 39.7 mm -105.42 -50.2 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.49 146.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -92.89 165.12 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.7 t -95.39 118.16 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.2 t -50.37 -38.54 43.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 51.57 83.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.461 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 1.9 t -70.87 141.32 51.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 110.86 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.064 179.923 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.7 m -134.05 160.3 38.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 0.0 110.818 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.4 m -104.18 173.8 6.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 149.54 156.99 7.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 96.1 p -94.84 160.87 14.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t -174.27 145.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.51 -62.99 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.464 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 62.48 42.43 8.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -107.36 41.82 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -94.4 145.01 25.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.56 134.22 2.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -167.56 169.9 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.3 tt -152.16 143.44 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 150' ' ' LYS . 3.3 mppt? -98.45 40.56 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -41.94 150.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.18 159.07 16.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.459 ' HD2' ' CE1' ' A' ' 155' ' ' HIS . 0.0 OUTLIER -134.72 151.32 50.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.8 t -105.39 131.02 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.459 ' CE1' ' HD2' ' A' ' 153' ' ' LYS . 64.0 m-70 -78.17 113.53 16.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -94.08 106.41 18.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 160' ' ' HIS . 87.5 t -124.83 126.67 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . 28.7 mmmt 34.76 39.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 t 74.98 43.92 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.566 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 92.1 m-70 -137.76 115.4 11.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -80.77 74.25 7.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 33.1 m-85 -70.3 128.75 37.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 80.9 p -136.01 126.43 26.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.3 115.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.8 t -134.45 154.14 51.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.17 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -105.36 103.7 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -77.9 111.91 21.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.64 19.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.644 2.229 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -140.48 156.68 69.37 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.712 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 109.0 2.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.676 2.25 . . . . 0.0 112.355 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.439 HG23 ' CB ' ' A' ' 196' ' ' ALA . 12.8 t -99.16 157.91 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.113 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 1.4 p90 -87.6 129.01 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 40.0 t -79.37 119.01 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.1 t -82.31 26.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.27 -59.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -101.81 -13.37 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.4 m170 62.16 53.37 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.95 131.13 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -40.91 114.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.1 t -84.76 92.58 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -174.02 153.05 2.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 89.28 -60.7 3.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.527 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.446 HD21 ' N ' ' A' ' 183' ' ' LEU . 4.3 mm? -111.91 159.74 18.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 186' ' ' GLN . 12.3 m-20 58.81 37.35 24.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.475 ' HG2' ' N ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -34.06 -33.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 184' ' ' ASN . 23.7 mt-30 -93.68 112.84 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -115.32 -142.78 7.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.464 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.556 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 14.8 m-85 -150.54 134.99 17.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -132.3 117.99 18.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 41.7 t -63.36 163.72 10.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -99.71 -27.06 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -87.98 -68.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.3 p -81.49 -24.64 36.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 190' ' ' CYS . 4.0 m-80 62.71 51.06 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.23 125.69 34.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.059 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.439 ' CB ' HG23 ' A' ' 171' ' ' THR . . . -94.09 130.24 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.409 HG21 ' C ' ' A' ' 196' ' ' ALA . 28.4 pt -154.16 170.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -71.37 159.86 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.556 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 2.2 ttpm? -66.33 -29.19 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 -27.21 24.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.3 m -81.69 21.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 188' ' ' TYR . 19.8 tt -79.55 -39.22 20.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -77.73 -28.4 50.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -84.64 32.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 62.3 t -107.48 114.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.4 mp -103.09 -54.74 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.68 122.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -82.84 158.36 22.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.566 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.8 t -88.06 137.5 32.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 t -119.53 -31.52 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.2 99.64 2.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 6.2 t -166.38 161.11 16.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.859 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.078 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.6 t -171.49 169.82 6.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.859 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.2 m -170.94 172.89 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.17 -174.79 38.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 t -171.42 152.92 3.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.393 . . . . 0.0 110.824 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.4 t -165.13 171.35 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.57 142.7 3.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.527 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -152.75 148.15 26.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 57.5 mtt85 -149.76 140.07 22.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -79.38 86.84 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -103.8 70.88 0.27 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.466 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.8 178.3 4.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 111.081 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.57 146.37 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -175.16 133.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -171.47 141.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.04 159.61 41.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.137 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.08 174.67 12.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.1 t -105.06 132.49 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -88.25 141.98 28.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -96.95 110.75 23.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.0 t -134.68 126.46 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . 22.7 mmtt 37.2 38.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 3.4 t 70.23 42.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.558 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.1 m-70 -132.9 128.6 36.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -92.65 74.78 5.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 38.4 m-85 -65.12 140.49 58.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 26.4 p -139.76 121.87 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.162 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.09 114.48 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.512 HG22 ' CZ ' ' A' ' 167' ' ' PHE . 14.4 t -142.46 149.0 38.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -110.43 125.12 52.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.512 ' CZ ' HG22 ' A' ' 165' ' ' THR . 18.1 m-85 -100.92 106.65 45.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -5.1 15.37 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.694 2.263 . . . . 0.0 112.36 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -126.93 158.92 67.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 116.26 4.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.634 2.222 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 88.9 m -121.16 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.23 138.32 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.92 159.24 30.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.6 m -105.82 -26.85 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' A' ' 204' ' ' LYS . 75.2 t -80.24 -62.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.9 p -86.79 -27.0 23.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 10.6 m80 72.84 40.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 179' ' ' PHE . 37.9 mt-10 -125.27 128.89 48.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 178' ' ' GLU . 1.5 p90 -36.61 119.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 198' ' ' HIS . 47.1 t -95.78 68.86 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.556 ' CG ' ' O ' ' A' ' 181' ' ' TRP . 4.1 p-90 -134.62 35.75 3.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 183' ' ' LEU . . . -98.15 178.17 31.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.509 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 182' ' ' GLY . 5.6 tp -36.2 -53.32 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.331 . . . . 0.0 110.934 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -90.13 76.43 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.929 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -74.06 -37.21 64.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.466 ' N ' ' HG2' ' A' ' 185' ' ' LYS . 28.7 tt0 -41.02 110.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.33 -153.47 8.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.483 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.431 ' HB3' ' CD1' ' A' ' 162' ' ' PHE . 42.0 m-85 -134.55 137.74 44.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -123.84 124.77 43.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 52.2 t -73.15 143.3 47.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -89.97 18.41 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.855 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -128.54 -61.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 26.5 p -91.85 -16.21 27.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 60.4 48.12 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.33 124.22 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 128.86 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 43.9 pt -145.39 173.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.567 ' CE1' HG21 ' A' ' 180' ' ' VAL . 46.4 m80 -67.73 175.42 2.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -75.35 -31.88 60.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -91.1 -41.36 11.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.7 m -43.77 -25.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 203' ' ' ASP . 16.7 tt -45.8 -36.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.467 ' N ' HG21 ' A' ' 202' ' ' ILE . 8.4 t70 -73.53 -37.45 65.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.404 ' O ' ' CG1' ' A' ' 175' ' ' VAL . 9.7 mmmm -82.57 40.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.27 116.18 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.11 -41.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -42.29 154.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -107.76 138.82 43.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.558 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -72.5 140.37 48.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 211' ' ' GLY . 6.5 t -102.03 -30.75 11.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.437 ' N ' HG21 ' A' ' 210' ' ' THR . . . 56.08 110.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 94.5 p -132.85 143.99 49.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.3 t -154.86 149.15 26.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.935 0.398 . . . . 0.0 110.844 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.9 m -159.15 175.16 13.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.881 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -153.57 -173.39 22.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 54.9 p -156.75 172.13 19.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 110.821 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.1 t -167.61 161.6 13.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -152.61 -179.82 28.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.462 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -160.4 162.74 33.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 110.887 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.32 149.18 29.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.0 mtt-85 -128.69 169.03 14.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.49 64.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -46.84 174.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.728 0.299 . . . . 0.0 111.087 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.0 tt -121.17 150.34 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -128.43 106.46 9.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -107.81 145.01 34.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.77 171.32 16.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -163.47 149.9 11.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -127.47 124.7 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -84.45 116.52 23.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.832 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.47 112.64 24.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.94 125.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm 47.98 36.42 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 11.0 t 72.51 39.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.7 m-70 -132.29 122.45 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -90.7 76.55 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.517 ' CD2' HG13 ' A' ' 202' ' ' ILE . 42.7 m-85 -75.03 107.69 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.9 p -113.26 130.94 56.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.5 101.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.531 HG23 ' CE1' ' A' ' 167' ' ' PHE . 14.9 t -121.67 152.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -113.0 114.54 27.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.531 ' CE1' HG23 ' A' ' 165' ' ' THR . 30.2 m-85 -88.48 128.47 52.83 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.674 0.749 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.92 154.51 67.64 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.535 0.683 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.475 ' HB3' ' CB ' ' A' ' 181' ' ' TRP . 53.7 Cg_endo -69.77 115.94 4.33 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.4 t -105.62 153.41 21.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.36 116.28 28.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.3 t -44.9 160.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.416 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 1.6 m -103.99 -34.29 8.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 80.6 t -76.61 -68.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.4 p -80.29 -24.51 39.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.416 ' NE2' ' O ' ' A' ' 174' ' ' SER . 39.2 m80 64.27 47.94 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -120.61 152.02 38.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -50.68 116.52 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.567 HG22 ' CE1' ' A' ' 198' ' ' HIS . 81.2 t -103.93 73.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.475 ' CB ' ' HB3' ' A' ' 170' ' ' PRO . 1.2 t90 -176.46 162.82 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 183' ' ' LEU . . . 123.94 54.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 182' ' ' GLY . 6.8 mp 35.33 40.94 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.944 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -102.03 -61.32 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -175.09 158.02 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -78.38 161.48 27.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -108.69 -153.52 16.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.456 ' CD2' ' HA ' ' A' ' 199' ' ' LYS . 12.4 m-85 -127.28 150.14 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.92 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.433 ' CB ' HG22 ' A' ' 165' ' ' THR . 33.5 tt0 -138.52 119.46 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 42.5 t -74.43 132.27 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -83.3 24.24 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -131.37 -55.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -98.53 -24.81 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.8 t30 73.73 45.34 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.77 120.85 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.89 121.06 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 46.0 pt -143.97 171.35 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.567 ' CE1' HG22 ' A' ' 180' ' ' VAL . 58.2 m80 -65.16 175.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.456 ' HA ' ' CD2' ' A' ' 188' ' ' TYR . 24.0 mtpt -77.39 -28.66 52.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 202' ' ' ILE . 18.9 pttm -93.46 -38.8 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.27 -20.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.517 HG13 ' CD2' ' A' ' 162' ' ' PHE . 19.2 tt -51.54 -26.03 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 202' ' ' ILE . 14.5 t0 -80.48 -32.95 36.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -83.4 33.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.2 t -112.82 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.11 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 89.8 mt -120.65 -38.09 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -47.72 138.39 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -84.6 140.67 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 6.5 t -71.48 141.01 50.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 62.5 p -110.01 -43.4 3.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 96.14 53.56 1.47 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.486 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -91.86 149.5 21.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.89 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.105 179.929 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.8 m 62.13 43.21 8.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.9 m -104.76 123.3 47.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.821 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -143.95 -171.82 14.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.8 p -152.39 154.27 35.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.5 t -83.17 175.63 9.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.61 174.74 17.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -123.11 133.11 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 144.25 45.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -111.48 177.89 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -143.66 -166.96 11.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.1 172.85 7.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.01 144.61 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -95.16 148.87 21.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -102.56 156.52 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.49 138.26 26.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -160.34 148.89 16.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.44 133.99 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -95.38 125.61 40.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.814 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -90.2 114.64 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.83 127.8 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mmtp 39.85 43.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 87.1 m 63.57 44.96 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -137.23 131.74 32.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.77 77.17 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 39.0 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 42.4 p -140.85 123.33 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.47 109.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.1 t -134.42 150.29 50.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.59 115.55 30.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 41.0 m-85 -91.44 107.49 22.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.61 0.719 . . . . 0.0 110.86 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.455 ' HG2' ' NE2' ' A' ' 169' ' ' GLN . 54.2 Cg_endo -69.74 -6.37 18.42 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.311 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.455 ' NE2' ' HG2' ' A' ' 168' ' ' PRO . 14.7 mp0 -129.38 153.65 80.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 109.5 2.35 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.653 2.235 . . . . 0.0 112.331 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.8 m -104.58 157.33 17.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 37.7 p90 -92.86 112.89 25.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.853 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.5 t -61.86 127.82 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.0 t -83.75 19.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 90.0 t -127.38 -59.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -98.95 -16.17 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.2 m170 62.47 49.43 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -125.85 139.62 53.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -40.14 132.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.529 HG23 ' CE1' ' A' ' 198' ' ' HIS . 75.2 t -119.8 91.06 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -146.05 174.5 11.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.69 148.55 21.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.46 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.72 -45.38 92.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -81.21 -176.62 6.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.96 47.89 11.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.947 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -40.19 160.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -117.28 -169.64 15.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.464 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.57 ' CE2' ' HG2' ' A' ' 199' ' ' LYS . 11.4 m-85 -138.31 130.06 28.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -121.99 119.52 31.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.8 t -65.6 162.66 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -94.83 -24.22 17.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 15.7 mt-30 -94.52 -75.09 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 31.6 p -72.67 -22.17 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 192' ' ' GLN . 7.6 m-80 59.22 52.99 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -92.12 130.02 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.401 ' C ' HG23 ' A' ' 197' ' ' ILE . . . -95.69 120.97 36.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.401 HG23 ' C ' ' A' ' 196' ' ' ALA . 23.1 pt -145.47 165.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.529 ' CE1' HG23 ' A' ' 180' ' ' VAL . 53.2 m80 -73.96 154.55 39.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.57 ' HG2' ' CE2' ' A' ' 188' ' ' TYR . 45.0 mtmt -57.74 -36.47 72.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -74.72 -30.35 61.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 57.1 m -83.99 28.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.441 HG21 ' N ' ' A' ' 203' ' ' ASP . 20.8 tt -85.72 -38.96 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.441 ' N ' HG21 ' A' ' 202' ' ' ILE . 5.2 m-20 -80.35 -23.35 40.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -84.3 29.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -104.16 121.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.415 HD12 ' NZ ' ' A' ' 158' ' ' LYS . 49.1 mm -116.43 -47.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.18 125.72 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.05 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -75.53 153.39 37.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.549 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.9 t -78.98 126.19 30.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.4 t -116.6 38.25 3.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -89.62 65.99 2.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.556 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.4 26.14 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 110.845 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.085 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.5 m -152.8 156.26 38.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.9 m -159.35 168.78 25.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.839 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 175.04 176.08 43.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.528 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 92.8 p -161.09 134.98 6.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.831 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.4 t -146.98 140.29 25.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.39 -173.56 13.35 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -148.44 163.69 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.347 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -136.01 130.83 34.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -148.4 144.35 27.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.18 102.59 0.21 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.476 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.23 163.6 14.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.6 tt -148.61 154.02 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.115 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -143.53 142.14 31.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -136.09 157.82 45.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -109.15 -175.65 2.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.88 166.99 22.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.412 ' CG1' ' HB3' ' A' ' 161' ' ' GLU . 62.5 t -115.58 110.5 32.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.13 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -70.69 159.2 34.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.67 110.13 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 160' ' ' HIS . 85.2 t -137.94 130.33 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.6 mmtm 36.95 45.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.1 m 64.56 46.13 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.573 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.1 m-70 -136.99 128.76 28.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.412 ' HB3' ' CG1' ' A' ' 154' ' ' VAL . 56.7 mt-10 -87.27 76.6 9.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -78.03 126.46 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.545 ' CG2' ' CZ ' ' A' ' 191' ' ' ARG . 6.1 t -147.16 135.52 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.159 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.45 ' HB1' ' CG ' ' A' ' 186' ' ' GLN . . . -42.71 115.29 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.56 HG21 ' CE1' ' A' ' 167' ' ' PHE . 10.2 t -135.43 158.57 44.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.03 118.13 33.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.56 ' CE1' HG21 ' A' ' 165' ' ' THR . 24.9 m-85 -94.63 127.66 42.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.2 32.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.718 2.279 . . . . 0.0 112.375 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -127.11 158.84 67.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.58 0.705 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.19 2.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.718 2.279 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.442 HG21 ' CB ' ' A' ' 196' ' ' ALA . 12.9 t -96.95 157.74 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -97.22 140.36 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.466 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 48.7 t -80.09 124.49 28.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 t -86.17 22.11 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.6 t -121.87 -48.32 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.65 -11.36 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 17.5 m170 63.2 52.24 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 179' ' ' PHE . 13.6 mm-40 -131.85 136.02 47.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 178' ' ' GLU . 5.5 m-85 -36.97 126.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.485 HG22 ' CE1' ' A' ' 198' ' ' HIS . 46.4 t -111.48 80.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -174.37 156.22 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 79.37 -58.96 4.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 183' ' ' LEU . 4.5 mm? -102.12 166.45 10.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.8 p30 39.54 42.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.85 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -49.57 175.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.45 ' CG ' ' HB1' ' A' ' 164' ' ' ALA . 8.4 tt0 65.85 54.24 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.05 -161.86 2.63 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.465 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 11.8 m-85 -126.47 131.14 51.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 110.895 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -126.75 124.38 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 49.3 t -77.13 130.12 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.545 ' CZ ' ' CG2' ' A' ' 163' ' ' THR . 0.2 OUTLIER -81.2 19.08 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -124.95 -61.55 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.4 p -93.11 -24.56 18.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 73.54 46.64 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.8 121.55 38.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.442 ' CB ' HG21 ' A' ' 171' ' ' THR . . . -95.85 123.06 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.416 HG23 ' C ' ' A' ' 196' ' ' ALA . 41.8 pt -141.97 167.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.485 ' CE1' HG22 ' A' ' 180' ' ' VAL . 44.8 m80 -70.73 151.13 45.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.87 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.57 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 23.8 tttt -57.94 -34.98 70.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -80.95 -26.07 36.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 87.2 m -83.04 27.45 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.5 tt -86.06 -39.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -74.17 -29.82 61.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 36.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.09 128.9 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 207' ' ' ALA . 88.4 mt -126.08 -52.94 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.84 116.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.094 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 160.41 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 9.1 t -87.81 144.53 26.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.2 t -93.45 -40.18 10.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 74.69 109.27 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.469 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 1.1 t -111.49 25.85 11.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.898 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.104 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.7 p -167.3 133.16 2.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.4 t -174.52 161.96 3.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.06 98.43 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.7 t -66.02 100.78 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.878 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 t -112.58 109.46 19.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.63 159.94 23.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.502 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -150.15 118.34 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -98.86 162.85 12.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -141.72 141.93 33.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -132.18 154.44 21.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -123.24 165.13 17.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.331 . . . . 0.0 111.074 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.4 tt -163.96 131.2 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.36 169.52 13.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -169.19 174.12 6.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.72 167.92 20.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -154.0 137.95 16.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.4 t -109.28 122.34 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -84.72 116.3 23.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.77 100.05 12.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.21 107.79 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 16.6 mmtm 62.63 41.3 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 m 63.94 39.16 8.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.897 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 97.4 m-70 -132.54 124.92 29.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -92.74 77.84 4.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.01 121.19 21.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 62.5 p -123.91 127.27 47.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.157 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.461 ' HB3' ' NE2' ' A' ' 186' ' ' GLN . . . -43.9 115.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.459 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 10.1 t -134.63 143.29 47.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -99.89 108.09 20.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.459 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 45.6 m-85 -81.19 127.41 74.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.661 0.743 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -26.69 27.46 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.244 . . . . 0.0 112.373 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -129.94 153.38 80.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.415 ' HB3' ' CB ' ' A' ' 181' ' ' TRP . 53.7 Cg_endo -69.76 110.15 2.48 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.2 t -97.73 153.64 18.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 1.3 p90 -81.7 118.77 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -54.04 160.49 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.1 t -103.16 -29.05 11.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.57 -66.82 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 16.7 p -81.19 -22.31 38.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 5.4 m170 63.48 45.17 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 179' ' ' PHE . 54.3 mt-10 -127.42 133.79 49.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.8 p90 -35.38 105.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 83.9 t -75.35 81.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.415 ' CB ' ' HB3' ' A' ' 170' ' ' PRO . 3.4 t-105 -176.2 140.31 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 174.42 -99.49 0.14 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.422 ' C ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -67.42 -176.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.919 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.41 ' O ' ' CG ' ' A' ' 185' ' ' LYS . 1.7 m120 -85.57 88.79 7.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.881 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 184' ' ' ASN . 48.5 mttt -161.21 176.9 10.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.461 ' NE2' ' HB3' ' A' ' 164' ' ' ALA . 10.2 pt20 -123.8 162.43 23.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -101.63 -153.02 25.54 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 23.1 m-85 -133.41 143.12 48.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -139.61 132.67 29.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.7 t -73.83 162.71 28.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -90.82 -20.08 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.83 -70.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 15.4 p -72.07 -16.24 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 50.3 48.21 22.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -82.25 118.76 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.31 121.55 33.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 40.0 pt -145.74 175.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -70.97 175.24 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.557 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 5.9 mtpm? -70.51 -43.67 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.4 pptp? -80.15 -36.08 35.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 1.8 m -51.02 -22.5 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.41 ' CG2' ' O ' ' A' ' 199' ' ' LYS . 16.6 tt -52.79 -38.33 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.6 -32.73 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -83.27 37.16 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.8 t -114.23 115.35 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.9 mt -110.65 -43.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.64 163.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 3.8 ttmp? -110.92 162.85 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.452 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -86.8 109.42 19.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.9 t -91.12 30.52 1.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 83.5 -48.31 4.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 28.1 t -161.22 147.6 14.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.857 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.074 179.903 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.9 p -134.38 -42.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.794 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.7 t 64.86 43.78 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.02 127.79 22.19 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.535 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.9 m -139.85 108.91 6.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 110.874 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 m -130.4 151.82 50.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -53.94 169.6 1.22 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -126.62 -66.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.326 . . . . 0.0 110.931 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -141.32 122.66 14.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.856 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -79.93 -46.9 15.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.35 122.26 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -127.22 163.67 23.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.742 0.306 . . . . 0.0 111.124 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.6 tt -110.68 141.98 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.4 ' HE3' ' N ' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -63.36 151.22 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -93.24 122.01 35.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.62 156.82 25.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -170.17 148.49 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.59 132.6 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -88.12 99.65 12.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -74.57 118.11 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.8 t -139.8 122.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.4 mptt 42.04 44.9 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.939 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 4.2 m 63.31 42.47 6.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.4 m-70 -137.16 119.15 15.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -84.32 79.35 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -73.62 139.14 45.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.6 p -141.5 125.86 17.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.2 106.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.1 t -125.1 160.97 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.159 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -112.56 115.79 29.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.562 ' CE2' ' HB3' ' A' ' 196' ' ' ALA . 21.0 m-85 -89.56 110.64 40.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.628 0.728 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -15.09 36.69 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 0.0 112.355 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -129.97 160.91 62.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.923 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.32 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 m -102.09 147.36 26.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -89.58 109.43 20.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.87 159.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 p -99.36 -28.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.6 -73.48 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.7 p -75.31 -22.64 57.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 63.13 44.42 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.54 142.79 49.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -42.67 123.07 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.57 HG23 ' CE1' ' A' ' 198' ' ' HIS . 92.8 t -100.03 80.17 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.455 ' NE1' ' O ' ' A' ' 167' ' ' PHE . 0.4 OUTLIER -176.38 139.17 0.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.32 -97.44 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.455 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.8 mt -71.23 178.65 3.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.86 45.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -110.28 174.19 5.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -132.9 164.99 25.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -119.71 -125.29 3.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.52 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 199' ' ' LYS . 23.3 m-85 -149.17 146.22 27.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -145.62 114.75 7.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.76 161.11 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -96.12 -20.47 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -96.81 -70.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.943 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -72.55 -20.63 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 56.67 51.58 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.24 126.23 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.562 ' HB3' ' CE2' ' A' ' 167' ' ' PHE . . . -92.48 131.71 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.41 HG22 ' C ' ' A' ' 196' ' ' ALA . 29.7 pt -151.39 151.51 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.57 ' CE1' HG23 ' A' ' 180' ' ' VAL . 73.0 m80 -61.03 157.66 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.42 ' HD2' ' CZ ' ' A' ' 188' ' ' TYR . 0.2 OUTLIER -63.28 -14.31 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -98.51 -23.03 15.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 88.0 m -83.0 16.56 2.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.13 -38.98 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.162 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.12 -28.79 60.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -87.68 32.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.0 t -110.01 111.48 36.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.167 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 97.5 mt -111.23 -46.89 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -37.39 155.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -101.37 164.0 11.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.473 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -91.39 138.62 31.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 t -123.95 38.09 4.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -115.18 96.15 0.74 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.524 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 23.9 p -92.37 143.77 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.857 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.095 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.7 m80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.812 0.339 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -103.88 99.48 9.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.4 t -121.72 112.64 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 2.5 mptp? 58.66 41.1 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 5.9 t 65.63 37.69 5.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -134.6 125.96 28.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -92.29 81.73 4.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.28 121.63 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.8 p -126.64 123.44 37.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.115 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.36 104.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.1 t -130.45 149.06 52.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.167 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -105.69 108.71 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.35 111.46 20.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.66 0.743 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -7.03 20.02 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -129.19 154.29 80.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 87.6 m -116.7 135.38 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -78.11 136.22 37.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.31 159.47 17.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.416 ' H ' HG22 ' A' ' 197' ' ' ILE . 20.5 m -94.72 -23.64 17.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.0 t -96.48 -75.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.137 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.9 p -67.7 -22.2 65.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 40.3 m80 62.34 50.91 3.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -122.59 145.32 48.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -55.25 119.47 5.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 198' ' ' HIS . 25.4 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.413 ' CE2' HD12 ' A' ' 202' ' ' ILE . 11.4 m-85 -140.92 132.82 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 110.883 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -132.47 119.73 20.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.55 162.07 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -95.43 -24.37 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.34 -75.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.9 p -71.34 -24.0 62.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.37 51.95 2.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.49 129.99 36.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.83 126.15 40.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 201' ' ' CYS . 29.9 pt -149.86 153.62 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.174 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.3 m80 -67.02 159.94 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -59.2 -35.86 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -76.04 -23.28 55.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.615 ' O ' HD12 ' A' ' 197' ' ' ILE . 66.2 m -87.91 24.5 1.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.413 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.1 tt -87.61 -30.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.82 -19.54 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.537 ' HB2' HG11 ' A' ' 175' ' ' VAL . 11.4 mmtp -89.23 25.02 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.41 117.68 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 25.6 mm -116.17 -47.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.31 141.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -89.55 156.97 18.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 3.5 t -83.48 133.51 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -82.21 110.43 17.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 160' ' ' HIS . 70.9 t -134.12 126.29 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.607 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.0 mptt 36.41 46.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 66.2 m 63.14 42.35 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 94.9 m-70 -136.99 131.77 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -96.36 79.18 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -69.45 133.84 48.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.3 p -136.7 125.53 24.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.09 113.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 189' ' ' GLN . 15.3 t -133.02 158.41 42.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.172 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.03 100.88 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.437 ' CZ ' ' CB ' ' A' ' 196' ' ' ALA . 84.1 m-85 -75.29 118.96 74.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.606 0.717 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -9.03 25.1 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.656 2.237 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.63 158.01 54.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 110.1 2.48 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.7 2.267 . . . . 0.0 112.334 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.52 HG21 ' CB ' ' A' ' 196' ' ' ALA . 9.8 t -98.14 150.71 21.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 177' ' ' HIS . 2.1 t80 -76.97 107.66 9.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 t -57.25 127.16 30.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.1 p -82.92 25.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.614 HG23 HG21 ' A' ' 197' ' ' ILE . 88.8 t -131.91 -53.63 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -106.85 -17.91 14.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 4.8 m170 72.8 49.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -136.96 140.13 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -46.16 120.4 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.734 HG22 ' CE1' ' A' ' 198' ' ' HIS . 60.0 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 199' ' ' LYS . 17.8 m-85 -148.83 132.77 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.922 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.591 ' HB2' HG21 ' A' ' 165' ' ' THR . 21.7 tt0 -132.34 127.39 35.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.9 t -69.49 162.06 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -92.31 -18.64 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -103.72 -73.87 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.453 ' C ' ' CG ' ' A' ' 194' ' ' ASN . 27.8 p -72.48 -14.46 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.453 ' CG ' ' C ' ' A' ' 193' ' ' CYS . 1.0 OUTLIER 48.47 53.44 12.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.93 126.14 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 171' ' ' THR . . . -96.38 121.14 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 201' ' ' CYS . 40.2 pt -143.61 163.21 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.734 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.7 m80 -67.87 152.13 46.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 188' ' ' TYR . 47.5 mtpt -57.32 -27.32 62.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -84.7 -25.36 28.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.722 ' O ' HD12 ' A' ' 197' ' ' ILE . 77.4 m -85.13 26.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.7 tt -87.1 -33.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.79 -23.98 31.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -89.24 28.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 201' ' ' CYS . 86.2 t -104.49 119.7 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.088 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 87.5 mt -114.28 -54.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.44 118.0 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -73.59 158.59 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.9 t -86.77 131.05 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 -179.944 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -104.05 102.15 11.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -127.78 108.02 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.11 43.24 21.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 66.04 35.87 6.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CB ' ' CE2' ' A' ' 162' ' ' PHE . 97.7 m-70 -129.27 117.86 21.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -76.75 50.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 160' ' ' HIS . 37.2 m-85 -60.2 105.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -122.16 136.27 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.12 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.56 124.86 3.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.42 HG21 ' HB2' ' A' ' 189' ' ' GLN . 15.2 t -143.2 153.49 42.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -102.65 128.82 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.05 109.33 58.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.707 2.272 . . . . 0.0 112.309 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -144.76 157.51 54.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 127.19 14.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 88.4 m -128.96 138.72 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -75.39 129.73 37.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.0 t -60.7 157.4 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.543 ' H ' HG22 ' A' ' 197' ' ' ILE . 17.9 t -98.63 -29.2 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.445 HG11 ' HB2' ' A' ' 204' ' ' LYS . 99.0 t -85.16 -74.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.1 p -71.09 -23.87 62.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 63.54 53.88 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 179' ' ' PHE . 20.8 mt-10 -134.44 130.86 37.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 178' ' ' GLU . 8.5 p90 -34.73 123.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 84.1 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -154.08 140.55 18.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.42 ' HB2' HG21 ' A' ' 165' ' ' THR . 66.5 tt0 -140.81 109.69 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -58.78 161.42 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -95.13 -19.84 19.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -98.84 -74.57 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.47 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 30.7 p -71.3 -12.63 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 193' ' ' CYS . 0.7 OUTLIER 47.16 52.01 12.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.92 122.68 32.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.79 115.31 27.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.09 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 174' ' ' SER . 27.3 pt -140.64 173.91 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -63.59 172.61 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -78.1 -15.43 58.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.8 pptp? -106.03 -32.21 8.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 3.4 m -55.43 -16.68 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.59 -26.83 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.85 -31.72 61.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.445 ' HB2' HG11 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -92.67 32.87 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 201' ' ' CYS . 54.5 t -110.69 89.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.8 mt -91.25 -44.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.62 135.19 1.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -79.1 153.74 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.477 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 8.1 t -79.57 113.26 17.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 45.4 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.824 0.345 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -112.34 123.78 51.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.6 t -140.01 107.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.508 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.5 mttm 62.36 47.91 5.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.61 37.92 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.522 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 99.6 m-70 -131.04 113.55 14.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -84.13 76.3 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -71.9 138.79 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 73.3 p -140.72 128.71 22.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.56 116.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 15.3 t -138.67 142.07 39.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.88 110.62 22.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 13.3 m-85 -88.13 111.37 42.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.749 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -16.16 37.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.301 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -114.23 154.29 46.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 109.57 2.35 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.661 2.24 . . . . 0.0 112.317 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 57.1 m -113.69 135.01 54.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 7.3 p90 -77.14 115.67 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -44.93 159.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.561 ' H ' HG22 ' A' ' 197' ' ' ILE . 18.2 m -99.29 -26.12 14.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.1 t -88.69 -71.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.8 p -75.23 -23.78 57.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.833 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.5 m80 64.21 51.87 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 179' ' ' PHE . 62.2 mt-10 -133.18 131.53 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 178' ' ' GLU . 27.3 p90 -32.91 113.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.447 HG22 ' NE2' ' A' ' 198' ' ' HIS . 68.1 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -150.4 129.82 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 110.946 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.457 ' HB2' HG21 ' A' ' 165' ' ' THR . 12.4 tt0 -123.72 131.62 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 11.4 t -76.22 161.81 28.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -93.23 -20.38 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.24 -75.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.6 p -69.92 -15.18 63.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 51.6 52.61 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.19 123.39 33.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -98.29 120.99 39.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 174' ' ' SER . 38.2 pt -141.36 171.97 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.447 ' NE2' HG22 ' A' ' 180' ' ' VAL . 81.2 m-70 -63.01 -177.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -79.21 -37.15 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -87.32 -37.18 17.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 4.6 m -49.07 -18.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.41 ' HA ' HD11 ' A' ' 197' ' ' ILE . 16.6 tt -54.97 -32.5 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.81 -35.56 64.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.541 ' HB2' HG11 ' A' ' 175' ' ' VAL . 6.9 mmpt? -84.68 35.05 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.29 118.7 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 206' ' ' ILE . 3.8 mp -119.65 -56.86 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -35.02 112.4 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -64.38 150.25 46.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.522 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.8 t -73.07 137.19 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 77.6 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.838 0.352 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -76.22 113.4 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.78 106.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.495 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.0 mptp? 60.62 42.59 13.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 63.3 m 64.41 37.85 8.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.3 m-70 -131.47 119.02 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -83.07 79.45 9.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -72.76 135.75 45.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 p -140.01 123.32 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -51.14 112.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -141.02 148.54 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -94.3 134.19 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -107.71 105.02 55.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.637 0.732 . . . . 0.0 110.901 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -3.53 12.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -128.92 153.54 80.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.709 2.273 . . . . 0.0 112.333 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.5 m -126.87 136.04 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -83.57 123.03 29.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 3.0 t -54.23 156.39 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 33.9 p -100.79 -17.41 16.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.3 t -97.77 -68.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -80.03 -14.86 58.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.5 m170 57.49 49.09 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 179' ' ' PHE . 70.9 mt-10 -128.29 130.94 48.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.7 p90 -35.46 134.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 198' ' ' HIS . 63.6 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 16.0 m-85 -136.33 140.33 43.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -135.92 115.22 12.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 14.4 t -63.09 138.34 58.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -85.67 20.48 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -132.32 -64.52 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.8 p -86.94 -15.52 38.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 59.48 54.06 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.39 128.06 52.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 129.9 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 33.2 pt -151.03 153.68 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.583 ' CE1' HG22 ' A' ' 180' ' ' VAL . 60.8 m80 -64.57 161.65 17.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.53 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 7.6 mtpm? -64.04 -27.2 68.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -22.56 24.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.2 m -83.98 14.57 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 203' ' ' ASP . 18.1 tt -79.47 -41.87 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.453 ' N ' HG23 ' A' ' 202' ' ' ILE . 64.0 m-20 -73.84 -26.81 60.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -88.07 38.16 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.5 t -111.02 112.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.411 ' O ' ' C ' ' A' ' 207' ' ' ALA . 77.4 mt -106.76 -50.78 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.14 143.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.076 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -97.23 137.57 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.539 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.5 t -65.47 140.52 58.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.168 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -88.87 109.13 19.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.9 t -132.12 136.92 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.466 ' O ' ' CE1' ' A' ' 160' ' ' HIS . 21.6 mmtm 38.96 43.07 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 2.2 m 64.75 41.7 4.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.466 ' CE1' ' O ' ' A' ' 158' ' ' LYS . 44.1 m80 -136.27 142.17 43.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.73 75.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -66.43 105.13 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 p -109.95 121.25 44.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.99 105.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -127.9 149.9 50.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -107.18 105.08 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.62 114.58 33.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -6.96 19.81 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.751 2.3 . . . . 0.0 112.383 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -140.1 159.5 63.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.599 0.714 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 179' ' ' PHE . 53.7 Cg_endo -69.78 116.5 4.59 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.666 2.244 . . . . 0.0 112.327 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.9 t -114.38 156.87 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.75 146.98 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.9 t -79.53 160.05 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.477 ' H ' HG22 ' A' ' 197' ' ' ILE . 46.6 t -101.84 -30.38 11.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.46 -73.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -75.02 -25.12 58.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 63.18 50.13 3.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -123.2 135.59 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 170' ' ' PRO . 4.2 t80 -39.63 122.18 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.613 HG22 ' CE1' ' A' ' 198' ' ' HIS . 22.5 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -122.35 135.65 54.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -124.83 121.82 35.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 25.9 t -64.21 163.01 13.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -90.4 -21.82 21.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -103.25 -73.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.5 p -71.36 -12.15 61.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 194' ' ' ASN . 5.1 p-10 43.05 52.87 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -91.24 130.32 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.19 122.4 35.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 174' ' ' SER . 28.6 pt -142.81 147.82 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.613 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.2 m80 -57.69 151.46 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.84 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -57.27 -19.7 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -90.99 -27.41 18.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.458 ' O ' HD12 ' A' ' 197' ' ' ILE . 84.9 m -82.62 20.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.21 -37.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -82.84 -24.22 33.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -85.28 31.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.7 t -101.52 127.0 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.43 -44.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -53.75 125.07 17.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.79 167.29 11.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 7.8 t -88.31 113.13 23.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.141 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.781 0.324 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -96.29 112.0 23.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 158' ' ' LYS . 97.3 t -140.65 135.53 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mptt 36.31 45.19 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 99.0 m 63.31 46.08 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.1 m-70 -136.3 178.37 7.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -130.66 50.23 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.538 ' CD2' HG13 ' A' ' 202' ' ' ILE . 23.2 m-85 -51.43 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.46 HG21 ' NH2' ' A' ' 191' ' ' ARG . 7.3 t -117.95 136.67 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.182 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.55 124.16 3.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.418 HG21 ' HB2' ' A' ' 189' ' ' GLN . 13.6 t -145.75 159.89 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -124.94 109.89 13.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -85.26 119.27 72.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.276 . . . . 0.0 112.309 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -147.74 158.28 42.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.614 0.721 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 124.48 11.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.481 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.2 t -117.68 157.47 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -84.78 115.75 22.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.478 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 49.1 t -64.81 126.56 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.54 ' H ' HG22 ' A' ' 197' ' ' ILE . 23.0 t -87.12 26.96 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.625 HG23 HG21 ' A' ' 197' ' ' ILE . 53.5 t -129.76 -55.34 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.89 -16.03 14.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.9 m170 63.59 51.87 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -134.99 132.63 38.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -40.25 109.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.767 HG22 ' CE1' ' A' ' 198' ' ' HIS . 82.6 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.168 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.94 143.87 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.835 0.35 . . . . 0.0 110.926 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.418 ' HB2' HG21 ' A' ' 165' ' ' THR . 46.0 tt0 -143.52 119.71 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 28.2 t -63.46 163.08 11.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.46 ' NH2' HG21 ' A' ' 163' ' ' THR . 21.3 mmt-85 -98.03 -22.79 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -92.28 -68.4 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.99 -25.36 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 63.53 50.15 2.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -89.44 119.39 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.076 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.481 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -92.58 121.04 33.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.625 HG21 HG23 ' A' ' 175' ' ' VAL . 43.1 pt -144.18 174.91 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.767 ' CE1' HG22 ' A' ' 180' ' ' VAL . 52.9 m80 -68.42 178.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.584 ' O ' HG22 ' A' ' 202' ' ' ILE . 37.3 tttm -73.84 -53.88 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 202' ' ' ILE . 10.7 pttm -70.97 -43.7 67.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 18.7 m -43.16 -22.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 199' ' ' LYS . 19.3 tt -50.37 -38.26 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -34.95 71.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.428 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 36.8 mmtt -82.72 36.82 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.55 126.17 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.65 -55.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -37.98 139.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.103 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -90.07 159.36 16.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 5.2 t -79.54 110.18 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.346 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.46 ' CE1' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m-70 -125.22 105.49 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 88.7 t -137.83 120.68 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 52.91 39.44 29.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.3 t 65.99 40.01 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -132.01 119.94 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.46 ' OE1' ' CE1' ' A' ' 156' ' ' HIS . 6.6 mm-40 -78.35 70.58 4.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -71.48 97.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.1 t -112.12 134.44 53.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.25 120.32 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.57 HG23 ' CE1' ' A' ' 167' ' ' PHE . 5.1 t -139.29 149.74 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -105.82 117.46 34.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 165' ' ' THR . 18.8 m-85 -91.13 109.73 37.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.728 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -7.56 21.37 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.701 2.267 . . . . 0.0 112.348 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -136.04 160.72 66.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 121.9 8.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.751 2.301 . . . . 0.0 112.326 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.8 m -115.66 150.18 37.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.412 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 32.8 p90 -96.74 111.43 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 12.7 t -47.56 157.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 p -97.56 -22.67 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.763 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.5 t -92.81 -74.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -73.27 -23.62 60.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 63.56 46.27 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.98 148.66 43.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -45.01 130.57 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.559 HG22 ' CE1' ' A' ' 198' ' ' HIS . 69.1 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.534 ' CZ ' ' HG2' ' A' ' 199' ' ' LYS . 14.5 m-85 -104.0 131.98 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -129.78 118.71 22.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 8.9 t -62.68 161.68 11.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -96.49 -20.71 18.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -97.21 -71.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 21.5 p -74.18 -20.55 60.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 57.83 53.51 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.38 128.7 41.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -94.84 125.79 39.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 201' ' ' CYS . 23.7 pt -152.09 147.27 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.076 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.559 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.5 m80 -60.01 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.534 ' HG2' ' CZ ' ' A' ' 188' ' ' TYR . 41.7 mttt -58.67 -22.83 58.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -22.85 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.576 ' O ' HD12 ' A' ' 197' ' ' ILE . 79.2 m -86.77 27.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 tt -88.27 -30.39 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -80.58 -25.45 38.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.763 ' HB2' HG11 ' A' ' 175' ' ' VAL . 24.3 mttm -88.77 31.48 0.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.58 110.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' ALA . 46.7 mm -109.27 -54.3 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.38 145.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.131 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -91.92 167.11 12.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.6 t -98.64 124.97 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.812 0.339 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -110.57 107.12 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.833 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 160' ' ' HIS . 58.2 t -129.65 131.46 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.078 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 157' ' ' VAL . 14.2 mptt 37.41 45.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 59.1 m 63.47 41.22 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 157' ' ' VAL . 53.7 m80 -133.25 120.88 21.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.6 70.39 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -75.69 103.68 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.1 t -119.9 138.94 53.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.52 119.82 2.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.5 t -141.25 141.39 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -97.21 118.85 34.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -90.63 108.84 30.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -5.68 16.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.725 2.284 . . . . 0.0 112.289 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -133.88 153.95 80.15 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 m -108.62 156.35 19.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 172' ' ' PHE . 19.0 p90 -103.74 131.95 50.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.06 155.28 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 m -100.49 -24.29 14.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.23 -72.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -74.43 -21.29 59.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 8.2 m170 63.2 47.67 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -124.52 143.85 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -48.23 128.17 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' A' ' 198' ' ' HIS . 21.3 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 199' ' ' LYS . 20.8 m-85 -124.78 135.51 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.46 112.92 9.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.9 t -57.72 159.17 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -96.98 -16.99 20.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -97.85 -68.43 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.68 -23.45 53.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.98 53.33 3.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.75 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.51 118.75 31.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 29.8 pt -140.02 158.12 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.407 ' CE1' HG22 ' A' ' 180' ' ' VAL . 68.1 m80 -62.64 161.35 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 188' ' ' TYR . 50.9 tttt -68.75 -11.17 60.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -105.19 -20.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.69 15.66 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 203' ' ' ASP . 17.6 tt -79.27 -40.09 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.425 ' N ' HG23 ' A' ' 202' ' ' ILE . 6.8 p-10 -71.55 -25.52 62.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.407 ' HD2' ' CG ' ' A' ' 203' ' ' ASP . 0.6 OUTLIER -90.54 37.25 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.44 96.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.68 -44.82 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -41.75 154.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.08 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -99.31 159.96 14.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.2 t -85.51 145.14 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.821 0.343 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -101.69 99.62 9.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 160' ' ' HIS . 90.1 t -117.87 134.67 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.568 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 1.5 mmmp? 33.79 47.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.864 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 64.3 m 64.61 45.08 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.5 m-70 -135.09 118.75 17.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.83 75.56 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -72.34 144.53 48.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.7 p -134.01 127.33 32.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.82 119.17 3.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -143.99 153.26 42.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -116.5 112.77 21.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -87.74 111.18 40.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.668 0.747 . . . . 0.0 110.863 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -6.39 18.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.328 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -128.83 152.53 79.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.61 0.719 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.67 2.247 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.0 m -113.9 138.47 50.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -66.93 129.72 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.1 t -72.04 159.26 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 197' ' ' ILE . 29.1 t -98.09 -29.21 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.47 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.9 t -87.55 -75.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.3 p -72.17 -22.11 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 60.91 45.45 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.35 169.67 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -62.84 122.86 17.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -154.43 134.59 13.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -132.58 127.85 35.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.4 t -71.76 162.02 30.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -88.72 -20.02 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -105.61 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 25.7 p -66.56 -10.61 47.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 42.57 49.92 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.75 28.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -94.94 122.05 37.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.464 HG21 HG23 ' A' ' 175' ' ' VAL . 36.4 pt -145.54 173.75 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -66.9 176.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -24.13 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -96.57 -38.11 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.48 -25.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 203' ' ' ASP . 19.2 tt -49.02 -39.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.153 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 202' ' ' ILE . 39.6 m-20 -70.25 -32.72 70.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.47 ' HB2' HG11 ' A' ' 175' ' ' VAL . 27.5 mmmt -86.04 38.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.4 125.51 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 80.7 mt -120.64 -40.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.14 136.09 42.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.443 ' HG3' ' NZ ' ' A' ' 158' ' ' LYS . 7.0 mtpm? -83.1 167.05 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.401 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.3 t -84.6 122.18 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 39.3 m80 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.802 0.334 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -78.06 111.4 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.698 HG21 HD11 ' A' ' 202' ' ' ILE . 54.7 t -130.99 115.36 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 10.9 mptt 53.16 40.93 32.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 42.0 m 67.04 40.27 2.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -134.79 118.1 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -79.25 80.41 5.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -80.69 107.23 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 77.0 p -111.53 126.8 55.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.83 108.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.6 t -132.8 146.34 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.159 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.36 143.15 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.97 124.96 28.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.615 0.722 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -23.97 29.77 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.654 2.236 . . . . 0.0 112.311 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -127.45 152.47 76.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 127.93 15.33 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 180' ' ' VAL . 4.7 t -120.21 149.82 41.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -79.14 128.76 33.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.73 159.63 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.426 ' H ' HG22 ' A' ' 197' ' ' ILE . 25.6 m -95.93 -19.16 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 204' ' ' LYS . 90.2 t -100.31 -72.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.5 p -71.62 -22.48 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 62.83 44.38 6.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.83 151.27 37.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -52.43 130.61 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 171' ' ' THR . 66.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.532 ' CE2' ' HG2' ' A' ' 199' ' ' LYS . 26.9 m-85 -128.69 147.55 50.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.0 110.887 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.591 ' OE1' ' HB2' ' A' ' 196' ' ' ALA . 28.6 tp60 -143.7 110.58 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 5.3 t -57.94 157.81 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -96.34 -14.76 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -99.28 -67.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.42 -22.26 54.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 59.78 47.89 9.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.69 133.33 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.591 ' HB2' ' OE1' ' A' ' 189' ' ' GLN . . . -99.55 124.24 44.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 174' ' ' SER . 42.7 pt -145.15 175.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.52 ' NE2' HG22 ' A' ' 180' ' ' VAL . 67.7 m80 -85.99 163.87 17.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.532 ' HG2' ' CE2' ' A' ' 188' ' ' TYR . 34.2 mttm -67.29 -20.22 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -92.51 -27.16 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.638 ' O ' HG23 ' A' ' 205' ' ' VAL . 76.3 m -82.56 11.04 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.698 HD11 HG21 ' A' ' 157' ' ' VAL . 20.1 tt -73.16 -34.98 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.85 -27.08 49.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.433 ' HB2' HG11 ' A' ' 175' ' ' VAL . 20.3 mttm -88.75 32.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 201' ' ' CYS . 76.8 t -111.12 88.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.184 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.1 mp -85.13 -55.74 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.81 116.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -73.86 144.43 45.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.75 134.11 53.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -100.96 107.62 19.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 85.2 t -131.66 125.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 45.33 36.52 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 67.92 44.4 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.9 m-70 -134.66 118.31 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.448 ' OE2' ' NH2' ' A' ' 191' ' ' ARG . 21.0 mt-10 -91.92 78.17 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -67.84 150.07 49.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 43.6 p -142.0 117.82 10.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.5 106.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -133.6 157.65 45.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.141 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -112.75 107.66 16.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.849 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -81.55 112.11 31.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.436 ' HG2' ' CD ' ' A' ' 169' ' ' GLN . 53.5 Cg_endo -69.78 -7.01 19.97 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.313 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.436 ' CD ' ' HG2' ' A' ' 168' ' ' PRO . 19.6 mp0 -125.46 152.71 71.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.608 0.718 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 110.53 2.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 180' ' ' VAL . 1.3 m -109.26 157.42 18.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.157 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -96.48 129.7 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.6 t -69.29 128.63 37.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 197' ' ' ILE . 72.2 m -85.62 19.52 2.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 204' ' ' LYS . 98.2 t -125.07 -57.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.69 -13.91 17.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 4.7 m170 63.93 52.26 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 179' ' ' PHE . 25.9 mt-10 -132.67 136.71 46.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.458 ' C ' ' O ' ' A' ' 178' ' ' GLU . 29.9 m-85 -33.35 137.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.538 HG22 ' NE2' ' A' ' 198' ' ' HIS . 88.0 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -149.1 137.15 20.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -130.24 120.03 23.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.404 ' HB3' ' N ' ' A' ' 194' ' ' ASN . 4.7 t -66.93 162.02 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.448 ' NH2' ' OE2' ' A' ' 161' ' ' GLU . 18.9 mtm105 -92.93 -24.91 18.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -99.78 -74.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.4 p -72.51 -9.74 58.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.404 ' N ' ' HB3' ' A' ' 190' ' ' CYS . 1.3 p-10 42.99 54.17 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.46 131.96 34.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.105 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -97.7 115.66 28.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 201' ' ' CYS . 12.5 pt -143.11 159.49 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.538 ' NE2' HG22 ' A' ' 180' ' ' VAL . 46.2 m80 -65.23 159.61 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -65.02 -35.09 80.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 201' ' ' CYS . 0.0 OUTLIER -77.96 -26.62 48.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.486 ' O ' HD12 ' A' ' 197' ' ' ILE . 86.0 m -84.21 22.53 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.45 -36.03 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -83.16 -25.27 32.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.717 ' O ' HG13 ' A' ' 175' ' ' VAL . 30.3 mmtm -86.11 31.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.449 HG22 ' CG2' ' A' ' 175' ' ' VAL . 96.7 t -104.94 116.52 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.19 -47.47 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -38.59 137.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.473 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 19.7 ttpt -88.38 156.0 19.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -91.88 113.39 25.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.2 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -97.49 98.57 10.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 65.3 t -120.15 116.58 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.608 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.9 mptt 43.39 45.94 5.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 65.2 m 62.88 40.05 9.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 91.9 m-70 -135.64 123.67 22.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -87.91 88.95 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -82.51 122.88 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -129.67 123.3 30.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.08 101.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.8 t -126.23 155.42 41.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -112.09 112.99 25.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -84.94 126.48 67.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -11.05 30.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.706 2.271 . . . . 0.0 112.382 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.16 152.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 117.62 5.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.3 t -114.67 136.41 53.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.134 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.24 128.83 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.04 159.64 9.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 197' ' ' ILE . 12.6 m -97.36 -26.45 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.92 -75.15 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 12.7 p -70.55 -20.79 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.87 49.45 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 179' ' ' PHE . 5.9 mm-40 -126.95 133.49 50.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 178' ' ' GLU . 12.1 p90 -36.05 111.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.666 HG22 ' CE1' ' A' ' 198' ' ' HIS . 58.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -140.47 137.08 33.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -132.44 118.26 19.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 10.6 t -58.56 162.67 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -94.14 -13.56 26.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -112.36 -62.59 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 194' ' ' ASN . 17.3 p -87.92 4.95 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 193' ' ' CYS . 7.5 p-10 34.08 45.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.413 ' HB2' ' SG ' ' A' ' 193' ' ' CYS . . . -72.48 119.41 16.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.096 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.31 115.05 27.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.085 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 201' ' ' CYS . 29.9 pt -141.88 158.32 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.666 ' CE1' HG22 ' A' ' 180' ' ' VAL . 72.7 m80 -63.22 161.2 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -65.03 -18.88 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.59 -23.72 16.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.542 ' O ' HD12 ' A' ' 197' ' ' ILE . 81.3 m -83.35 22.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 203' ' ' ASP . 21.1 tt -84.3 -39.57 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.422 ' N ' HG23 ' A' ' 202' ' ' ILE . 3.4 p30 -75.33 -30.74 60.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -84.39 36.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -108.74 108.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 39.7 mm -105.42 -50.2 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.49 146.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -92.89 165.12 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.556 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.7 t -95.39 118.16 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.929 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -94.08 106.41 18.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 160' ' ' HIS . 87.5 t -124.83 126.67 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . 28.7 mmmt 34.76 39.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 t 74.98 43.92 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.554 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 92.1 m-70 -137.76 115.4 11.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -80.77 74.25 7.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 33.1 m-85 -70.3 128.75 37.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 80.9 p -136.01 126.43 26.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.3 115.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.8 t -134.45 154.14 51.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.17 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -105.36 103.7 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -77.9 111.91 21.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.64 19.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.644 2.229 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -140.48 156.68 69.37 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.712 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 109.0 2.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.676 2.25 . . . . 0.0 112.355 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.559 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.8 t -99.16 157.91 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.113 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 1.4 p90 -87.6 129.01 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 40.0 t -79.37 119.01 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.1 t -82.31 26.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 204' ' ' LYS . 57.9 t -128.27 -59.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -101.81 -13.37 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.4 m170 62.16 53.37 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.95 131.13 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -40.91 114.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.464 -0.255 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.573 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 14.8 m-85 -150.54 134.99 17.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -132.3 117.99 18.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 41.7 t -63.36 163.72 10.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -99.71 -27.06 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.4 ' HB2' ' SG ' ' A' ' 209' ' ' CYS . 36.6 mm-40 -87.98 -68.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.3 p -81.49 -24.64 36.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 190' ' ' CYS . 4.0 m-80 62.71 51.06 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.23 125.69 34.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.059 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.559 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -94.09 130.24 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 201' ' ' CYS . 28.4 pt -154.16 170.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -71.37 159.86 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.573 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 2.2 ttpm? -66.33 -29.19 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 -27.21 24.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.553 ' O ' HD12 ' A' ' 197' ' ' ILE . 72.3 m -81.69 21.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.8 tt -79.55 -39.22 20.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.405 ' N ' HG23 ' A' ' 202' ' ' ILE . 34.3 m-20 -77.73 -28.4 50.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.619 ' O ' HG13 ' A' ' 175' ' ' VAL . 13.5 mmmm -84.64 32.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 201' ' ' CYS . 62.3 t -107.48 114.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.4 mp -103.09 -54.74 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.68 122.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -82.84 158.36 22.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.8 t -88.06 137.5 32.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.1 m170 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.79 0.329 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -96.95 110.75 23.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.0 t -134.68 126.46 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . 22.7 mmtt 37.2 38.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 3.4 t 70.23 42.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.1 m-70 -132.9 128.6 36.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -92.65 74.78 5.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 38.4 m-85 -65.12 140.49 58.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 26.4 p -139.76 121.87 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.162 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.09 114.48 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.5 HG23 ' CZ ' ' A' ' 167' ' ' PHE . 14.4 t -142.46 149.0 38.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -110.43 125.12 52.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.5 ' CZ ' HG23 ' A' ' 165' ' ' THR . 18.1 m-85 -100.92 106.65 45.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -5.1 15.37 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.694 2.263 . . . . 0.0 112.36 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -126.93 158.92 67.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 116.26 4.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.634 2.222 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 88.9 m -121.16 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.23 138.32 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.92 159.24 30.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 197' ' ' ILE . 3.6 m -105.82 -26.85 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.552 HG23 HG21 ' A' ' 197' ' ' ILE . 75.2 t -80.24 -62.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.9 p -86.79 -27.0 23.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 10.6 m80 72.84 40.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 179' ' ' PHE . 37.9 mt-10 -125.27 128.89 48.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 178' ' ' GLU . 1.5 p90 -36.61 119.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 198' ' ' HIS . 47.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.452 ' HB3' ' CD1' ' A' ' 162' ' ' PHE . 42.0 m-85 -134.55 137.74 44.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -123.84 124.77 43.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 52.2 t -73.15 143.3 47.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -89.97 18.41 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.855 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -128.54 -61.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 26.5 p -91.85 -16.21 27.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 60.4 48.12 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.33 124.22 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 128.86 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.552 HG21 HG23 ' A' ' 175' ' ' VAL . 43.9 pt -145.39 173.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.759 ' CE1' HG22 ' A' ' 180' ' ' VAL . 46.4 m80 -67.73 175.42 2.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -75.35 -31.88 60.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -91.1 -41.36 11.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.7 m -43.77 -25.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.7 tt -45.8 -36.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.53 -37.45 65.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.484 ' O ' HG13 ' A' ' 175' ' ' VAL . 9.7 mmmm -82.57 40.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.27 116.18 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.11 -41.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -42.29 154.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -107.76 138.82 43.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -72.5 140.37 48.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.864 0.364 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.47 112.64 24.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.94 125.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm 47.98 36.42 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 11.0 t 72.51 39.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.7 m-70 -132.29 122.45 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -90.7 76.55 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.512 ' CD2' HG13 ' A' ' 202' ' ' ILE . 42.7 m-85 -75.03 107.69 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.9 p -113.26 130.94 56.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.5 101.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 189' ' ' GLN . 14.9 t -121.67 152.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -113.0 114.54 27.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -88.48 128.47 52.83 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.674 0.749 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.92 154.51 67.64 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.535 0.683 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 115.94 4.33 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.4 t -105.62 153.41 21.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.36 116.28 28.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.3 t -44.9 160.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.425 ' H ' HG22 ' A' ' 197' ' ' ILE . 1.6 m -103.99 -34.29 8.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 204' ' ' LYS . 80.6 t -76.61 -68.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.4 p -80.29 -24.51 39.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.416 ' NE2' ' O ' ' A' ' 174' ' ' SER . 39.2 m80 64.27 47.94 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 180' ' ' VAL . 15.4 mm-40 -120.61 152.02 38.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -50.68 116.52 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 198' ' ' HIS . 81.2 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 199' ' ' LYS . 12.4 m-85 -127.28 150.14 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.92 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.431 ' HB2' HG21 ' A' ' 165' ' ' THR . 7.5 tt0 -138.52 119.46 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 42.5 t -74.43 132.27 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -83.3 24.24 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.4 ' HB2' ' SG ' ' A' ' 209' ' ' CYS . 6.5 mm100 -131.37 -55.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -98.53 -24.81 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.8 t30 73.73 45.34 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.77 120.85 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.89 121.06 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 174' ' ' SER . 46.0 pt -143.97 171.35 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.576 ' CE1' HG22 ' A' ' 180' ' ' VAL . 58.2 m80 -65.16 175.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 188' ' ' TYR . 24.0 mtpt -77.39 -28.66 52.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 202' ' ' ILE . 18.9 pttm -93.46 -38.8 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.27 -20.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' A' ' 162' ' ' PHE . 19.2 tt -51.54 -26.03 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.48 -32.95 36.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.63 ' HB2' HG11 ' A' ' 175' ' ' VAL . 1.3 mmmp? -83.4 33.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.2 t -112.82 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.11 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 89.8 mt -120.65 -38.09 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -47.72 138.39 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -84.6 140.67 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.543 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 6.5 t -71.48 141.01 50.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 62.5 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.847 0.356 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -90.2 114.64 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.83 127.8 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mmtp 39.85 43.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 87.1 m 63.57 44.96 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -137.23 131.74 32.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.77 77.17 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 39.0 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 42.4 p -140.85 123.33 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.47 109.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.1 t -134.42 150.29 50.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.59 115.55 30.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 41.0 m-85 -91.44 107.49 22.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.61 0.719 . . . . 0.0 110.86 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.461 ' HG2' ' NE2' ' A' ' 169' ' ' GLN . 54.2 Cg_endo -69.74 -6.37 18.42 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.311 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.461 ' NE2' ' HG2' ' A' ' 168' ' ' PRO . 14.7 mp0 -129.38 153.65 80.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 53.7 Cg_endo -69.86 109.5 2.35 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.653 2.235 . . . . 0.0 112.331 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 172' ' ' PHE . 21.8 m -104.58 157.33 17.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.438 ' N ' HG22 ' A' ' 171' ' ' THR . 37.7 p90 -92.86 112.89 25.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.853 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.5 t -61.86 127.82 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.0 t -83.75 19.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.588 HG23 HG21 ' A' ' 197' ' ' ILE . 90.0 t -127.38 -59.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -98.95 -16.17 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.2 m170 62.47 49.43 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -125.85 139.62 53.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -40.14 132.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.989 HG22 ' NE2' ' A' ' 198' ' ' HIS . 75.2 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 11.4 m-85 -138.31 130.06 28.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -121.99 119.52 31.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 34.8 t -65.6 162.66 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -94.83 -24.22 17.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 15.7 mt-30 -94.52 -75.09 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 31.6 p -72.67 -22.17 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 192' ' ' GLN . 7.6 m-80 59.22 52.99 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -92.12 130.02 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.69 120.97 36.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.588 HG21 HG23 ' A' ' 175' ' ' VAL . 23.1 pt -145.47 165.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.989 ' NE2' HG22 ' A' ' 180' ' ' VAL . 53.2 m80 -73.96 154.55 39.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 45.0 mtmt -57.74 -36.47 72.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -74.72 -30.35 61.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.557 ' O ' HD12 ' A' ' 197' ' ' ILE . 57.1 m -83.99 28.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 203' ' ' ASP . 20.8 tt -85.72 -38.96 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.4 ' N ' HG23 ' A' ' 202' ' ' ILE . 5.2 m-20 -80.35 -23.35 40.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.524 ' HB2' HG11 ' A' ' 175' ' ' VAL . 26.1 mmtm -84.3 29.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -104.16 121.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.43 -47.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.18 125.72 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.05 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -75.53 153.39 37.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.538 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.9 t -78.98 126.19 30.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 -179.93 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.67 110.13 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 160' ' ' HIS . 85.2 t -137.94 130.33 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.6 mmtm 36.95 45.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.1 m 64.56 46.13 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.565 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.1 m-70 -136.99 128.76 28.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -87.27 76.6 9.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -78.03 126.46 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.655 HG21 ' CZ ' ' A' ' 191' ' ' ARG . 6.1 t -147.16 135.52 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.159 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.71 115.29 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.785 HG21 ' HB2' ' A' ' 189' ' ' GLN . 10.2 t -135.43 158.57 44.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.03 118.13 33.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.455 ' CZ ' HG23 ' A' ' 165' ' ' THR . 24.9 m-85 -94.63 127.66 42.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.2 32.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.718 2.279 . . . . 0.0 112.375 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -127.11 158.84 67.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.58 0.705 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.19 2.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.718 2.279 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.633 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.9 t -96.95 157.74 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -97.22 140.36 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.473 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 48.7 t -80.09 124.49 28.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 t -86.17 22.11 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.6 t -121.87 -48.32 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.65 -11.36 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 17.5 m170 63.2 52.24 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 179' ' ' PHE . 13.6 mm-40 -131.85 136.02 47.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 178' ' ' GLU . 5.5 m-85 -36.97 126.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.591 HG22 ' CE1' ' A' ' 198' ' ' HIS . 46.4 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.591 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 11.8 m-85 -126.47 131.14 51.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 110.895 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.785 ' HB2' HG21 ' A' ' 165' ' ' THR . 45.2 tt0 -126.75 124.38 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 49.3 t -77.13 130.12 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.655 ' CZ ' HG21 ' A' ' 163' ' ' THR . 0.2 OUTLIER -81.2 19.08 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -124.95 -61.55 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.4 p -93.11 -24.56 18.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 73.54 46.64 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.8 121.55 38.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -95.85 123.06 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 201' ' ' CYS . 41.8 pt -141.97 167.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.591 ' CE1' HG22 ' A' ' 180' ' ' VAL . 44.8 m80 -70.73 151.13 45.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.87 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.591 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 23.8 tttt -57.94 -34.98 70.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -80.95 -26.07 36.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.559 ' O ' HD12 ' A' ' 197' ' ' ILE . 87.2 m -83.04 27.45 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 203' ' ' ASP . 19.5 tt -86.06 -39.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 202' ' ' ILE . 8.1 t70 -74.17 -29.82 61.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 36.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.09 128.9 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 207' ' ' ALA . 88.4 mt -126.08 -52.94 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.84 116.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.094 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 160.41 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 9.1 t -87.81 144.53 26.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 -179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.808 0.337 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.77 100.05 12.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.21 107.79 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm 62.63 41.3 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 m 63.94 39.16 8.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.897 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -132.54 124.92 29.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -92.74 77.84 4.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.01 121.19 21.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 62.5 p -123.91 127.27 47.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.157 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.9 115.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.459 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 10.1 t -134.63 143.29 47.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -99.89 108.09 20.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.459 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 45.6 m-85 -81.19 127.41 74.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.661 0.743 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -26.69 27.46 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.244 . . . . 0.0 112.373 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -129.94 153.38 80.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 110.15 2.48 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.2 t -97.73 153.64 18.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 1.3 p90 -81.7 118.77 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -54.04 160.49 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.1 t -103.16 -29.05 11.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.57 -66.82 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 16.7 p -81.19 -22.31 38.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.48 45.17 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 179' ' ' PHE . 54.3 mt-10 -127.42 133.79 49.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.8 p90 -35.38 105.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 198' ' ' HIS . 83.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.567 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 23.1 m-85 -133.41 143.12 48.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -139.61 132.67 29.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.7 t -73.83 162.71 28.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -90.82 -20.08 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.83 -70.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 15.4 p -72.07 -16.24 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 50.3 48.21 22.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -82.25 118.76 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.31 121.55 33.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 202' ' ' ILE . 40.0 pt -145.74 175.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.449 ' CE1' HG22 ' A' ' 180' ' ' VAL . 64.9 m80 -70.97 175.24 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.668 ' O ' HG22 ' A' ' 202' ' ' ILE . 5.9 mtpm? -70.51 -43.67 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.4 pptp? -80.15 -36.08 35.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 1.8 m -51.02 -22.5 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 199' ' ' LYS . 16.6 tt -52.79 -38.33 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.6 -32.73 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -83.27 37.16 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.8 t -114.23 115.35 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.9 mt -110.65 -43.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.64 163.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 3.8 ttmp? -110.92 162.85 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 208' ' ' LYS . 4.2 t -86.8 109.42 19.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.954 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.812 0.339 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -74.57 118.11 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.8 t -139.8 122.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 42.04 44.9 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 4.2 m 63.31 42.47 6.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -137.16 119.15 15.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -84.32 79.35 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -73.62 139.14 45.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.6 p -141.5 125.86 17.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.2 106.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.1 t -125.1 160.97 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.159 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -112.56 115.79 29.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -89.56 110.64 40.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.628 0.728 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -15.09 36.69 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 0.0 112.355 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -129.97 160.91 62.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.923 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.32 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 m -102.09 147.36 26.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -89.58 109.43 20.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.87 159.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 p -99.36 -28.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.6 -73.48 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.7 p -75.31 -22.64 57.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 63.13 44.42 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.54 142.79 49.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -42.67 123.07 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.608 HG22 ' CE1' ' A' ' 198' ' ' HIS . 92.8 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.443 ' CZ ' ' HD2' ' A' ' 199' ' ' LYS . 23.3 m-85 -149.17 146.22 27.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -145.62 114.75 7.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.76 161.11 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -96.12 -20.47 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -96.81 -70.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.943 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -72.55 -20.63 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 56.67 51.58 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.24 126.23 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.48 131.71 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 29.7 pt -151.39 151.51 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' HIS . . . . . 0.608 ' CE1' HG22 ' A' ' 180' ' ' VAL . 73.0 m80 -61.03 157.66 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 188' ' ' TYR . 0.2 OUTLIER -63.28 -14.31 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -98.51 -23.03 15.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.652 ' O ' HG23 ' A' ' 205' ' ' VAL . 88.0 m -83.0 16.56 2.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.9 tt -81.13 -38.98 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 202' ' ' ILE . 0.7 OUTLIER -75.12 -28.79 60.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 201' ' ' CYS . 1.6 mptt -87.68 32.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 201' ' ' CYS . 55.0 t -110.01 111.48 36.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.167 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 97.5 mt -111.23 -46.89 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -37.39 155.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -101.37 164.0 11.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.6 t -91.39 138.62 31.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 210' ' ' THR . 15.0 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.1 t -163.72 170.56 16.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.854 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.1 p -166.77 150.97 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -143.7 173.16 24.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.452 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 m -121.14 129.81 53.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.846 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.8 t -47.2 -46.7 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.34 140.07 4.52 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.525 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -117.36 125.92 51.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -133.61 146.6 51.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.28 170.16 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 140.09 57.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.64 42.31 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.74 0.305 . . . . 0.0 111.118 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 149' ' ' ILE . 14.7 tt -128.81 117.57 44.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.186 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -95.66 -58.85 2.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 152' ' ' ALA . 34.9 tp60 -166.79 147.51 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.451 ' N ' ' HG3' ' A' ' 151' ' ' GLN . . . -142.45 126.79 17.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.086 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.51 160.15 8.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 161' ' ' GLU . 95.6 t -137.92 141.86 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.141 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -93.53 125.85 38.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -103.88 99.48 9.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.4 t -121.72 112.64 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 2.5 mptp? 58.66 41.1 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 5.9 t 65.63 37.69 5.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -134.6 125.96 28.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.468 ' HB3' HG11 ' A' ' 154' ' ' VAL . 40.2 mt-10 -92.29 81.73 4.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.28 121.63 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.8 p -126.64 123.44 37.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.115 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.36 104.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.1 t -130.45 149.06 52.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.167 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.572 ' CE2' ' NE2' ' A' ' 186' ' ' GLN . 15.2 m-85 -105.69 108.71 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.35 111.46 20.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.66 0.743 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -7.03 20.02 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -129.19 154.29 80.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 87.6 m -116.7 135.38 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -78.11 136.22 37.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.31 159.47 17.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.416 ' H ' HG22 ' A' ' 197' ' ' ILE . 20.5 m -94.72 -23.64 17.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.0 t -96.48 -75.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.137 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.9 p -67.7 -22.2 65.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 40.3 m80 62.34 50.91 3.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -122.59 145.32 48.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -55.25 119.47 5.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 198' ' ' HIS . 25.4 t -98.81 65.21 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.541 ' CG ' ' O ' ' A' ' 181' ' ' TRP . 4.7 p-90 -124.38 37.29 4.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.47 139.39 20.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.521 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.7 128.23 35.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.886 0.374 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.433 ' O ' ' ND2' ' A' ' 184' ' ' ASN . 0.2 OUTLIER 61.44 45.56 8.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -124.91 99.89 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.572 ' NE2' ' CE2' ' A' ' 166' ' ' PHE . 5.4 tp-100 -70.08 131.81 44.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -114.41 -156.28 11.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.459 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.413 ' CE2' HD12 ' A' ' 202' ' ' ILE . 11.4 m-85 -140.92 132.82 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 110.883 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -132.47 119.73 20.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.55 162.07 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -95.43 -24.37 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.34 -75.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.9 p -71.34 -24.0 62.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.37 51.95 2.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.49 129.99 36.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.83 126.15 40.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 201' ' ' CYS . 29.9 pt -149.86 153.62 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.174 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.3 m80 -67.02 159.94 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -59.2 -35.86 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -76.04 -23.28 55.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.615 ' O ' HD12 ' A' ' 197' ' ' ILE . 66.2 m -87.91 24.5 1.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.413 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.1 tt -87.61 -30.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.82 -19.54 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.537 ' HB2' HG11 ' A' ' 175' ' ' VAL . 11.4 mmtp -89.23 25.02 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.41 117.68 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 25.6 mm -116.17 -47.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.31 141.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -89.55 156.97 18.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 3.5 t -83.48 133.51 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.521 HG23 ' N ' ' A' ' 211' ' ' GLY . 10.0 t -86.91 -47.21 9.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 210' ' ' THR . . . 103.57 154.04 23.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.8 t -123.2 140.41 53.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 110.834 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 179.922 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -151.73 137.4 17.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.873 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.6 m -129.66 162.46 28.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.4 174.4 39.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.7 m -146.41 162.54 38.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.934 0.397 . . . . 0.0 110.792 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.4 m -103.8 -62.1 1.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.04 141.47 0.63 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -148.17 134.43 19.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -139.58 133.61 30.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -151.7 128.39 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.33 132.98 6.45 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -133.71 165.96 23.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 0.0 111.104 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.7 tt -140.43 151.35 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -79.48 122.56 26.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -66.53 151.13 47.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -165.39 147.38 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.089 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.413 ' HE3' ' CE1' ' A' ' 155' ' ' HIS . 15.3 pttt -150.2 168.23 24.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.6 t -114.51 129.54 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.413 ' CE1' ' HE3' ' A' ' 153' ' ' LYS . 32.0 m170 -109.01 116.56 32.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -82.21 110.43 17.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 160' ' ' HIS . 70.9 t -134.12 126.29 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.607 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.0 mptt 36.41 46.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 66.2 m 63.14 42.35 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 94.9 m-70 -136.99 131.77 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -96.36 79.18 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -69.45 133.84 48.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.3 p -136.7 125.53 24.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.09 113.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 189' ' ' GLN . 15.3 t -133.02 158.41 42.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.172 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.03 100.88 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.437 ' CZ ' ' CB ' ' A' ' 196' ' ' ALA . 84.1 m-85 -75.29 118.96 74.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.606 0.717 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -9.03 25.1 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.656 2.237 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.63 158.01 54.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 110.1 2.48 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.7 2.267 . . . . 0.0 112.334 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.52 HG21 ' CB ' ' A' ' 196' ' ' ALA . 9.8 t -98.14 150.71 21.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 177' ' ' HIS . 2.1 t80 -76.97 107.66 9.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 t -57.25 127.16 30.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.1 p -82.92 25.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.614 HG23 HG21 ' A' ' 197' ' ' ILE . 88.8 t -131.91 -53.63 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -106.85 -17.91 14.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 4.8 m170 72.8 49.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -136.96 140.13 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -46.16 120.4 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.734 HG22 ' CE1' ' A' ' 198' ' ' HIS . 60.0 t -99.78 84.25 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -133.68 -34.49 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -67.32 -159.74 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 25.0 mt 62.5 44.14 7.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.355 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.57 43.4 12.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt 42.58 43.56 3.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -127.37 137.0 52.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -156.65 -140.6 2.99 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.501 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 199' ' ' LYS . 17.8 m-85 -148.83 132.77 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.922 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.591 ' HB2' HG21 ' A' ' 165' ' ' THR . 21.7 tt0 -132.34 127.39 35.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.9 t -69.49 162.06 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -92.31 -18.64 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -103.72 -73.87 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.453 ' C ' ' CG ' ' A' ' 194' ' ' ASN . 27.8 p -72.48 -14.46 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.453 ' CG ' ' C ' ' A' ' 193' ' ' CYS . 1.0 OUTLIER 48.47 53.44 12.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.93 126.14 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 171' ' ' THR . . . -96.38 121.14 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 201' ' ' CYS . 40.2 pt -143.61 163.21 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.734 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.7 m80 -67.87 152.13 46.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 188' ' ' TYR . 47.5 mtpt -57.32 -27.32 62.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -84.7 -25.36 28.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.722 ' O ' HD12 ' A' ' 197' ' ' ILE . 77.4 m -85.13 26.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.7 tt -87.1 -33.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.79 -23.98 31.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -89.24 28.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 201' ' ' CYS . 86.2 t -104.49 119.7 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.088 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 87.5 mt -114.28 -54.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.44 118.0 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -73.59 158.59 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.9 t -86.77 131.05 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t -104.78 -21.54 13.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 139.92 -134.57 6.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.5 m -91.91 129.28 37.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.85 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.079 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -100.69 139.04 36.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.85 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.4 m -160.87 151.04 17.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.82 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.79 -179.92 26.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.551 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.4 t -161.83 123.98 2.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.85 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 t -132.25 159.6 38.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.848 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.18 105.43 0.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.492 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -165.57 151.49 9.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.792 0.33 . . . . 0.0 110.936 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -134.28 171.45 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.18 147.2 30.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.922 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.42 150.5 21.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.07 106.45 5.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.735 0.302 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.8 tt -149.96 138.7 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -103.78 173.73 6.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -137.92 175.9 9.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.36 159.15 42.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.73 118.28 5.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 161' ' ' GLU . 84.6 t -100.57 148.58 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -110.46 138.92 46.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -104.05 102.15 11.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -127.78 108.02 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.11 43.24 21.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 66.04 35.87 6.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CB ' ' CE2' ' A' ' 162' ' ' PHE . 97.7 m-70 -129.27 117.86 21.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.413 ' HB3' HG11 ' A' ' 154' ' ' VAL . 5.7 mp0 -76.75 50.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 160' ' ' HIS . 37.2 m-85 -60.2 105.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -122.16 136.27 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.12 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.56 124.86 3.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.42 HG21 ' HB2' ' A' ' 189' ' ' GLN . 15.2 t -143.2 153.49 42.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -102.65 128.82 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.05 109.33 58.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.707 2.272 . . . . 0.0 112.309 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -144.76 157.51 54.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 127.19 14.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 88.4 m -128.96 138.72 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -75.39 129.73 37.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.0 t -60.7 157.4 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.543 ' H ' HG22 ' A' ' 197' ' ' ILE . 17.9 t -98.63 -29.2 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.445 HG11 ' HB2' ' A' ' 204' ' ' LYS . 99.0 t -85.16 -74.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.1 p -71.09 -23.87 62.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 63.54 53.88 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 179' ' ' PHE . 20.8 mt-10 -134.44 130.86 37.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 178' ' ' GLU . 8.5 p90 -34.73 123.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 198' ' ' HIS . 84.1 t -103.72 87.78 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -172.78 110.91 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 151.37 -132.45 3.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 183' ' ' LEU . 7.7 tt -44.92 -43.93 9.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.06 85.57 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 186' ' ' GLN . 16.5 pttm -76.89 -42.22 40.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 185' ' ' LYS . 35.8 mt-30 -78.88 136.94 37.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -140.95 -136.98 3.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.48 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -154.08 140.55 18.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.42 ' HB2' HG21 ' A' ' 165' ' ' THR . 66.5 tt0 -140.81 109.69 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -58.78 161.42 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -95.13 -19.84 19.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -98.84 -74.57 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.47 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 30.7 p -71.3 -12.63 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 193' ' ' CYS . 0.7 OUTLIER 47.16 52.01 12.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.92 122.68 32.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.79 115.31 27.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.09 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 174' ' ' SER . 27.3 pt -140.64 173.91 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.477 ' CE1' HG22 ' A' ' 180' ' ' VAL . 58.8 m80 -63.59 172.61 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -78.1 -15.43 58.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.8 pptp? -106.03 -32.21 8.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 3.4 m -55.43 -16.68 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.59 -26.83 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.85 -31.72 61.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.445 ' HB2' HG11 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -92.67 32.87 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 201' ' ' CYS . 54.5 t -110.69 89.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.8 mt -91.25 -44.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.62 135.19 1.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -79.1 153.74 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.477 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 8.1 t -79.57 113.26 17.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 45.4 p -104.82 39.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -44.86 -40.71 6.94 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.471 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.1 t -54.18 138.85 37.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 110.866 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.121 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 81.7 p -153.24 123.6 7.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.865 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.1 m -139.01 153.3 48.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -134.45 174.21 21.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.1 t -165.2 163.1 20.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.5 p -169.24 143.54 2.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.847 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -149.55 92.35 0.14 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.49 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -118.23 169.13 9.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.904 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -128.08 158.14 38.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -134.56 162.21 32.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.5 161.13 22.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.44 158.51 16.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.332 . . . . 0.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 149' ' ' ILE . 4.2 tp -78.15 121.7 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -68.0 104.03 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -101.24 141.04 34.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.07 173.41 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.096 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -143.96 151.39 39.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.5 t -119.27 133.52 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -106.86 136.53 46.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.832 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -112.34 123.78 51.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.6 t -140.01 107.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.508 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.5 mttm 62.36 47.91 5.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.61 37.92 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.522 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 99.6 m-70 -131.04 113.55 14.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -84.13 76.3 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -71.9 138.79 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 73.3 p -140.72 128.71 22.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.56 116.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 15.3 t -138.67 142.07 39.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 186' ' ' GLN . 20.7 m-85 -106.88 110.62 22.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 13.3 m-85 -88.13 111.37 42.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.749 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -16.16 37.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.301 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -114.23 154.29 46.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 109.57 2.35 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.661 2.24 . . . . 0.0 112.317 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 57.1 m -113.69 135.01 54.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 7.3 p90 -77.14 115.67 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -44.93 159.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.561 ' H ' HG22 ' A' ' 197' ' ' ILE . 18.2 m -99.29 -26.12 14.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.1 t -88.69 -71.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.8 p -75.23 -23.78 57.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.833 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.5 m80 64.21 51.87 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 179' ' ' PHE . 62.2 mt-10 -133.18 131.53 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 178' ' ' GLU . 27.3 p90 -32.91 113.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.647 HG22 ' CE1' ' A' ' 198' ' ' HIS . 68.1 t -93.74 93.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -174.63 107.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -126.52 -119.7 2.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.542 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.9 tt -120.04 108.51 14.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 44.86 40.48 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -101.63 149.24 24.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 7.6 pt20 -121.4 155.22 35.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -118.67 -137.8 5.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -150.4 129.82 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 110.946 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.457 ' HB2' HG21 ' A' ' 165' ' ' THR . 12.4 tt0 -123.72 131.62 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 11.4 t -76.22 161.81 28.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -93.23 -20.38 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.24 -75.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.6 p -69.92 -15.18 63.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 51.6 52.61 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.19 123.39 33.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -98.29 120.99 39.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 174' ' ' SER . 38.2 pt -141.36 171.97 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.647 ' CE1' HG22 ' A' ' 180' ' ' VAL . 49.7 m80 -63.01 -177.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -79.21 -37.15 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -87.32 -37.18 17.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 4.6 m -49.07 -18.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.41 ' HA ' HD11 ' A' ' 197' ' ' ILE . 16.6 tt -54.97 -32.5 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.81 -35.56 64.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.541 ' HB2' HG11 ' A' ' 175' ' ' VAL . 6.9 mmpt? -84.68 35.05 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.29 118.7 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 206' ' ' ILE . 3.8 mp -119.65 -56.86 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -35.02 112.4 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -64.38 150.25 46.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.522 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.8 t -73.07 137.19 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 77.6 p -113.81 -42.57 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 113.92 -41.95 2.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.482 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.0 t -115.46 163.73 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 110.862 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.094 179.894 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 t -154.27 152.27 30.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 0.0 110.854 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.8 p -132.47 154.28 50.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -141.29 -170.99 12.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.471 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.8 t -115.52 165.32 13.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 0.0 110.825 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.3 m -152.1 160.94 43.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -169.6 157.43 29.13 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -123.49 173.64 7.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -155.07 162.56 41.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -145.06 166.39 25.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -111.31 112.96 3.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.454 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.36 42.23 1.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.806 0.336 . . . . 0.0 111.08 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 149' ' ' ILE . 6.9 tt -126.46 126.51 69.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -146.14 151.38 37.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -143.76 131.92 21.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.951 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.43 175.85 9.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.075 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 135.89 47.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.7 141.16 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.094 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -116.16 107.92 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -76.22 113.4 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.78 106.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.495 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.0 mptp? 60.62 42.59 13.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 63.3 m 64.41 37.85 8.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.3 m-70 -131.47 119.02 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -83.07 79.45 9.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -72.76 135.75 45.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 p -140.01 123.32 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -51.14 112.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -141.02 148.54 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -94.3 134.19 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -107.71 105.02 55.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.637 0.732 . . . . 0.0 110.901 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -3.53 12.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -128.92 153.54 80.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.709 2.273 . . . . 0.0 112.333 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.5 m -126.87 136.04 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -83.57 123.03 29.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 3.0 t -54.23 156.39 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 33.9 p -100.79 -17.41 16.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.3 t -97.77 -68.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -80.03 -14.86 58.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.5 m170 57.49 49.09 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 179' ' ' PHE . 70.9 mt-10 -128.29 130.94 48.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.7 p90 -35.46 134.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 198' ' ' HIS . 63.6 t -111.6 79.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -174.42 153.89 2.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 83.36 -71.62 2.97 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.57 -43.4 20.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -113.51 89.34 3.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -74.75 -48.5 25.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -80.98 127.89 33.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -136.15 -157.35 7.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 16.0 m-85 -136.33 140.33 43.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -135.92 115.22 12.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 14.4 t -63.09 138.34 58.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -85.67 20.48 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -132.32 -64.52 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.8 p -86.94 -15.52 38.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 59.48 54.06 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.39 128.06 52.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 129.9 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 33.2 pt -151.03 153.68 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.583 ' CE1' HG22 ' A' ' 180' ' ' VAL . 60.8 m80 -64.57 161.65 17.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.53 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 7.6 mtpm? -64.04 -27.2 68.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -22.56 24.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.2 m -83.98 14.57 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 203' ' ' ASP . 18.1 tt -79.47 -41.87 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.453 ' N ' HG23 ' A' ' 202' ' ' ILE . 64.0 m-20 -73.84 -26.81 60.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -88.07 38.16 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.5 t -111.02 112.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.411 ' O ' ' C ' ' A' ' 207' ' ' ALA . 77.4 mt -106.76 -50.78 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.14 143.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.076 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -97.23 137.57 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.539 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.5 t -65.47 140.52 58.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.6 p -129.11 36.52 4.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.168 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.1 -96.26 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.452 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 60.5 p -56.7 113.68 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.87 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.918 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.3 m -147.6 170.38 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.894 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 t -162.15 144.77 11.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -129.54 153.6 20.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 87.3 p -168.04 136.65 2.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.842 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.7 m -144.33 119.27 9.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -105.76 138.1 14.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.437 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -166.63 134.32 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.28 167.37 9.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -124.54 -58.89 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 163.76 106.67 0.2 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.54 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.06 -8.34 57.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 0.0 111.038 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.7 tp -57.16 131.35 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -102.94 129.9 49.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -86.06 125.14 33.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.9 165.82 26.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -166.37 118.78 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.48 135.82 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -98.94 104.39 16.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -88.87 109.13 19.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.9 t -132.12 136.92 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.606 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 21.6 mmtm 38.96 43.07 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 2.2 m 64.75 41.7 4.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 87.2 m-70 -136.27 142.17 43.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.73 75.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -66.43 105.13 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 p -109.95 121.25 44.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.99 105.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -127.9 149.9 50.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -107.18 105.08 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.62 114.58 33.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -6.96 19.81 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.751 2.3 . . . . 0.0 112.383 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -140.1 159.5 63.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.599 0.714 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 179' ' ' PHE . 53.7 Cg_endo -69.78 116.5 4.59 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.666 2.244 . . . . 0.0 112.327 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.9 t -114.38 156.87 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.75 146.98 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.9 t -79.53 160.05 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.477 ' H ' HG22 ' A' ' 197' ' ' ILE . 46.6 t -101.84 -30.38 11.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.46 -73.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -75.02 -25.12 58.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 63.18 50.13 3.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -123.2 135.59 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 170' ' ' PRO . 4.2 t80 -39.63 122.18 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.613 HG22 ' CE1' ' A' ' 198' ' ' HIS . 22.5 t -98.88 83.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -173.88 148.21 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.954 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 98.06 -100.91 2.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.449 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.2 mt -52.57 -55.65 20.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.917 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -98.51 117.11 32.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -108.23 44.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -164.94 144.58 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.53 -176.04 27.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -122.35 135.65 54.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -124.83 121.82 35.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 25.9 t -64.21 163.01 13.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -90.4 -21.82 21.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -103.25 -73.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.5 p -71.36 -12.15 61.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 194' ' ' ASN . 5.1 p-10 43.05 52.87 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -91.24 130.32 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.19 122.4 35.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 174' ' ' SER . 28.6 pt -142.81 147.82 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.613 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.2 m80 -57.69 151.46 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.84 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -57.27 -19.7 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -90.99 -27.41 18.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.458 ' O ' HD12 ' A' ' 197' ' ' ILE . 84.9 m -82.62 20.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.21 -37.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -82.84 -24.22 33.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -85.28 31.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.7 t -101.52 127.0 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.43 -44.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -53.75 125.07 17.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.79 167.29 11.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.468 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 7.8 t -88.31 113.13 23.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.8 p -84.14 34.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.141 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -81.77 -41.65 9.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 43.4 t -57.27 164.09 1.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 110.821 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 179.877 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.2 m -129.09 87.23 2.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.368 . . . . 0.0 110.885 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.9 m -75.94 -58.55 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.813 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.66 164.06 36.74 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.54 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.1 m -129.71 106.29 8.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.0 110.853 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.5 p -153.66 172.55 17.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.86 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 147.06 -171.16 27.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.505 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -150.05 166.73 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -102.1 167.16 10.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.82 162.02 26.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.04 154.39 12.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.557 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -173.39 173.38 3.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.313 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.4 tt -141.02 135.27 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -111.12 150.57 29.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -152.01 150.14 29.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.615 ' CB ' ' HB3' ' A' ' 164' ' ' ALA . . . -79.24 165.28 23.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.451 ' HD2' ' CD2' ' A' ' 155' ' ' HIS . 0.0 OUTLIER -143.94 164.11 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 161' ' ' GLU . 90.4 t -86.27 129.14 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.451 ' CD2' ' HD2' ' A' ' 153' ' ' LYS . 52.6 m-70 -107.33 144.05 34.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -96.29 112.0 23.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 158' ' ' LYS . 97.3 t -140.65 135.53 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mptt 36.31 45.19 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 99.0 m 63.31 46.08 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.1 m-70 -136.3 178.37 7.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.448 ' HB3' HG13 ' A' ' 154' ' ' VAL . 33.7 mt-10 -130.66 50.23 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.538 ' CD2' HG13 ' A' ' 202' ' ' ILE . 23.2 m-85 -51.43 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.46 HG21 ' NH2' ' A' ' 191' ' ' ARG . 7.3 t -117.95 136.67 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.182 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.615 ' HB3' ' CB ' ' A' ' 152' ' ' ALA . . . -43.55 124.16 3.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.418 HG21 ' HB2' ' A' ' 189' ' ' GLN . 13.6 t -145.75 159.89 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -124.94 109.89 13.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -85.26 119.27 72.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.276 . . . . 0.0 112.309 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -147.74 158.28 42.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.614 0.721 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 124.48 11.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.481 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.2 t -117.68 157.47 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -84.78 115.75 22.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.478 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 49.1 t -64.81 126.56 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.54 ' H ' HG22 ' A' ' 197' ' ' ILE . 23.0 t -87.12 26.96 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.625 HG23 HG21 ' A' ' 197' ' ' ILE . 53.5 t -129.76 -55.34 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.89 -16.03 14.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.9 m170 63.59 51.87 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -134.99 132.63 38.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -40.25 109.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.767 HG22 ' CE1' ' A' ' 198' ' ' HIS . 82.6 t -82.51 79.62 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -175.33 115.77 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 174.68 -109.26 0.29 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.7 tp -86.74 -44.51 11.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -80.98 151.91 28.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -151.5 -179.73 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 65.64 54.36 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.24 -156.03 1.09 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.94 143.87 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.835 0.35 . . . . 0.0 110.926 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.418 ' HB2' HG21 ' A' ' 165' ' ' THR . 46.0 tt0 -143.52 119.71 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 28.2 t -63.46 163.08 11.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.46 ' NH2' HG21 ' A' ' 163' ' ' THR . 21.3 mmt-85 -98.03 -22.79 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -92.28 -68.4 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.99 -25.36 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 63.53 50.15 2.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -89.44 119.39 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.076 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.481 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -92.58 121.04 33.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.625 HG21 HG23 ' A' ' 175' ' ' VAL . 43.1 pt -144.18 174.91 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.767 ' CE1' HG22 ' A' ' 180' ' ' VAL . 52.9 m80 -68.42 178.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.584 ' O ' HG22 ' A' ' 202' ' ' ILE . 37.3 tttm -73.84 -53.88 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 202' ' ' ILE . 10.7 pttm -70.97 -43.7 67.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 18.7 m -43.16 -22.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 199' ' ' LYS . 19.3 tt -50.37 -38.26 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -34.95 71.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.428 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 36.8 mmtt -82.72 36.82 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.55 126.17 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.65 -55.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -37.98 139.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.103 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -90.07 159.36 16.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 5.2 t -79.54 110.18 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.8 t -68.54 -27.87 66.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 69.24 -84.24 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 82.3 p -68.52 140.0 55.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.893 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 179.973 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 t -151.58 137.39 18.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.934 0.397 . . . . 0.0 110.84 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.6 p -170.82 122.45 0.6 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.96 -81.06 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.9 t 67.97 42.22 1.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.875 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -56.28 155.39 6.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.1 157.56 25.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -144.3 109.23 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.749 0.309 . . . . 0.0 110.931 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -154.6 139.98 17.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -170.75 124.64 0.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.08 -112.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.23 160.38 18.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 5.1 tp -74.74 138.06 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.126 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -117.01 127.63 54.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -145.51 119.21 9.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.45 176.09 8.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.6 95.24 4.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.931 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.58 127.97 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -97.73 157.98 15.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.46 ' CE1' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m-70 -125.22 105.49 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 88.7 t -137.83 120.68 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 52.91 39.44 29.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.3 t 65.99 40.01 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -132.01 119.94 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.46 ' OE1' ' CE1' ' A' ' 156' ' ' HIS . 6.6 mm-40 -78.35 70.58 4.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -71.48 97.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.1 t -112.12 134.44 53.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.25 120.32 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.57 HG23 ' CE1' ' A' ' 167' ' ' PHE . 5.1 t -139.29 149.74 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -105.82 117.46 34.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 165' ' ' THR . 18.8 m-85 -91.13 109.73 37.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.728 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -7.56 21.37 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.701 2.267 . . . . 0.0 112.348 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -136.04 160.72 66.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 121.9 8.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.751 2.301 . . . . 0.0 112.326 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.8 m -115.66 150.18 37.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.412 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 32.8 p90 -96.74 111.43 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 12.7 t -47.56 157.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 p -97.56 -22.67 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.763 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.5 t -92.81 -74.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -73.27 -23.62 60.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 63.56 46.27 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.98 148.66 43.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -45.01 130.57 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.559 HG22 ' CE1' ' A' ' 198' ' ' HIS . 69.1 t -108.79 75.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 3.0 p-90 -173.9 150.94 1.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 109.47 -65.02 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.521 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.08 142.44 25.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.502 ' O ' ' NE2' ' A' ' 186' ' ' GLN . 9.5 m-20 -57.13 -30.32 64.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.844 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -67.08 143.6 56.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 184' ' ' ASN . 16.1 mm-40 -91.48 176.21 6.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.939 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -112.09 166.75 12.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.52 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.534 ' CZ ' ' HG2' ' A' ' 199' ' ' LYS . 14.5 m-85 -104.0 131.98 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -129.78 118.71 22.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 8.9 t -62.68 161.68 11.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -96.49 -20.71 18.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -97.21 -71.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 21.5 p -74.18 -20.55 60.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 57.83 53.51 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.38 128.7 41.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -94.84 125.79 39.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 201' ' ' CYS . 23.7 pt -152.09 147.27 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.076 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.559 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.5 m80 -60.01 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.534 ' HG2' ' CZ ' ' A' ' 188' ' ' TYR . 41.7 mttt -58.67 -22.83 58.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -22.85 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.576 ' O ' HD12 ' A' ' 197' ' ' ILE . 79.2 m -86.77 27.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 tt -88.27 -30.39 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -80.58 -25.45 38.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.763 ' HB2' HG11 ' A' ' 175' ' ' VAL . 24.3 mttm -88.77 31.48 0.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.58 110.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' ALA . 46.7 mm -109.27 -54.3 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.38 145.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.131 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -91.92 167.11 12.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.6 t -98.64 124.97 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p -78.2 -45.69 22.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 42.92 -97.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.505 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 73.8 m -78.52 120.77 23.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.378 . . . . 0.0 110.886 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.919 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 93.2 p -174.59 176.66 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.851 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.1 t -154.49 174.91 14.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.71 163.4 14.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 m -149.65 173.55 13.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.378 . . . . 0.0 110.862 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.8 t -134.71 174.33 10.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.15 121.27 2.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.481 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -143.4 176.38 9.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.778 0.323 . . . . 0.0 110.893 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -148.34 160.77 42.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -133.38 124.68 27.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.07 -153.95 15.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -172.63 160.22 4.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 111.08 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.7 tp -63.06 140.64 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -151.68 143.48 23.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.02 150.89 24.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.89 146.33 14.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -159.63 145.68 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 163' ' ' THR . 91.4 t -104.66 108.99 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -74.38 144.73 44.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -110.57 107.12 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.833 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 160' ' ' HIS . 58.2 t -129.65 131.46 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.078 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 14.2 mptt 37.41 45.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 59.1 m 63.47 41.22 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.545 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -133.25 120.88 21.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.6 70.39 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -75.69 103.68 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.525 ' HB ' HG22 ' A' ' 154' ' ' VAL . 3.1 t -119.9 138.94 53.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.52 119.82 2.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.5 t -141.25 141.39 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -97.21 118.85 34.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -90.63 108.84 30.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -5.68 16.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.725 2.284 . . . . 0.0 112.289 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -133.88 153.95 80.15 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 m -108.62 156.35 19.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 172' ' ' PHE . 19.0 p90 -103.74 131.95 50.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.06 155.28 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 m -100.49 -24.29 14.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.23 -72.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -74.43 -21.29 59.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 8.2 m170 63.2 47.67 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -124.52 143.85 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -48.23 128.17 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' A' ' 198' ' ' HIS . 21.3 t -99.93 79.89 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -172.44 109.47 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 149.05 -94.53 0.16 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -61.55 -62.48 1.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 0.0 110.925 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -96.27 79.98 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -47.18 -40.84 16.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.922 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 185' ' ' LYS . 7.6 pt20 -95.74 175.29 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -164.95 -155.87 8.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 199' ' ' LYS . 20.8 m-85 -124.78 135.51 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.46 112.92 9.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.9 t -57.72 159.17 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -96.98 -16.99 20.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -97.85 -68.43 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.68 -23.45 53.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.98 53.33 3.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.75 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.51 118.75 31.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 29.8 pt -140.02 158.12 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.407 ' CE1' HG22 ' A' ' 180' ' ' VAL . 68.1 m80 -62.64 161.35 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 188' ' ' TYR . 50.9 tttt -68.75 -11.17 60.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -105.19 -20.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.69 15.66 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 203' ' ' ASP . 17.6 tt -79.27 -40.09 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.425 ' N ' HG23 ' A' ' 202' ' ' ILE . 6.8 p-10 -71.55 -25.52 62.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.407 ' HD2' ' CG ' ' A' ' 203' ' ' ASP . 0.6 OUTLIER -90.54 37.25 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.44 96.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.68 -44.82 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -41.75 154.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.08 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -99.31 159.96 14.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -85.51 145.14 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 211' ' ' GLY . 8.9 t -106.51 -40.81 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 210' ' ' THR . . . 72.2 46.28 35.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.1 t -97.64 128.48 44.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.854 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.1 t -171.71 173.37 4.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.8 m -149.31 173.24 13.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -149.99 178.69 27.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.8 t -150.75 166.97 28.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -132.84 168.56 18.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -101.46 -175.04 28.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.2 166.78 29.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -135.32 165.65 24.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -164.94 152.14 11.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.09 111.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.465 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.5 170.13 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.084 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 149' ' ' ILE . 18.4 tt -109.95 121.88 63.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 151' ' ' GLN . 30.0 tptt -70.85 124.28 23.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 150' ' ' LYS . 17.8 mp0 -35.89 130.74 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.91 128.22 18.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -137.07 153.76 50.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 163' ' ' THR . 68.4 t -99.88 131.69 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -93.87 128.43 40.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -101.69 99.62 9.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 160' ' ' HIS . 90.1 t -117.87 134.67 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.568 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 1.5 mmmp? 33.79 47.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.864 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 64.3 m 64.61 45.08 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.5 m-70 -135.09 118.75 17.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.83 75.56 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -72.34 144.53 48.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.419 HG22 HG22 ' A' ' 154' ' ' VAL . 81.7 p -134.01 127.33 32.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.82 119.17 3.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -143.99 153.26 42.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -116.5 112.77 21.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -87.74 111.18 40.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.668 0.747 . . . . 0.0 110.863 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -6.39 18.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.328 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -128.83 152.53 79.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.61 0.719 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.67 2.247 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.0 m -113.9 138.47 50.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -66.93 129.72 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.1 t -72.04 159.26 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 197' ' ' ILE . 29.1 t -98.09 -29.21 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.47 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.9 t -87.55 -75.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.3 p -72.17 -22.11 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 60.91 45.45 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.35 169.67 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -62.84 122.86 17.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 198' ' ' HIS . 48.4 t -110.24 88.14 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.12 157.86 43.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.967 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 147.89 143.78 3.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.71 -44.62 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 0.0 110.949 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -111.77 51.79 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -127.67 87.16 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.464 ' HG2' ' N ' ' A' ' 187' ' ' GLY . 14.5 tt0 -71.0 146.89 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.464 ' N ' ' HG2' ' A' ' 186' ' ' GLN . . . -127.0 -151.5 7.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.439 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -154.43 134.59 13.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -132.58 127.85 35.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.4 t -71.76 162.02 30.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -88.72 -20.02 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -105.61 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 25.7 p -66.56 -10.61 47.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 42.57 49.92 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.75 28.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -94.94 122.05 37.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.464 HG21 HG23 ' A' ' 175' ' ' VAL . 36.4 pt -145.54 173.75 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.576 ' CE1' HG22 ' A' ' 180' ' ' VAL . 74.2 m80 -66.9 176.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -24.13 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -96.57 -38.11 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.48 -25.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 203' ' ' ASP . 19.2 tt -49.02 -39.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.153 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 202' ' ' ILE . 39.6 m-20 -70.25 -32.72 70.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.47 ' HB2' HG11 ' A' ' 175' ' ' VAL . 27.5 mmmt -86.04 38.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.4 125.51 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 80.7 mt -120.64 -40.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.14 136.09 42.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.443 ' HG3' ' NZ ' ' A' ' 158' ' ' LYS . 7.0 mtpm? -83.1 167.05 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.401 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.3 t -84.6 122.18 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 31.4 p -86.58 -46.53 10.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 80.32 103.46 0.29 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.5 p -58.22 152.37 17.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.863 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.145 179.862 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.1 t -117.23 135.15 54.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.88 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.4 m -124.14 142.04 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.91 118.11 0.85 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.455 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.3 t -163.53 122.99 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.884 0.373 . . . . 0.0 110.869 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 95.4 p -157.67 109.55 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.62 123.26 1.46 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.19 165.48 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.935 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -112.96 90.61 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -133.61 85.37 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.67 55.79 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.503 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -117.38 42.32 2.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.73 0.3 . . . . 0.0 111.059 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.5 tt -123.19 135.88 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -127.24 153.7 45.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -104.16 121.38 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.45 139.55 53.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.54 133.94 17.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.86 124.39 37.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -103.34 105.1 15.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -78.06 111.4 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.698 HG21 HD11 ' A' ' 202' ' ' ILE . 54.7 t -130.99 115.36 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 10.9 mptt 53.16 40.93 32.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 42.0 m 67.04 40.27 2.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -134.79 118.1 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -79.25 80.41 5.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -80.69 107.23 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 77.0 p -111.53 126.8 55.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.83 108.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.6 t -132.8 146.34 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.159 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.36 143.15 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.97 124.96 28.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.615 0.722 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -23.97 29.77 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.654 2.236 . . . . 0.0 112.311 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -127.45 152.47 76.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.52 ' HB3' ' CG ' ' A' ' 181' ' ' TRP . 53.8 Cg_endo -69.71 127.93 15.33 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 180' ' ' VAL . 4.7 t -120.21 149.82 41.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -79.14 128.76 33.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.73 159.63 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.426 ' H ' HG22 ' A' ' 197' ' ' ILE . 25.6 m -95.93 -19.16 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 204' ' ' LYS . 90.2 t -100.31 -72.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.5 p -71.62 -22.48 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 62.83 44.38 6.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.83 151.27 37.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -52.43 130.61 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 171' ' ' THR . 66.4 t -103.5 67.36 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.52 ' CG ' ' HB3' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -106.85 46.96 0.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -73.88 87.88 0.66 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.3 tt -42.8 -52.96 4.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -99.13 -40.18 8.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 140.95 57.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -105.83 161.64 14.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -123.31 -168.3 13.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.532 ' CE2' ' HG2' ' A' ' 199' ' ' LYS . 26.9 m-85 -128.69 147.55 50.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.0 110.887 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.591 ' OE1' ' HB2' ' A' ' 196' ' ' ALA . 28.6 tp60 -143.7 110.58 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 5.3 t -57.94 157.81 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -96.34 -14.76 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -99.28 -67.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.42 -22.26 54.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 59.78 47.89 9.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.69 133.33 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.591 ' HB2' ' OE1' ' A' ' 189' ' ' GLN . . . -99.55 124.24 44.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 174' ' ' SER . 42.7 pt -145.15 175.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.52 ' NE2' HG22 ' A' ' 180' ' ' VAL . 67.7 m80 -85.99 163.87 17.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.532 ' HG2' ' CE2' ' A' ' 188' ' ' TYR . 34.2 mttm -67.29 -20.22 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -92.51 -27.16 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.638 ' O ' HG23 ' A' ' 205' ' ' VAL . 76.3 m -82.56 11.04 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.698 HD11 HG21 ' A' ' 157' ' ' VAL . 20.1 tt -73.16 -34.98 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.85 -27.08 49.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.433 ' HB2' HG11 ' A' ' 175' ' ' VAL . 20.3 mttm -88.75 32.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 201' ' ' CYS . 76.8 t -111.12 88.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.184 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.1 mp -85.13 -55.74 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.81 116.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -73.86 144.43 45.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.75 134.11 53.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 67.8 p -107.34 -37.96 6.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 137.47 158.05 7.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 74.3 p -57.12 149.14 20.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.099 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.1 p -114.3 120.8 41.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 110.869 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.1 m -92.94 -51.61 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 68.64 137.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.472 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -148.25 128.34 13.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 99.9 p -89.03 112.11 22.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -143.03 56.9 0.56 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.518 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -66.65 137.07 56.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -85.26 157.8 20.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -147.75 165.51 30.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.05 162.79 9.23 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.04 177.57 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.03 -179.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.7 tptm 70.06 41.23 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -117.37 93.09 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.948 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -173.69 152.04 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 106.32 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.8 t -139.2 135.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -97.37 134.42 40.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -100.96 107.62 19.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 85.2 t -131.66 125.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 45.33 36.52 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 67.92 44.4 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.9 m-70 -134.66 118.31 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.448 ' OE2' ' NH2' ' A' ' 191' ' ' ARG . 21.0 mt-10 -91.92 78.17 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -67.84 150.07 49.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 43.6 p -142.0 117.82 10.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.5 106.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -133.6 157.65 45.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.141 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -112.75 107.66 16.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.849 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -81.55 112.11 31.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.436 ' HG2' ' CD ' ' A' ' 169' ' ' GLN . 53.5 Cg_endo -69.78 -7.01 19.97 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.313 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.436 ' CD ' ' HG2' ' A' ' 168' ' ' PRO . 19.6 mp0 -125.46 152.71 71.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.608 0.718 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 110.53 2.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 180' ' ' VAL . 1.3 m -109.26 157.42 18.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.157 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -96.48 129.7 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.6 t -69.29 128.63 37.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 197' ' ' ILE . 72.2 m -85.62 19.52 2.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 204' ' ' LYS . 98.2 t -125.07 -57.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.69 -13.91 17.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 4.7 m170 63.93 52.26 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 179' ' ' PHE . 25.9 mt-10 -132.67 136.71 46.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.458 ' C ' ' O ' ' A' ' 178' ' ' GLU . 29.9 m-85 -33.35 137.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.538 HG22 ' NE2' ' A' ' 198' ' ' HIS . 88.0 t -123.39 102.1 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -172.85 174.75 3.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 136.33 133.85 3.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.21 -61.01 2.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.79 0.329 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -85.72 42.41 0.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -131.66 168.44 17.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -148.35 157.09 43.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -135.38 -149.73 5.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.508 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -149.1 137.15 20.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -130.24 120.03 23.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.404 ' HB3' ' N ' ' A' ' 194' ' ' ASN . 4.7 t -66.93 162.02 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.448 ' NH2' ' OE2' ' A' ' 161' ' ' GLU . 18.9 mtm105 -92.93 -24.91 18.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -99.78 -74.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.4 p -72.51 -9.74 58.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.404 ' N ' ' HB3' ' A' ' 190' ' ' CYS . 1.3 p-10 42.99 54.17 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.46 131.96 34.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.105 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -97.7 115.66 28.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 201' ' ' CYS . 12.5 pt -143.11 159.49 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.538 ' NE2' HG22 ' A' ' 180' ' ' VAL . 46.2 m80 -65.23 159.61 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -65.02 -35.09 80.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 201' ' ' CYS . 0.0 OUTLIER -77.96 -26.62 48.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.486 ' O ' HD12 ' A' ' 197' ' ' ILE . 86.0 m -84.21 22.53 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.45 -36.03 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -83.16 -25.27 32.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.717 ' O ' HG13 ' A' ' 175' ' ' VAL . 30.3 mmtm -86.11 31.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.449 HG22 ' CG2' ' A' ' 175' ' ' VAL . 96.7 t -104.94 116.52 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.19 -47.47 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -38.59 137.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.473 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 19.7 ttpt -88.38 156.0 19.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -91.88 113.39 25.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.2 p -95.21 -46.62 6.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 87.86 98.66 0.91 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.53 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 213' ' ' ALA . 14.3 t -134.54 166.79 22.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 0.0 110.855 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 212' ' ' SER . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.1 p -170.49 136.51 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.842 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.1 t -167.46 159.47 12.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.845 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.82 176.25 45.69 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.4 t -167.11 159.95 13.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.9 t -162.98 157.54 21.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -159.62 150.35 20.65 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.47 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -145.34 120.68 10.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -130.15 137.15 49.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -156.03 153.13 28.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -102.96 -154.83 24.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -130.3 167.51 18.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.741 0.305 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.84 143.38 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -161.13 107.48 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -150.28 163.33 38.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.67 172.07 7.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.099 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.89 172.63 10.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.4 t -137.84 144.44 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -105.31 137.53 42.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -97.49 98.57 10.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 65.3 t -120.15 116.58 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.608 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.9 mptt 43.39 45.94 5.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 65.2 m 62.88 40.05 9.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 91.9 m-70 -135.64 123.67 22.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -87.91 88.95 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -82.51 122.88 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -129.67 123.3 30.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.08 101.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.8 t -126.23 155.42 41.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -112.09 112.99 25.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -84.94 126.48 67.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -11.05 30.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.706 2.271 . . . . 0.0 112.382 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.16 152.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 117.62 5.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.3 t -114.67 136.41 53.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.134 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.24 128.83 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.04 159.64 9.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 197' ' ' ILE . 12.6 m -97.36 -26.45 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.92 -75.15 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 12.7 p -70.55 -20.79 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.87 49.45 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 179' ' ' PHE . 5.9 mm-40 -126.95 133.49 50.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 178' ' ' GLU . 12.1 p90 -36.05 111.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.666 HG22 ' CE1' ' A' ' 198' ' ' HIS . 58.5 t -87.92 86.26 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -175.95 124.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -151.62 -113.03 0.56 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.6 mt -147.12 117.74 7.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 57.5 42.24 24.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -128.75 92.57 3.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -74.17 140.04 44.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -105.44 -150.4 19.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -140.47 137.08 33.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -132.44 118.26 19.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 10.6 t -58.56 162.67 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -94.14 -13.56 26.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -112.36 -62.59 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 194' ' ' ASN . 17.3 p -87.92 4.95 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 193' ' ' CYS . 7.5 p-10 34.08 45.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.413 ' HB2' ' SG ' ' A' ' 193' ' ' CYS . . . -72.48 119.41 16.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.096 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.31 115.05 27.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.085 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 201' ' ' CYS . 29.9 pt -141.88 158.32 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.666 ' CE1' HG22 ' A' ' 180' ' ' VAL . 72.7 m80 -63.22 161.2 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -65.03 -18.88 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.59 -23.72 16.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.542 ' O ' HD12 ' A' ' 197' ' ' ILE . 81.3 m -83.35 22.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 203' ' ' ASP . 21.1 tt -84.3 -39.57 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.422 ' N ' HG23 ' A' ' 202' ' ' ILE . 3.4 p30 -75.33 -30.74 60.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -84.39 36.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -108.74 108.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 39.7 mm -105.42 -50.2 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.49 146.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -92.89 165.12 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.556 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.7 t -95.39 118.16 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.2 t -50.37 -38.54 43.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 51.57 83.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.461 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 1.9 t -70.87 141.32 51.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 110.86 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.064 179.923 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.7 m -134.05 160.3 38.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 0.0 110.818 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.4 m -104.18 173.8 6.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 149.54 156.99 7.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 96.1 p -94.84 160.87 14.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t -174.27 145.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.51 -62.99 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.464 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 62.48 42.43 8.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -107.36 41.82 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -94.4 145.01 25.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.56 134.22 2.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -167.56 169.9 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.3 tt -152.16 143.44 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 150' ' ' LYS . 3.3 mppt? -98.45 40.56 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -41.94 150.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.18 159.07 16.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -134.72 151.32 50.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.524 HG11 ' HB3' ' A' ' 161' ' ' GLU . 90.8 t -105.39 131.02 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -78.17 113.53 16.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -94.08 106.41 18.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 160' ' ' HIS . 87.5 t -124.83 126.67 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . 28.7 mmmt 34.76 39.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 t 74.98 43.92 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.554 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 92.1 m-70 -137.76 115.4 11.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.524 ' HB3' HG11 ' A' ' 154' ' ' VAL . 38.1 mt-10 -80.77 74.25 7.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 33.1 m-85 -70.3 128.75 37.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 80.9 p -136.01 126.43 26.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.3 115.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.8 t -134.45 154.14 51.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.17 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -105.36 103.7 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -77.9 111.91 21.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.64 19.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.644 2.229 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -140.48 156.68 69.37 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.712 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 109.0 2.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.676 2.25 . . . . 0.0 112.355 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.559 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.8 t -99.16 157.91 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.113 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 1.4 p90 -87.6 129.01 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 40.0 t -79.37 119.01 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.1 t -82.31 26.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 204' ' ' LYS . 57.9 t -128.27 -59.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -101.81 -13.37 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.4 m170 62.16 53.37 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.95 131.13 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -40.91 114.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.1 t -84.76 92.58 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -174.02 153.05 2.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 89.28 -60.7 3.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.527 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.91 159.74 18.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.907 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 186' ' ' GLN . 12.3 m-20 58.81 37.35 24.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.469 ' HG2' ' N ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -34.06 -33.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 184' ' ' ASN . 23.7 mt-30 -93.68 112.84 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -115.32 -142.78 7.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.464 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.573 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 14.8 m-85 -150.54 134.99 17.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -132.3 117.99 18.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 41.7 t -63.36 163.72 10.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -99.71 -27.06 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.4 ' HB2' ' SG ' ' A' ' 209' ' ' CYS . 36.6 mm-40 -87.98 -68.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.3 p -81.49 -24.64 36.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 190' ' ' CYS . 4.0 m-80 62.71 51.06 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.23 125.69 34.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.059 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.559 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -94.09 130.24 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 201' ' ' CYS . 28.4 pt -154.16 170.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -71.37 159.86 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.573 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 2.2 ttpm? -66.33 -29.19 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 -27.21 24.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.553 ' O ' HD12 ' A' ' 197' ' ' ILE . 72.3 m -81.69 21.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.8 tt -79.55 -39.22 20.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.405 ' N ' HG23 ' A' ' 202' ' ' ILE . 34.3 m-20 -77.73 -28.4 50.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.619 ' O ' HG13 ' A' ' 175' ' ' VAL . 13.5 mmmm -84.64 32.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 201' ' ' CYS . 62.3 t -107.48 114.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.4 mp -103.09 -54.74 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.68 122.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -82.84 158.36 22.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.8 t -88.06 137.5 32.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 t -119.53 -31.52 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.2 99.64 2.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 6.2 t -166.38 161.11 16.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.859 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.078 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.6 t -171.49 169.82 6.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.859 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.2 m -170.94 172.89 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.17 -174.79 38.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 t -171.42 152.92 3.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.393 . . . . 0.0 110.824 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.4 t -165.13 171.35 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.57 142.7 3.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.527 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -152.75 148.15 26.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 57.5 mtt85 -149.76 140.07 22.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -79.38 86.84 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -103.8 70.88 0.27 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.466 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.8 178.3 4.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 111.081 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.57 146.37 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -175.16 133.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -171.47 141.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.04 159.61 41.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.137 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.08 174.67 12.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.755 HG22 HG22 ' A' ' 163' ' ' THR . 64.1 t -105.06 132.49 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -88.25 141.98 28.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -96.95 110.75 23.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.0 t -134.68 126.46 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . 22.7 mmtt 37.2 38.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 3.4 t 70.23 42.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.1 m-70 -132.9 128.6 36.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.751 ' HB3' HG11 ' A' ' 154' ' ' VAL . 11.7 mt-10 -92.65 74.78 5.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.899 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 38.4 m-85 -65.12 140.49 58.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.755 HG22 HG22 ' A' ' 154' ' ' VAL . 26.4 p -139.76 121.87 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.162 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.09 114.48 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.5 HG23 ' CZ ' ' A' ' 167' ' ' PHE . 14.4 t -142.46 149.0 38.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -110.43 125.12 52.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.5 ' CZ ' HG23 ' A' ' 165' ' ' THR . 18.1 m-85 -100.92 106.65 45.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -5.1 15.37 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.694 2.263 . . . . 0.0 112.36 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -126.93 158.92 67.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 116.26 4.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.634 2.222 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 88.9 m -121.16 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.23 138.32 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.92 159.24 30.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 197' ' ' ILE . 3.6 m -105.82 -26.85 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.552 HG23 HG21 ' A' ' 197' ' ' ILE . 75.2 t -80.24 -62.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.9 p -86.79 -27.0 23.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 10.6 m80 72.84 40.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 179' ' ' PHE . 37.9 mt-10 -125.27 128.89 48.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 178' ' ' GLU . 1.5 p90 -36.61 119.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 198' ' ' HIS . 47.1 t -95.78 68.86 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.556 ' O ' ' CG ' ' A' ' 181' ' ' TRP . 4.1 p-90 -134.62 35.75 3.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 183' ' ' LEU . . . -98.15 178.17 31.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.509 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 182' ' ' GLY . 5.6 tp -36.2 -53.32 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.331 . . . . 0.0 110.934 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -90.13 76.43 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.929 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.492 ' H ' ' CD ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -74.06 -37.21 64.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.453 ' N ' ' HG2' ' A' ' 185' ' ' LYS . 28.7 tt0 -41.02 110.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.33 -153.47 8.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.483 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.452 ' HB3' ' CD1' ' A' ' 162' ' ' PHE . 42.0 m-85 -134.55 137.74 44.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -123.84 124.77 43.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 52.2 t -73.15 143.3 47.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -89.97 18.41 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.855 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -128.54 -61.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 26.5 p -91.85 -16.21 27.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 60.4 48.12 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.33 124.22 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 128.86 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.552 HG21 HG23 ' A' ' 175' ' ' VAL . 43.9 pt -145.39 173.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.759 ' CE1' HG22 ' A' ' 180' ' ' VAL . 46.4 m80 -67.73 175.42 2.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -75.35 -31.88 60.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -91.1 -41.36 11.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.7 m -43.77 -25.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.7 tt -45.8 -36.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.53 -37.45 65.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.484 ' O ' HG13 ' A' ' 175' ' ' VAL . 9.7 mmmm -82.57 40.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.27 116.18 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.11 -41.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -42.29 154.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -107.76 138.82 43.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -72.5 140.37 48.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 t -102.03 -30.75 11.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.08 110.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 94.5 p -132.85 143.99 49.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.3 t -154.86 149.15 26.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.935 0.398 . . . . 0.0 110.844 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.9 m -159.15 175.16 13.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.881 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -153.57 -173.39 22.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 54.9 p -156.75 172.13 19.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 110.821 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.1 t -167.61 161.6 13.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -152.61 -179.82 28.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.462 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -160.4 162.74 33.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 110.887 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.32 149.18 29.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.0 mtt-85 -128.69 169.03 14.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.49 64.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -46.84 174.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.728 0.299 . . . . 0.0 111.087 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.0 tt -121.17 150.34 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -128.43 106.46 9.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -107.81 145.01 34.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.77 171.32 16.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -163.47 149.9 11.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -127.47 124.7 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -84.45 116.52 23.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.832 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.47 112.64 24.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.94 125.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm 47.98 36.42 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 11.0 t 72.51 39.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.7 m-70 -132.29 122.45 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -90.7 76.55 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.512 ' CD2' HG13 ' A' ' 202' ' ' ILE . 42.7 m-85 -75.03 107.69 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.9 p -113.26 130.94 56.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.5 101.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 189' ' ' GLN . 14.9 t -121.67 152.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -113.0 114.54 27.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -88.48 128.47 52.83 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.674 0.749 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.92 154.51 67.64 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.535 0.683 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.474 ' HB3' ' CB ' ' A' ' 181' ' ' TRP . 53.7 Cg_endo -69.77 115.94 4.33 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.4 t -105.62 153.41 21.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.36 116.28 28.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.3 t -44.9 160.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.425 ' H ' HG22 ' A' ' 197' ' ' ILE . 1.6 m -103.99 -34.29 8.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 204' ' ' LYS . 80.6 t -76.61 -68.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.4 p -80.29 -24.51 39.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.416 ' NE2' ' O ' ' A' ' 174' ' ' SER . 39.2 m80 64.27 47.94 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 180' ' ' VAL . 15.4 mm-40 -120.61 152.02 38.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -50.68 116.52 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 198' ' ' HIS . 81.2 t -103.93 73.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.474 ' CB ' ' HB3' ' A' ' 170' ' ' PRO . 1.2 t90 -176.46 162.82 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 183' ' ' LEU . . . 123.94 54.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 183' ' ' LEU . 6.8 mp 35.33 40.94 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.944 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -102.03 -61.32 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -175.09 158.02 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -78.38 161.48 27.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -108.69 -153.52 16.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 199' ' ' LYS . 12.4 m-85 -127.28 150.14 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.92 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.431 ' HB2' HG21 ' A' ' 165' ' ' THR . 7.5 tt0 -138.52 119.46 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 42.5 t -74.43 132.27 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -83.3 24.24 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.4 ' HB2' ' SG ' ' A' ' 209' ' ' CYS . 6.5 mm100 -131.37 -55.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -98.53 -24.81 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.8 t30 73.73 45.34 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.77 120.85 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.89 121.06 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 174' ' ' SER . 46.0 pt -143.97 171.35 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.576 ' CE1' HG22 ' A' ' 180' ' ' VAL . 58.2 m80 -65.16 175.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 188' ' ' TYR . 24.0 mtpt -77.39 -28.66 52.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 202' ' ' ILE . 18.9 pttm -93.46 -38.8 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.27 -20.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' A' ' 162' ' ' PHE . 19.2 tt -51.54 -26.03 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.48 -32.95 36.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.63 ' HB2' HG11 ' A' ' 175' ' ' VAL . 1.3 mmmp? -83.4 33.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.2 t -112.82 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.11 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 89.8 mt -120.65 -38.09 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -47.72 138.39 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -84.6 140.67 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.543 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 6.5 t -71.48 141.01 50.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 62.5 p -110.01 -43.4 3.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 96.14 53.56 1.47 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.486 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -91.86 149.5 21.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.89 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.105 179.929 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.8 m 62.13 43.21 8.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.9 m -104.76 123.3 47.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.821 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -143.95 -171.82 14.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.8 p -152.39 154.27 35.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.5 t -83.17 175.63 9.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.61 174.74 17.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -123.11 133.11 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 144.25 45.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -111.48 177.89 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -143.66 -166.96 11.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.1 172.85 7.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.01 144.61 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -95.16 148.87 21.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -102.56 156.52 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.49 138.26 26.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -160.34 148.89 16.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.494 HG11 ' HG3' ' A' ' 161' ' ' GLU . 84.6 t -82.44 133.99 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -95.38 125.61 40.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.814 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -90.2 114.64 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.83 127.8 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mmtp 39.85 43.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 87.1 m 63.57 44.96 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -137.23 131.74 32.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.494 ' HG3' HG11 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -97.77 77.17 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 39.0 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 42.4 p -140.85 123.33 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.47 109.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.1 t -134.42 150.29 50.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.59 115.55 30.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 41.0 m-85 -91.44 107.49 22.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.61 0.719 . . . . 0.0 110.86 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.461 ' HG2' ' NE2' ' A' ' 169' ' ' GLN . 54.2 Cg_endo -69.74 -6.37 18.42 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.311 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.461 ' NE2' ' HG2' ' A' ' 168' ' ' PRO . 14.7 mp0 -129.38 153.65 80.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 53.7 Cg_endo -69.86 109.5 2.35 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.653 2.235 . . . . 0.0 112.331 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 172' ' ' PHE . 21.8 m -104.58 157.33 17.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.438 ' N ' HG22 ' A' ' 171' ' ' THR . 37.7 p90 -92.86 112.89 25.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.853 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.5 t -61.86 127.82 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.0 t -83.75 19.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.588 HG23 HG21 ' A' ' 197' ' ' ILE . 90.0 t -127.38 -59.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -98.95 -16.17 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.2 m170 62.47 49.43 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -125.85 139.62 53.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -40.14 132.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.989 HG22 ' NE2' ' A' ' 198' ' ' HIS . 75.2 t -119.8 91.06 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -146.05 174.5 11.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.69 148.55 21.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.46 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.72 -45.38 92.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -81.21 -176.62 6.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.404 ' HA ' ' NZ ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER 58.96 47.89 11.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.947 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -40.19 160.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -117.28 -169.64 15.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.464 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 11.4 m-85 -138.31 130.06 28.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -121.99 119.52 31.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 34.8 t -65.6 162.66 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -94.83 -24.22 17.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 15.7 mt-30 -94.52 -75.09 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 31.6 p -72.67 -22.17 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 192' ' ' GLN . 7.6 m-80 59.22 52.99 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -92.12 130.02 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.69 120.97 36.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.588 HG21 HG23 ' A' ' 175' ' ' VAL . 23.1 pt -145.47 165.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.989 ' NE2' HG22 ' A' ' 180' ' ' VAL . 53.2 m80 -73.96 154.55 39.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 45.0 mtmt -57.74 -36.47 72.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -74.72 -30.35 61.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.557 ' O ' HD12 ' A' ' 197' ' ' ILE . 57.1 m -83.99 28.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 203' ' ' ASP . 20.8 tt -85.72 -38.96 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.4 ' N ' HG23 ' A' ' 202' ' ' ILE . 5.2 m-20 -80.35 -23.35 40.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.524 ' HB2' HG11 ' A' ' 175' ' ' VAL . 26.1 mmtm -84.3 29.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -104.16 121.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.43 -47.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.18 125.72 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.05 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -75.53 153.39 37.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.538 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.9 t -78.98 126.19 30.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.4 t -116.6 38.25 3.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -89.62 65.99 2.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.556 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.4 26.14 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 110.845 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.085 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.5 m -152.8 156.26 38.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.9 m -159.35 168.78 25.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.839 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 175.04 176.08 43.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.528 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 92.8 p -161.09 134.98 6.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.831 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.4 t -146.98 140.29 25.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.39 -173.56 13.35 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -148.44 163.69 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.347 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -136.01 130.83 34.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -148.4 144.35 27.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.18 102.59 0.21 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.476 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.23 163.6 14.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.6 tt -148.61 154.02 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.115 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -143.53 142.14 31.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -136.09 157.82 45.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -109.15 -175.65 2.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.414 ' HE2' ' NE2' ' A' ' 155' ' ' HIS . 0.0 OUTLIER -137.88 166.99 22.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 161' ' ' GLU . 62.5 t -115.58 110.5 32.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.13 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.414 ' NE2' ' HE2' ' A' ' 153' ' ' LYS . 82.8 m-70 -70.69 159.2 34.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.67 110.13 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 160' ' ' HIS . 85.2 t -137.94 130.33 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.6 mmtm 36.95 45.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.1 m 64.56 46.13 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.565 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.1 m-70 -136.99 128.76 28.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.403 ' HB3' ' CG1' ' A' ' 154' ' ' VAL . 56.7 mt-10 -87.27 76.6 9.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -78.03 126.46 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.655 HG21 ' CZ ' ' A' ' 191' ' ' ARG . 6.1 t -147.16 135.52 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.159 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.71 115.29 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.785 HG21 ' HB2' ' A' ' 189' ' ' GLN . 10.2 t -135.43 158.57 44.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.03 118.13 33.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.455 ' CZ ' HG23 ' A' ' 165' ' ' THR . 24.9 m-85 -94.63 127.66 42.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.2 32.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.718 2.279 . . . . 0.0 112.375 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -127.11 158.84 67.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.58 0.705 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.19 2.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.718 2.279 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.633 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.9 t -96.95 157.74 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -97.22 140.36 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.473 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 48.7 t -80.09 124.49 28.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 t -86.17 22.11 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.6 t -121.87 -48.32 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.65 -11.36 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 17.5 m170 63.2 52.24 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 179' ' ' PHE . 13.6 mm-40 -131.85 136.02 47.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 178' ' ' GLU . 5.5 m-85 -36.97 126.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.591 HG22 ' CE1' ' A' ' 198' ' ' HIS . 46.4 t -111.48 80.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -174.37 156.22 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 79.37 -58.96 4.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.12 166.45 10.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.921 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.8 p30 39.54 42.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.85 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -49.57 175.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 65.85 54.24 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.05 -161.86 2.63 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.465 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.591 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 11.8 m-85 -126.47 131.14 51.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 110.895 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.785 ' HB2' HG21 ' A' ' 165' ' ' THR . 45.2 tt0 -126.75 124.38 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 49.3 t -77.13 130.12 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.655 ' CZ ' HG21 ' A' ' 163' ' ' THR . 0.2 OUTLIER -81.2 19.08 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -124.95 -61.55 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.4 p -93.11 -24.56 18.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 73.54 46.64 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.8 121.55 38.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -95.85 123.06 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 201' ' ' CYS . 41.8 pt -141.97 167.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.591 ' CE1' HG22 ' A' ' 180' ' ' VAL . 44.8 m80 -70.73 151.13 45.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.87 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.591 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 23.8 tttt -57.94 -34.98 70.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -80.95 -26.07 36.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.559 ' O ' HD12 ' A' ' 197' ' ' ILE . 87.2 m -83.04 27.45 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 203' ' ' ASP . 19.5 tt -86.06 -39.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 202' ' ' ILE . 8.1 t70 -74.17 -29.82 61.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 36.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.09 128.9 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 207' ' ' ALA . 88.4 mt -126.08 -52.94 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.84 116.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.094 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 160.41 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 9.1 t -87.81 144.53 26.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 211' ' ' GLY . 10.2 t -93.45 -40.18 10.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 210' ' ' THR . . . 74.69 109.27 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.469 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 1.1 t -111.49 25.85 11.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.898 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.104 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.7 p -167.3 133.16 2.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.4 t -174.52 161.96 3.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.06 98.43 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.7 t -66.02 100.78 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.878 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 t -112.58 109.46 19.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.63 159.94 23.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.502 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -150.15 118.34 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -98.86 162.85 12.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -141.72 141.93 33.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -132.18 154.44 21.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -123.24 165.13 17.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.331 . . . . 0.0 111.074 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.4 tt -163.96 131.2 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.36 169.52 13.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -169.19 174.12 6.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.72 167.92 20.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -154.0 137.95 16.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.4 t -109.28 122.34 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -84.72 116.3 23.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.77 100.05 12.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.21 107.79 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 16.6 mmtm 62.63 41.3 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 m 63.94 39.16 8.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.897 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 97.4 m-70 -132.54 124.92 29.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -92.74 77.84 4.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.01 121.19 21.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 62.5 p -123.91 127.27 47.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.157 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.9 115.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.459 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 10.1 t -134.63 143.29 47.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -99.89 108.09 20.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.459 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 45.6 m-85 -81.19 127.41 74.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.661 0.743 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -26.69 27.46 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.244 . . . . 0.0 112.373 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -129.94 153.38 80.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.42 ' HB3' ' CB ' ' A' ' 181' ' ' TRP . 53.7 Cg_endo -69.76 110.15 2.48 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.2 t -97.73 153.64 18.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 1.3 p90 -81.7 118.77 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -54.04 160.49 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.1 t -103.16 -29.05 11.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.57 -66.82 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 16.7 p -81.19 -22.31 38.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.48 45.17 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 179' ' ' PHE . 54.3 mt-10 -127.42 133.79 49.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.8 p90 -35.38 105.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 198' ' ' HIS . 83.9 t -75.35 81.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.42 ' CB ' ' HB3' ' A' ' 170' ' ' PRO . 3.4 t-105 -176.2 140.31 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 174.42 -99.49 0.14 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -67.42 -176.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.919 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.41 ' O ' ' CG ' ' A' ' 185' ' ' LYS . 1.7 m120 -85.57 88.79 7.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.881 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 184' ' ' ASN . 48.5 mttt -161.21 176.9 10.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -123.8 162.43 23.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -101.63 -153.02 25.54 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.567 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 23.1 m-85 -133.41 143.12 48.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -139.61 132.67 29.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.7 t -73.83 162.71 28.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -90.82 -20.08 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.83 -70.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 15.4 p -72.07 -16.24 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 50.3 48.21 22.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -82.25 118.76 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.31 121.55 33.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 202' ' ' ILE . 40.0 pt -145.74 175.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.449 ' CE1' HG22 ' A' ' 180' ' ' VAL . 64.9 m80 -70.97 175.24 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.668 ' O ' HG22 ' A' ' 202' ' ' ILE . 5.9 mtpm? -70.51 -43.67 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.4 pptp? -80.15 -36.08 35.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 1.8 m -51.02 -22.5 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 199' ' ' LYS . 16.6 tt -52.79 -38.33 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.6 -32.73 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -83.27 37.16 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.8 t -114.23 115.35 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.9 mt -110.65 -43.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.64 163.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 3.8 ttmp? -110.92 162.85 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 208' ' ' LYS . 4.2 t -86.8 109.42 19.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.9 t -91.12 30.52 1.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 83.5 -48.31 4.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 28.1 t -161.22 147.6 14.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.857 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.074 179.903 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.9 p -134.38 -42.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.794 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.7 t 64.86 43.78 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.02 127.79 22.19 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.535 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.9 m -139.85 108.91 6.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 110.874 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 m -130.4 151.82 50.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -53.94 169.6 1.22 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -126.62 -66.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.326 . . . . 0.0 110.931 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -141.32 122.66 14.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.856 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -79.93 -46.9 15.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.35 122.26 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -127.22 163.67 23.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.742 0.306 . . . . 0.0 111.124 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.6 tt -110.68 141.98 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.36 151.22 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -93.24 122.01 35.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.62 156.82 25.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -170.17 148.49 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.59 132.6 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -88.12 99.65 12.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -74.57 118.11 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.8 t -139.8 122.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.4 mptt 42.04 44.9 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.939 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 4.2 m 63.31 42.47 6.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.4 m-70 -137.16 119.15 15.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -84.32 79.35 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -73.62 139.14 45.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.6 p -141.5 125.86 17.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.2 106.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.1 t -125.1 160.97 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.159 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -112.56 115.79 29.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.455 ' O ' ' NE1' ' A' ' 181' ' ' TRP . 21.0 m-85 -89.56 110.64 40.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.628 0.728 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -15.09 36.69 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 0.0 112.355 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -129.97 160.91 62.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.923 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.32 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 m -102.09 147.36 26.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -89.58 109.43 20.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.87 159.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 p -99.36 -28.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.6 -73.48 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.7 p -75.31 -22.64 57.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 63.13 44.42 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.54 142.79 49.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -42.67 123.07 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.608 HG22 ' CE1' ' A' ' 198' ' ' HIS . 92.8 t -100.03 80.17 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.455 ' NE1' ' O ' ' A' ' 167' ' ' PHE . 0.4 OUTLIER -176.38 139.17 0.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.32 -97.44 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.455 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.8 mt -71.23 178.65 3.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.86 45.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -110.28 174.19 5.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -132.9 164.99 25.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -119.71 -125.29 3.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.52 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.443 ' CZ ' ' HD2' ' A' ' 199' ' ' LYS . 23.3 m-85 -149.17 146.22 27.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -145.62 114.75 7.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.76 161.11 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -96.12 -20.47 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -96.81 -70.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.943 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -72.55 -20.63 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 56.67 51.58 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.24 126.23 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.48 131.71 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 29.7 pt -151.39 151.51 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.608 ' CE1' HG22 ' A' ' 180' ' ' VAL . 73.0 m80 -61.03 157.66 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 188' ' ' TYR . 0.2 OUTLIER -63.28 -14.31 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -98.51 -23.03 15.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.652 ' O ' HG23 ' A' ' 205' ' ' VAL . 88.0 m -83.0 16.56 2.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.9 tt -81.13 -38.98 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 202' ' ' ILE . 0.7 OUTLIER -75.12 -28.79 60.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 201' ' ' CYS . 1.6 mptt -87.68 32.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 201' ' ' CYS . 55.0 t -110.01 111.48 36.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.167 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 97.5 mt -111.23 -46.89 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -37.39 155.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -101.37 164.0 11.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.463 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -91.39 138.62 31.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 210' ' ' THR . 15.0 t -123.95 38.09 4.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -115.18 96.15 0.74 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.524 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 23.9 p -92.37 143.77 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.857 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.095 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.7 m80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.812 0.339 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -103.88 99.48 9.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.4 t -121.72 112.64 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 2.5 mptp? 58.66 41.1 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 5.9 t 65.63 37.69 5.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -134.6 125.96 28.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -92.29 81.73 4.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.28 121.63 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.8 p -126.64 123.44 37.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.115 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.36 104.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.1 t -130.45 149.06 52.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.167 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -105.69 108.71 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.35 111.46 20.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.66 0.743 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -7.03 20.02 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -129.19 154.29 80.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 87.6 m -116.7 135.38 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -78.11 136.22 37.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.31 159.47 17.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.416 ' H ' HG22 ' A' ' 197' ' ' ILE . 20.5 m -94.72 -23.64 17.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.0 t -96.48 -75.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.137 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.9 p -67.7 -22.2 65.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 40.3 m80 62.34 50.91 3.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -122.59 145.32 48.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -55.25 119.47 5.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 198' ' ' HIS . 25.4 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.413 ' CE2' HD12 ' A' ' 202' ' ' ILE . 11.4 m-85 -140.92 132.82 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 110.883 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -132.47 119.73 20.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.55 162.07 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -95.43 -24.37 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.34 -75.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.9 p -71.34 -24.0 62.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.37 51.95 2.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.49 129.99 36.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.83 126.15 40.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 201' ' ' CYS . 29.9 pt -149.86 153.62 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.174 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.3 m80 -67.02 159.94 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -59.2 -35.86 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -76.04 -23.28 55.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.615 ' O ' HD12 ' A' ' 197' ' ' ILE . 66.2 m -87.91 24.5 1.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.413 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.1 tt -87.61 -30.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.82 -19.54 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.537 ' HB2' HG11 ' A' ' 175' ' ' VAL . 11.4 mmtp -89.23 25.02 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.41 117.68 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 25.6 mm -116.17 -47.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.31 141.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -89.55 156.97 18.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 3.5 t -83.48 133.51 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -82.21 110.43 17.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 160' ' ' HIS . 70.9 t -134.12 126.29 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.607 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.0 mptt 36.41 46.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 66.2 m 63.14 42.35 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 94.9 m-70 -136.99 131.77 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -96.36 79.18 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -69.45 133.84 48.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.3 p -136.7 125.53 24.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.09 113.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 189' ' ' GLN . 15.3 t -133.02 158.41 42.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.172 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.03 100.88 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.437 ' CZ ' ' CB ' ' A' ' 196' ' ' ALA . 84.1 m-85 -75.29 118.96 74.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.606 0.717 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -9.03 25.1 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.656 2.237 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.63 158.01 54.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 110.1 2.48 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.7 2.267 . . . . 0.0 112.334 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.52 HG21 ' CB ' ' A' ' 196' ' ' ALA . 9.8 t -98.14 150.71 21.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 177' ' ' HIS . 2.1 t80 -76.97 107.66 9.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 t -57.25 127.16 30.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.1 p -82.92 25.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.614 HG23 HG21 ' A' ' 197' ' ' ILE . 88.8 t -131.91 -53.63 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -106.85 -17.91 14.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 4.8 m170 72.8 49.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -136.96 140.13 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -46.16 120.4 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.734 HG22 ' CE1' ' A' ' 198' ' ' HIS . 60.0 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 199' ' ' LYS . 17.8 m-85 -148.83 132.77 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.922 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.591 ' HB2' HG21 ' A' ' 165' ' ' THR . 21.7 tt0 -132.34 127.39 35.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.9 t -69.49 162.06 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -92.31 -18.64 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -103.72 -73.87 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.453 ' C ' ' CG ' ' A' ' 194' ' ' ASN . 27.8 p -72.48 -14.46 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.453 ' CG ' ' C ' ' A' ' 193' ' ' CYS . 1.0 OUTLIER 48.47 53.44 12.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.93 126.14 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 171' ' ' THR . . . -96.38 121.14 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 201' ' ' CYS . 40.2 pt -143.61 163.21 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.734 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.7 m80 -67.87 152.13 46.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 188' ' ' TYR . 47.5 mtpt -57.32 -27.32 62.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -84.7 -25.36 28.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.722 ' O ' HD12 ' A' ' 197' ' ' ILE . 77.4 m -85.13 26.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.7 tt -87.1 -33.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.79 -23.98 31.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -89.24 28.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 201' ' ' CYS . 86.2 t -104.49 119.7 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.088 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 87.5 mt -114.28 -54.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.44 118.0 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -73.59 158.59 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.9 t -86.77 131.05 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 -179.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -104.05 102.15 11.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -127.78 108.02 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.11 43.24 21.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 66.04 35.87 6.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CB ' ' CE2' ' A' ' 162' ' ' PHE . 97.7 m-70 -129.27 117.86 21.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -76.75 50.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 160' ' ' HIS . 37.2 m-85 -60.2 105.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -122.16 136.27 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.12 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.56 124.86 3.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.42 HG21 ' HB2' ' A' ' 189' ' ' GLN . 15.2 t -143.2 153.49 42.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -102.65 128.82 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.05 109.33 58.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.707 2.272 . . . . 0.0 112.309 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -144.76 157.51 54.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 127.19 14.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 88.4 m -128.96 138.72 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -75.39 129.73 37.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.0 t -60.7 157.4 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.543 ' H ' HG22 ' A' ' 197' ' ' ILE . 17.9 t -98.63 -29.2 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.445 HG11 ' HB2' ' A' ' 204' ' ' LYS . 99.0 t -85.16 -74.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.1 p -71.09 -23.87 62.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 63.54 53.88 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 179' ' ' PHE . 20.8 mt-10 -134.44 130.86 37.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 178' ' ' GLU . 8.5 p90 -34.73 123.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 198' ' ' HIS . 84.1 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -154.08 140.55 18.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.42 ' HB2' HG21 ' A' ' 165' ' ' THR . 66.5 tt0 -140.81 109.69 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -58.78 161.42 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -95.13 -19.84 19.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.458 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 20.6 mt-30 -98.84 -74.57 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.425 ' C ' ' CG ' ' A' ' 194' ' ' ASN . 30.7 p -71.3 -12.63 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 192' ' ' GLN . 0.6 OUTLIER 47.16 52.01 12.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.92 122.68 32.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.79 115.31 27.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.09 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 174' ' ' SER . 27.3 pt -140.64 173.91 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.477 ' CE1' HG22 ' A' ' 180' ' ' VAL . 58.8 m80 -63.59 172.61 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -78.1 -15.43 58.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.8 pptp? -106.03 -32.21 8.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 3.4 m -55.43 -16.68 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.59 -26.83 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.85 -31.72 61.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.445 ' HB2' HG11 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -92.67 32.87 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 201' ' ' CYS . 54.5 t -110.69 89.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.8 mt -91.25 -44.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.62 135.19 1.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -79.1 153.74 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.477 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 8.1 t -79.57 113.26 17.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 45.4 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.824 0.345 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -112.34 123.78 51.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.6 t -140.01 107.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.508 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.5 mttm 62.36 47.91 5.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.61 37.92 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.522 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 99.6 m-70 -131.04 113.55 14.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -84.13 76.3 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -71.9 138.79 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 73.3 p -140.72 128.71 22.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.56 116.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 15.3 t -138.67 142.07 39.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.88 110.62 22.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 13.3 m-85 -88.13 111.37 42.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.749 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -16.16 37.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.301 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -114.23 154.29 46.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 109.57 2.35 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.661 2.24 . . . . 0.0 112.317 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 57.1 m -113.69 135.01 54.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 7.3 p90 -77.14 115.67 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -44.93 159.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.561 ' H ' HG22 ' A' ' 197' ' ' ILE . 18.2 m -99.29 -26.12 14.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.1 t -88.69 -71.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.8 p -75.23 -23.78 57.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.833 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.5 m80 64.21 51.87 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 179' ' ' PHE . 62.2 mt-10 -133.18 131.53 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 178' ' ' GLU . 27.3 p90 -32.91 113.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.647 HG22 ' CE1' ' A' ' 198' ' ' HIS . 68.1 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -150.4 129.82 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 110.946 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.457 ' HB2' HG21 ' A' ' 165' ' ' THR . 17.1 tt0 -123.72 131.62 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 11.4 t -76.22 161.81 28.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -93.23 -20.38 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.24 -75.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.6 p -69.92 -15.18 63.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 51.6 52.61 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.19 123.39 33.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -98.29 120.99 39.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 174' ' ' SER . 38.2 pt -141.36 171.97 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.647 ' CE1' HG22 ' A' ' 180' ' ' VAL . 49.7 m80 -63.01 -177.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -79.21 -37.15 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -87.32 -37.18 17.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 4.6 m -49.07 -18.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.41 ' HA ' HD11 ' A' ' 197' ' ' ILE . 16.6 tt -54.97 -32.5 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.81 -35.56 64.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.541 ' HB2' HG11 ' A' ' 175' ' ' VAL . 6.9 mmpt? -84.68 35.05 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.29 118.7 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 206' ' ' ILE . 3.8 mp -119.65 -56.86 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -35.02 112.4 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -64.38 150.25 46.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.522 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.8 t -73.07 137.19 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 77.6 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.838 0.352 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -76.22 113.4 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.78 106.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.495 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.0 mptp? 60.62 42.59 13.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 63.3 m 64.41 37.85 8.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.3 m-70 -131.47 119.02 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -83.07 79.45 9.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -72.76 135.75 45.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 p -140.01 123.32 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -51.14 112.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -141.02 148.54 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -94.3 134.19 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -107.71 105.02 55.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.637 0.732 . . . . 0.0 110.901 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -3.53 12.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -128.92 153.54 80.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.709 2.273 . . . . 0.0 112.333 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.5 m -126.87 136.04 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -83.57 123.03 29.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 3.0 t -54.23 156.39 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 33.9 p -100.79 -17.41 16.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.3 t -97.77 -68.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -80.03 -14.86 58.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.5 m170 57.49 49.09 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 179' ' ' PHE . 70.9 mt-10 -128.29 130.94 48.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.7 p90 -35.46 134.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 198' ' ' HIS . 63.6 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 16.0 m-85 -136.33 140.33 43.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -135.92 115.22 12.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 14.4 t -63.09 138.34 58.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -85.67 20.48 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -132.32 -64.52 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.8 p -86.94 -15.52 38.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 59.48 54.06 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.39 128.06 52.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 129.9 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 33.2 pt -151.03 153.68 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.583 ' CE1' HG22 ' A' ' 180' ' ' VAL . 60.8 m80 -64.57 161.65 17.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.53 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 7.6 mtpm? -64.04 -27.2 68.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -22.56 24.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.2 m -83.98 14.57 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 203' ' ' ASP . 18.1 tt -79.47 -41.87 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.453 ' N ' HG23 ' A' ' 202' ' ' ILE . 64.0 m-20 -73.84 -26.81 60.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -88.07 38.16 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.5 t -111.02 112.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.411 ' O ' ' C ' ' A' ' 207' ' ' ALA . 77.4 mt -106.76 -50.78 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.14 143.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.076 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -97.23 137.57 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.539 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.5 t -65.47 140.52 58.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.168 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -88.87 109.13 19.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.9 t -132.12 136.92 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.606 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 21.6 mmtm 38.96 43.07 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 2.2 m 64.75 41.7 4.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 87.2 m-70 -136.27 142.17 43.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.73 75.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -66.43 105.13 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 p -109.95 121.25 44.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.99 105.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -127.9 149.9 50.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -107.18 105.08 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.62 114.58 33.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -6.96 19.81 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.751 2.3 . . . . 0.0 112.383 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -140.1 159.5 63.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.599 0.714 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 179' ' ' PHE . 53.7 Cg_endo -69.78 116.5 4.59 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.666 2.244 . . . . 0.0 112.327 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.9 t -114.38 156.87 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.75 146.98 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.9 t -79.53 160.05 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.477 ' H ' HG22 ' A' ' 197' ' ' ILE . 46.6 t -101.84 -30.38 11.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.46 -73.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -75.02 -25.12 58.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 63.18 50.13 3.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -123.2 135.59 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 170' ' ' PRO . 4.2 t80 -39.63 122.18 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.613 HG22 ' CE1' ' A' ' 198' ' ' HIS . 22.5 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -122.35 135.65 54.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -124.83 121.82 35.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 25.9 t -64.21 163.01 13.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -90.4 -21.82 21.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -103.25 -73.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.5 p -71.36 -12.15 61.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 194' ' ' ASN . 5.1 p-10 43.05 52.87 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -91.24 130.32 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.19 122.4 35.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 174' ' ' SER . 28.6 pt -142.81 147.82 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.613 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.2 m80 -57.69 151.46 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.84 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -57.27 -19.7 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -90.99 -27.41 18.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.458 ' O ' HD12 ' A' ' 197' ' ' ILE . 84.9 m -82.62 20.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.21 -37.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -82.84 -24.22 33.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -85.28 31.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.7 t -101.52 127.0 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.43 -44.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -53.75 125.07 17.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.79 167.29 11.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.468 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 7.8 t -88.31 113.13 23.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.141 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.781 0.324 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -96.29 112.0 23.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 158' ' ' LYS . 97.3 t -140.65 135.53 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mptt 36.31 45.19 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 99.0 m 63.31 46.08 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.1 m-70 -136.3 178.37 7.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -130.66 50.23 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.538 ' CD2' HG13 ' A' ' 202' ' ' ILE . 23.2 m-85 -51.43 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.46 HG21 ' NH2' ' A' ' 191' ' ' ARG . 7.3 t -117.95 136.67 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.182 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.55 124.16 3.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.418 HG21 ' HB2' ' A' ' 189' ' ' GLN . 13.6 t -145.75 159.89 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -124.94 109.89 13.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -85.26 119.27 72.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.276 . . . . 0.0 112.309 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -147.74 158.28 42.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.614 0.721 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 124.48 11.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.481 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.2 t -117.68 157.47 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -84.78 115.75 22.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.478 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 49.1 t -64.81 126.56 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.54 ' H ' HG22 ' A' ' 197' ' ' ILE . 23.0 t -87.12 26.96 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.625 HG23 HG21 ' A' ' 197' ' ' ILE . 53.5 t -129.76 -55.34 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.89 -16.03 14.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.9 m170 63.59 51.87 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -134.99 132.63 38.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -40.25 109.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.767 HG22 ' CE1' ' A' ' 198' ' ' HIS . 82.6 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.168 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.94 143.87 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.835 0.35 . . . . 0.0 110.926 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.418 ' HB2' HG21 ' A' ' 165' ' ' THR . 46.0 tt0 -143.52 119.71 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 28.2 t -63.46 163.08 11.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.46 ' NH2' HG21 ' A' ' 163' ' ' THR . 21.3 mmt-85 -98.03 -22.79 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -92.28 -68.4 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.99 -25.36 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 63.53 50.15 2.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -89.44 119.39 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.076 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.481 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -92.58 121.04 33.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.625 HG21 HG23 ' A' ' 175' ' ' VAL . 43.1 pt -144.18 174.91 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.767 ' CE1' HG22 ' A' ' 180' ' ' VAL . 52.9 m80 -68.42 178.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.584 ' O ' HG22 ' A' ' 202' ' ' ILE . 37.3 tttm -73.84 -53.88 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 202' ' ' ILE . 10.7 pttm -70.97 -43.7 67.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 18.7 m -43.16 -22.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 199' ' ' LYS . 19.3 tt -50.37 -38.26 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -34.95 71.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.428 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 36.8 mmtt -82.72 36.82 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.55 126.17 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.65 -55.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -37.98 139.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.103 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -90.07 159.36 16.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 5.2 t -79.54 110.18 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.346 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.46 ' CE1' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m-70 -125.22 105.49 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 88.7 t -137.83 120.68 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 52.91 39.44 29.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.3 t 65.99 40.01 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -132.01 119.94 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.46 ' OE1' ' CE1' ' A' ' 156' ' ' HIS . 6.6 mm-40 -78.35 70.58 4.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -71.48 97.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.1 t -112.12 134.44 53.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.25 120.32 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.57 HG23 ' CE1' ' A' ' 167' ' ' PHE . 5.1 t -139.29 149.74 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -105.82 117.46 34.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 165' ' ' THR . 18.8 m-85 -91.13 109.73 37.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.728 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -7.56 21.37 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.701 2.267 . . . . 0.0 112.348 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -136.04 160.72 66.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 121.9 8.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.751 2.301 . . . . 0.0 112.326 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.8 m -115.66 150.18 37.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.412 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 32.8 p90 -96.74 111.43 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 12.7 t -47.56 157.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 p -97.56 -22.67 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.763 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.5 t -92.81 -74.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -73.27 -23.62 60.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 63.56 46.27 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.98 148.66 43.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -45.01 130.57 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.559 HG22 ' CE1' ' A' ' 198' ' ' HIS . 69.1 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.534 ' CZ ' ' HG2' ' A' ' 199' ' ' LYS . 14.5 m-85 -104.0 131.98 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -129.78 118.71 22.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 8.9 t -62.68 161.68 11.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -96.49 -20.71 18.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -97.21 -71.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 21.5 p -74.18 -20.55 60.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 57.83 53.51 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.38 128.7 41.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -94.84 125.79 39.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 201' ' ' CYS . 23.7 pt -152.09 147.27 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.076 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.559 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.5 m80 -60.01 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.534 ' HG2' ' CZ ' ' A' ' 188' ' ' TYR . 41.7 mttt -58.67 -22.83 58.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -22.85 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.576 ' O ' HD12 ' A' ' 197' ' ' ILE . 79.2 m -86.77 27.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 tt -88.27 -30.39 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -80.58 -25.45 38.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.763 ' HB2' HG11 ' A' ' 175' ' ' VAL . 24.3 mttm -88.77 31.48 0.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.58 110.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' ALA . 46.7 mm -109.27 -54.3 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.38 145.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.131 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -91.92 167.11 12.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.6 t -98.64 124.97 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.812 0.339 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -110.57 107.12 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.833 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 160' ' ' HIS . 58.2 t -129.65 131.46 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.078 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 14.2 mptt 37.41 45.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 59.1 m 63.47 41.22 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.545 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -133.25 120.88 21.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.6 70.39 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -75.69 103.68 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.1 t -119.9 138.94 53.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.52 119.82 2.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.5 t -141.25 141.39 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -97.21 118.85 34.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -90.63 108.84 30.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -5.68 16.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.725 2.284 . . . . 0.0 112.289 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -133.88 153.95 80.15 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 m -108.62 156.35 19.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 172' ' ' PHE . 19.0 p90 -103.74 131.95 50.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.06 155.28 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 m -100.49 -24.29 14.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.23 -72.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -74.43 -21.29 59.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 8.2 m170 63.2 47.67 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -124.52 143.85 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -48.23 128.17 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' A' ' 198' ' ' HIS . 21.3 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 199' ' ' LYS . 20.8 m-85 -124.78 135.51 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.46 112.92 9.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.9 t -57.72 159.17 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -96.98 -16.99 20.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -97.85 -68.43 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.68 -23.45 53.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.98 53.33 3.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.75 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.51 118.75 31.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 29.8 pt -140.02 158.12 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.407 ' CE1' HG22 ' A' ' 180' ' ' VAL . 68.1 m80 -62.64 161.35 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 188' ' ' TYR . 50.9 tttt -68.75 -11.17 60.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -105.19 -20.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.69 15.66 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 203' ' ' ASP . 17.6 tt -79.27 -40.09 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.425 ' N ' HG23 ' A' ' 202' ' ' ILE . 6.8 p-10 -71.55 -25.52 62.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.407 ' HD2' ' CG ' ' A' ' 203' ' ' ASP . 0.6 OUTLIER -90.54 37.25 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.44 96.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.68 -44.82 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -41.75 154.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.08 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -99.31 159.96 14.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -85.51 145.14 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.821 0.343 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -101.69 99.62 9.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 160' ' ' HIS . 90.1 t -117.87 134.67 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.568 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 1.5 mmmp? 33.79 47.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.864 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 64.3 m 64.61 45.08 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.5 m-70 -135.09 118.75 17.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.83 75.56 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -72.34 144.53 48.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.7 p -134.01 127.33 32.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.82 119.17 3.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -143.99 153.26 42.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -116.5 112.77 21.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -87.74 111.18 40.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.668 0.747 . . . . 0.0 110.863 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -6.39 18.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.328 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -128.83 152.53 79.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.61 0.719 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.67 2.247 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.0 m -113.9 138.47 50.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -66.93 129.72 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.1 t -72.04 159.26 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 197' ' ' ILE . 29.1 t -98.09 -29.21 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.47 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.9 t -87.55 -75.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.3 p -72.17 -22.11 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 60.91 45.45 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.35 169.67 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -62.84 122.86 17.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 198' ' ' HIS . 48.4 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -154.43 134.59 13.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -132.58 127.85 35.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.4 t -71.76 162.02 30.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -88.72 -20.02 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -105.61 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 25.7 p -66.56 -10.61 47.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 42.57 49.92 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.75 28.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -94.94 122.05 37.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.464 HG21 HG23 ' A' ' 175' ' ' VAL . 36.4 pt -145.54 173.75 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.576 ' CE1' HG22 ' A' ' 180' ' ' VAL . 74.2 m80 -66.9 176.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -24.13 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -96.57 -38.11 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.48 -25.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 203' ' ' ASP . 19.2 tt -49.02 -39.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.153 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 202' ' ' ILE . 39.6 m-20 -70.25 -32.72 70.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.47 ' HB2' HG11 ' A' ' 175' ' ' VAL . 27.5 mmmt -86.04 38.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.4 125.51 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 80.7 mt -120.64 -40.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.14 136.09 42.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.443 ' HG3' ' NZ ' ' A' ' 158' ' ' LYS . 7.0 mtpm? -83.1 167.05 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.401 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.3 t -84.6 122.18 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 39.3 m80 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.802 0.334 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -78.06 111.4 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.698 HG21 HD11 ' A' ' 202' ' ' ILE . 54.7 t -130.99 115.36 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 10.9 mptt 53.16 40.93 32.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 42.0 m 67.04 40.27 2.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -134.79 118.1 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -79.25 80.41 5.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -80.69 107.23 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 77.0 p -111.53 126.8 55.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.83 108.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.6 t -132.8 146.34 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.159 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.36 143.15 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.97 124.96 28.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.615 0.722 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -23.97 29.77 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.654 2.236 . . . . 0.0 112.311 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -127.45 152.47 76.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 127.93 15.33 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 180' ' ' VAL . 4.7 t -120.21 149.82 41.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -79.14 128.76 33.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.73 159.63 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.426 ' H ' HG22 ' A' ' 197' ' ' ILE . 25.6 m -95.93 -19.16 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.457 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 90.2 t -100.31 -72.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.5 p -71.62 -22.48 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.457 ' CE1' ' O ' ' A' ' 175' ' ' VAL . 9.9 m80 62.83 44.38 6.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.83 151.27 37.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -52.43 130.61 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 171' ' ' THR . 66.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.532 ' CE2' ' HG2' ' A' ' 199' ' ' LYS . 26.9 m-85 -128.69 147.55 50.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.0 110.887 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.591 ' OE1' ' HB2' ' A' ' 196' ' ' ALA . 28.6 tp60 -143.7 110.58 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 5.3 t -57.94 157.81 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -96.34 -14.76 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -99.28 -67.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.42 -22.26 54.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 59.78 47.89 9.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.69 133.33 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.591 ' HB2' ' OE1' ' A' ' 189' ' ' GLN . . . -99.55 124.24 44.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 174' ' ' SER . 42.7 pt -145.15 175.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.52 ' NE2' HG22 ' A' ' 180' ' ' VAL . 67.7 m80 -85.99 163.87 17.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.532 ' HG2' ' CE2' ' A' ' 188' ' ' TYR . 34.2 mttm -67.29 -20.22 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -92.51 -27.16 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.638 ' O ' HG23 ' A' ' 205' ' ' VAL . 76.3 m -82.56 11.04 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.698 HD11 HG21 ' A' ' 157' ' ' VAL . 20.1 tt -73.16 -34.98 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.85 -27.08 49.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.433 ' HB2' HG11 ' A' ' 175' ' ' VAL . 20.3 mttm -88.75 32.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 201' ' ' CYS . 76.8 t -111.12 88.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.184 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.1 mp -85.13 -55.74 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.81 116.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -73.86 144.43 45.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.75 134.11 53.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -100.96 107.62 19.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 85.2 t -131.66 125.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 45.33 36.52 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 67.92 44.4 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.9 m-70 -134.66 118.31 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.448 ' OE2' ' NH2' ' A' ' 191' ' ' ARG . 21.0 mt-10 -91.92 78.17 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -67.84 150.07 49.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 43.6 p -142.0 117.82 10.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.5 106.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -133.6 157.65 45.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.141 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -112.75 107.66 16.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.849 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -81.55 112.11 31.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.436 ' HG2' ' CD ' ' A' ' 169' ' ' GLN . 53.5 Cg_endo -69.78 -7.01 19.97 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.313 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.436 ' CD ' ' HG2' ' A' ' 168' ' ' PRO . 19.6 mp0 -125.46 152.71 71.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.608 0.718 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 110.53 2.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 180' ' ' VAL . 1.3 m -109.26 157.42 18.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.157 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -96.48 129.7 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.6 t -69.29 128.63 37.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 197' ' ' ILE . 72.2 m -85.62 19.52 2.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 204' ' ' LYS . 98.2 t -125.07 -57.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.69 -13.91 17.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 4.7 m170 63.93 52.26 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 179' ' ' PHE . 25.9 mt-10 -132.67 136.71 46.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.458 ' C ' ' O ' ' A' ' 178' ' ' GLU . 29.9 m-85 -33.35 137.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.538 HG22 ' NE2' ' A' ' 198' ' ' HIS . 88.0 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -149.1 137.15 20.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -130.24 120.03 23.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.404 ' HB3' ' N ' ' A' ' 194' ' ' ASN . 4.7 t -66.93 162.02 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.448 ' NH2' ' OE2' ' A' ' 161' ' ' GLU . 18.9 mtm105 -92.93 -24.91 18.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -99.78 -74.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.4 p -72.51 -9.74 58.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.404 ' N ' ' HB3' ' A' ' 190' ' ' CYS . 1.3 p-10 42.99 54.17 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.46 131.96 34.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.105 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -97.7 115.66 28.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 201' ' ' CYS . 12.5 pt -143.11 159.49 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.538 ' NE2' HG22 ' A' ' 180' ' ' VAL . 46.2 m80 -65.23 159.61 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -65.02 -35.09 80.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 201' ' ' CYS . 0.0 OUTLIER -77.96 -26.62 48.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.486 ' O ' HD12 ' A' ' 197' ' ' ILE . 86.0 m -84.21 22.53 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.45 -36.03 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -83.16 -25.27 32.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.717 ' O ' HG13 ' A' ' 175' ' ' VAL . 30.3 mmtm -86.11 31.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.449 HG22 ' CG2' ' A' ' 175' ' ' VAL . 96.7 t -104.94 116.52 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.19 -47.47 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -38.59 137.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.473 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 19.7 ttpt -88.38 156.0 19.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -91.88 113.39 25.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.2 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -97.49 98.57 10.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 65.3 t -120.15 116.58 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.608 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.9 mptt 43.39 45.94 5.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 65.2 m 62.88 40.05 9.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 91.9 m-70 -135.64 123.67 22.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -87.91 88.95 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -82.51 122.88 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -129.67 123.3 30.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.08 101.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.8 t -126.23 155.42 41.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -112.09 112.99 25.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -84.94 126.48 67.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -11.05 30.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.706 2.271 . . . . 0.0 112.382 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.16 152.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 117.62 5.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.3 t -114.67 136.41 53.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.134 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.24 128.83 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.04 159.64 9.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 197' ' ' ILE . 12.6 m -97.36 -26.45 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.92 -75.15 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 12.7 p -70.55 -20.79 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 5.7 m170 60.87 49.45 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 179' ' ' PHE . 5.9 mm-40 -126.95 133.49 50.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 178' ' ' GLU . 12.1 p90 -36.05 111.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.666 HG22 ' CE1' ' A' ' 198' ' ' HIS . 58.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -140.47 137.08 33.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -132.44 118.26 19.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 10.6 t -58.56 162.67 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -94.14 -13.56 26.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -112.36 -62.59 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 194' ' ' ASN . 17.3 p -87.92 4.95 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 193' ' ' CYS . 2.0 p30 34.08 45.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.413 ' HB2' ' SG ' ' A' ' 193' ' ' CYS . . . -72.48 119.41 16.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.096 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.31 115.05 27.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.085 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 201' ' ' CYS . 29.9 pt -141.88 158.32 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.666 ' CE1' HG22 ' A' ' 180' ' ' VAL . 72.7 m80 -63.22 161.2 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -65.03 -18.88 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.59 -23.72 16.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.542 ' O ' HD12 ' A' ' 197' ' ' ILE . 81.3 m -83.35 22.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 203' ' ' ASP . 21.1 tt -84.3 -39.57 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.422 ' N ' HG23 ' A' ' 202' ' ' ILE . 3.4 p30 -75.33 -30.74 60.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -84.39 36.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -108.74 108.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 39.7 mm -105.42 -50.2 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.49 146.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -92.89 165.12 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.556 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.7 t -95.39 118.16 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.929 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -94.08 106.41 18.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 160' ' ' HIS . 87.5 t -124.83 126.67 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . 28.7 mmmt 34.76 39.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 t 74.98 43.92 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.554 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 92.1 m-70 -137.76 115.4 11.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -80.77 74.25 7.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 33.1 m-85 -70.3 128.75 37.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 80.9 p -136.01 126.43 26.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.3 115.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.8 t -134.45 154.14 51.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.17 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -105.36 103.7 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -77.9 111.91 21.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.64 19.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.644 2.229 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -140.48 156.68 69.37 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.712 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 109.0 2.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.676 2.25 . . . . 0.0 112.355 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.559 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.8 t -99.16 157.91 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.113 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 1.4 p90 -87.6 129.01 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 40.0 t -79.37 119.01 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.1 t -82.31 26.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 204' ' ' LYS . 57.9 t -128.27 -59.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -101.81 -13.37 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.4 m170 62.16 53.37 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.95 131.13 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -40.91 114.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.464 -0.255 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.573 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 14.8 m-85 -150.54 134.99 17.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -132.3 117.99 18.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 41.7 t -63.36 163.72 10.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -99.71 -27.06 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.4 ' HB2' ' SG ' ' A' ' 209' ' ' CYS . 36.6 mm-40 -87.98 -68.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.3 p -81.49 -24.64 36.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 190' ' ' CYS . 4.0 m-80 62.71 51.06 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.23 125.69 34.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.059 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.559 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -94.09 130.24 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 201' ' ' CYS . 28.4 pt -154.16 170.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -71.37 159.86 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.573 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 2.2 ttpm? -66.33 -29.19 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 -27.21 24.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.553 ' O ' HD12 ' A' ' 197' ' ' ILE . 72.3 m -81.69 21.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.8 tt -79.55 -39.22 20.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.405 ' N ' HG23 ' A' ' 202' ' ' ILE . 34.3 m-20 -77.73 -28.4 50.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.619 ' O ' HG13 ' A' ' 175' ' ' VAL . 13.5 mmmm -84.64 32.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 201' ' ' CYS . 62.3 t -107.48 114.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.4 mp -103.09 -54.74 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.68 122.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -82.84 158.36 22.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.8 t -88.06 137.5 32.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.1 m170 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.79 0.329 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -96.95 110.75 23.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.0 t -134.68 126.46 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . 22.7 mmtt 37.2 38.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 3.4 t 70.23 42.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.1 m-70 -132.9 128.6 36.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -92.65 74.78 5.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 38.4 m-85 -65.12 140.49 58.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 26.4 p -139.76 121.87 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.162 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.09 114.48 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.5 HG23 ' CZ ' ' A' ' 167' ' ' PHE . 14.4 t -142.46 149.0 38.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -110.43 125.12 52.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.5 ' CZ ' HG23 ' A' ' 165' ' ' THR . 18.1 m-85 -100.92 106.65 45.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -5.1 15.37 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.694 2.263 . . . . 0.0 112.36 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -126.93 158.92 67.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 116.26 4.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.634 2.222 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 88.9 m -121.16 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.23 138.32 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.92 159.24 30.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 197' ' ' ILE . 3.6 m -105.82 -26.85 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.552 HG23 HG21 ' A' ' 197' ' ' ILE . 75.2 t -80.24 -62.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.9 p -86.79 -27.0 23.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 10.6 m80 72.84 40.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 179' ' ' PHE . 37.9 mt-10 -125.27 128.89 48.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 178' ' ' GLU . 1.5 p90 -36.61 119.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 198' ' ' HIS . 47.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.452 ' HB3' ' CD1' ' A' ' 162' ' ' PHE . 42.0 m-85 -134.55 137.74 44.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -123.84 124.77 43.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 52.2 t -73.15 143.3 47.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -89.97 18.41 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.855 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -128.54 -61.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 26.5 p -91.85 -16.21 27.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 60.4 48.12 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.33 124.22 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 128.86 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.552 HG21 HG23 ' A' ' 175' ' ' VAL . 43.9 pt -145.39 173.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.759 ' CE1' HG22 ' A' ' 180' ' ' VAL . 46.4 m80 -67.73 175.42 2.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -75.35 -31.88 60.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -91.1 -41.36 11.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.7 m -43.77 -25.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.7 tt -45.8 -36.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.53 -37.45 65.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.484 ' O ' HG13 ' A' ' 175' ' ' VAL . 9.7 mmmm -82.57 40.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.27 116.18 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.11 -41.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -42.29 154.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -107.76 138.82 43.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -72.5 140.37 48.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.864 0.364 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.47 112.64 24.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.94 125.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm 47.98 36.42 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 11.0 t 72.51 39.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.7 m-70 -132.29 122.45 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -90.7 76.55 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.512 ' CD2' HG13 ' A' ' 202' ' ' ILE . 42.7 m-85 -75.03 107.69 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.9 p -113.26 130.94 56.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.5 101.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 189' ' ' GLN . 14.9 t -121.67 152.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -113.0 114.54 27.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -88.48 128.47 52.83 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.674 0.749 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.92 154.51 67.64 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.535 0.683 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 115.94 4.33 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.4 t -105.62 153.41 21.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.36 116.28 28.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.3 t -44.9 160.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.425 ' H ' HG22 ' A' ' 197' ' ' ILE . 1.6 m -103.99 -34.29 8.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 204' ' ' LYS . 80.6 t -76.61 -68.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.4 p -80.29 -24.51 39.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.416 ' NE2' ' O ' ' A' ' 174' ' ' SER . 39.2 m80 64.27 47.94 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 180' ' ' VAL . 15.4 mm-40 -120.61 152.02 38.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -50.68 116.52 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 198' ' ' HIS . 81.2 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 199' ' ' LYS . 12.4 m-85 -127.28 150.14 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.92 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.431 ' HB2' HG21 ' A' ' 165' ' ' THR . 33.5 tt0 -138.52 119.46 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 42.5 t -74.43 132.27 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -83.3 24.24 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.4 ' HB2' ' SG ' ' A' ' 209' ' ' CYS . 6.5 mm100 -131.37 -55.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -98.53 -24.81 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.8 t30 73.73 45.34 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.77 120.85 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.89 121.06 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 174' ' ' SER . 46.0 pt -143.97 171.35 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.576 ' CE1' HG22 ' A' ' 180' ' ' VAL . 58.2 m80 -65.16 175.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 188' ' ' TYR . 24.0 mtpt -77.39 -28.66 52.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 202' ' ' ILE . 18.9 pttm -93.46 -38.8 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.27 -20.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' A' ' 162' ' ' PHE . 19.2 tt -51.54 -26.03 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.48 -32.95 36.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.63 ' HB2' HG11 ' A' ' 175' ' ' VAL . 1.3 mmmp? -83.4 33.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.2 t -112.82 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.11 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 89.8 mt -120.65 -38.09 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -47.72 138.39 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -84.6 140.67 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.543 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 6.5 t -71.48 141.01 50.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 62.5 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.847 0.356 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -90.2 114.64 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.83 127.8 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mmtp 39.85 43.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 87.1 m 63.57 44.96 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -137.23 131.74 32.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.77 77.17 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 39.0 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 42.4 p -140.85 123.33 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.47 109.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.1 t -134.42 150.29 50.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.59 115.55 30.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 41.0 m-85 -91.44 107.49 22.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.61 0.719 . . . . 0.0 110.86 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.461 ' HG2' ' NE2' ' A' ' 169' ' ' GLN . 54.2 Cg_endo -69.74 -6.37 18.42 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.311 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.461 ' NE2' ' HG2' ' A' ' 168' ' ' PRO . 14.7 mp0 -129.38 153.65 80.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 53.7 Cg_endo -69.86 109.5 2.35 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.653 2.235 . . . . 0.0 112.331 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 172' ' ' PHE . 21.8 m -104.58 157.33 17.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.438 ' N ' HG22 ' A' ' 171' ' ' THR . 37.7 p90 -92.86 112.89 25.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.853 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.5 t -61.86 127.82 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.0 t -83.75 19.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.588 HG23 HG21 ' A' ' 197' ' ' ILE . 90.0 t -127.38 -59.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -98.95 -16.17 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.2 m170 62.47 49.43 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -125.85 139.62 53.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -40.14 132.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.989 HG22 ' NE2' ' A' ' 198' ' ' HIS . 75.2 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 11.4 m-85 -138.31 130.06 28.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -121.99 119.52 31.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 34.8 t -65.6 162.66 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -94.83 -24.22 17.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 15.7 mt-30 -94.52 -75.09 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 31.6 p -72.67 -22.17 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 192' ' ' GLN . 7.6 m-80 59.22 52.99 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -92.12 130.02 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.69 120.97 36.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.588 HG21 HG23 ' A' ' 175' ' ' VAL . 23.1 pt -145.47 165.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.989 ' NE2' HG22 ' A' ' 180' ' ' VAL . 53.2 m80 -73.96 154.55 39.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 45.0 mtmt -57.74 -36.47 72.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -74.72 -30.35 61.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.557 ' O ' HD12 ' A' ' 197' ' ' ILE . 57.1 m -83.99 28.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 203' ' ' ASP . 20.8 tt -85.72 -38.96 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.4 ' N ' HG23 ' A' ' 202' ' ' ILE . 5.2 m-20 -80.35 -23.35 40.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.524 ' HB2' HG11 ' A' ' 175' ' ' VAL . 26.1 mmtm -84.3 29.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -104.16 121.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.43 -47.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.18 125.72 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.05 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -75.53 153.39 37.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.538 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.9 t -78.98 126.19 30.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 -179.93 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.67 110.13 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 160' ' ' HIS . 85.2 t -137.94 130.33 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.6 mmtm 36.95 45.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.1 m 64.56 46.13 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.565 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.1 m-70 -136.99 128.76 28.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -87.27 76.6 9.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -78.03 126.46 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.655 HG21 ' CZ ' ' A' ' 191' ' ' ARG . 6.1 t -147.16 135.52 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.159 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.71 115.29 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.785 HG21 ' HB2' ' A' ' 189' ' ' GLN . 10.2 t -135.43 158.57 44.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.03 118.13 33.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.455 ' CZ ' HG23 ' A' ' 165' ' ' THR . 24.9 m-85 -94.63 127.66 42.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.2 32.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.718 2.279 . . . . 0.0 112.375 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -127.11 158.84 67.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.58 0.705 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.19 2.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.718 2.279 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.633 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.9 t -96.95 157.74 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -97.22 140.36 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.473 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 48.7 t -80.09 124.49 28.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 t -86.17 22.11 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.6 t -121.87 -48.32 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.65 -11.36 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 17.5 m170 63.2 52.24 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 179' ' ' PHE . 13.6 mm-40 -131.85 136.02 47.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 178' ' ' GLU . 5.5 m-85 -36.97 126.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.591 HG22 ' CE1' ' A' ' 198' ' ' HIS . 46.4 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.591 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 11.8 m-85 -126.47 131.14 51.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 110.895 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.785 ' HB2' HG21 ' A' ' 165' ' ' THR . 45.2 tt0 -126.75 124.38 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 49.3 t -77.13 130.12 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.655 ' CZ ' HG21 ' A' ' 163' ' ' THR . 0.2 OUTLIER -81.2 19.08 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -124.95 -61.55 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.4 p -93.11 -24.56 18.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 73.54 46.64 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.8 121.55 38.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -95.85 123.06 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 201' ' ' CYS . 41.8 pt -141.97 167.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.591 ' CE1' HG22 ' A' ' 180' ' ' VAL . 44.8 m80 -70.73 151.13 45.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.87 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.591 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 23.8 tttt -57.94 -34.98 70.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -80.95 -26.07 36.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.559 ' O ' HD12 ' A' ' 197' ' ' ILE . 87.2 m -83.04 27.45 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 203' ' ' ASP . 19.5 tt -86.06 -39.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 202' ' ' ILE . 8.1 t70 -74.17 -29.82 61.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 36.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.09 128.9 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 207' ' ' ALA . 88.4 mt -126.08 -52.94 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.84 116.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.094 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 160.41 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 9.1 t -87.81 144.53 26.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 -179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.808 0.337 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.77 100.05 12.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.21 107.79 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 16.6 mmtm 62.63 41.3 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 m 63.94 39.16 8.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.897 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 97.4 m-70 -132.54 124.92 29.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -92.74 77.84 4.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.01 121.19 21.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 62.5 p -123.91 127.27 47.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.157 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.9 115.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.459 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 10.1 t -134.63 143.29 47.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -99.89 108.09 20.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.459 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 45.6 m-85 -81.19 127.41 74.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.661 0.743 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -26.69 27.46 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.244 . . . . 0.0 112.373 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -129.94 153.38 80.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 110.15 2.48 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.2 t -97.73 153.64 18.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 1.3 p90 -81.7 118.77 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -54.04 160.49 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.1 t -103.16 -29.05 11.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.57 -66.82 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 16.7 p -81.19 -22.31 38.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 5.4 m170 63.48 45.17 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 179' ' ' PHE . 54.3 mt-10 -127.42 133.79 49.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.8 p90 -35.38 105.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 198' ' ' HIS . 83.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.567 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 23.1 m-85 -133.41 143.12 48.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -139.61 132.67 29.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.7 t -73.83 162.71 28.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -90.82 -20.08 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.83 -70.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 15.4 p -72.07 -16.24 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 50.3 48.21 22.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -82.25 118.76 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.31 121.55 33.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 202' ' ' ILE . 40.0 pt -145.74 175.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.449 ' CE1' HG22 ' A' ' 180' ' ' VAL . 64.9 m80 -70.97 175.24 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.668 ' O ' HG22 ' A' ' 202' ' ' ILE . 5.9 mtpm? -70.51 -43.67 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.4 pptp? -80.15 -36.08 35.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 1.8 m -51.02 -22.5 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 199' ' ' LYS . 16.6 tt -52.79 -38.33 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.6 -32.73 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -83.27 37.16 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.8 t -114.23 115.35 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.9 mt -110.65 -43.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.64 163.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 3.8 ttmp? -110.92 162.85 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 208' ' ' LYS . 4.2 t -86.8 109.42 19.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.954 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.812 0.339 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -74.57 118.11 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.8 t -139.8 122.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.4 mptt 42.04 44.9 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.939 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 4.2 m 63.31 42.47 6.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.4 m-70 -137.16 119.15 15.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -84.32 79.35 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -73.62 139.14 45.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.6 p -141.5 125.86 17.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.2 106.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.1 t -125.1 160.97 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.159 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -112.56 115.79 29.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -89.56 110.64 40.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.628 0.728 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -15.09 36.69 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 0.0 112.355 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -129.97 160.91 62.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.923 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.32 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 m -102.09 147.36 26.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -89.58 109.43 20.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.87 159.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 p -99.36 -28.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.6 -73.48 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.7 p -75.31 -22.64 57.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 63.13 44.42 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.54 142.79 49.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -42.67 123.07 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.608 HG22 ' CE1' ' A' ' 198' ' ' HIS . 92.8 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.443 ' CZ ' ' HD2' ' A' ' 199' ' ' LYS . 23.3 m-85 -149.17 146.22 27.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -145.62 114.75 7.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.76 161.11 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -96.12 -20.47 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -96.81 -70.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.943 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -72.55 -20.63 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 56.67 51.58 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.24 126.23 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.48 131.71 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 29.7 pt -151.39 151.51 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' HIS . . . . . 0.608 ' CE1' HG22 ' A' ' 180' ' ' VAL . 73.0 m80 -61.03 157.66 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 188' ' ' TYR . 0.2 OUTLIER -63.28 -14.31 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -98.51 -23.03 15.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.652 ' O ' HG23 ' A' ' 205' ' ' VAL . 88.0 m -83.0 16.56 2.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.9 tt -81.13 -38.98 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 202' ' ' ILE . 0.7 OUTLIER -75.12 -28.79 60.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 201' ' ' CYS . 1.6 mptt -87.68 32.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 201' ' ' CYS . 55.0 t -110.01 111.48 36.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.167 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 97.5 mt -111.23 -46.89 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -37.39 155.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -101.37 164.0 11.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.463 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -91.39 138.62 31.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 210' ' ' THR . 15.0 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.1 t -163.72 170.56 16.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.854 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.1 p -166.77 150.97 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -143.7 173.16 24.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.452 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 m -121.14 129.81 53.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.846 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.8 t -47.2 -46.7 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.34 140.07 4.52 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.525 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -117.36 125.92 51.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -133.61 146.6 51.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.28 170.16 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 140.09 57.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.64 42.31 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.74 0.305 . . . . 0.0 111.118 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 149' ' ' ILE . 14.7 tt -128.81 117.57 44.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.186 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -95.66 -58.85 2.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 152' ' ' ALA . 34.9 tp60 -166.79 147.51 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.451 ' N ' ' HG3' ' A' ' 151' ' ' GLN . . . -142.45 126.79 17.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.086 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.51 160.15 8.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 161' ' ' GLU . 95.6 t -137.92 141.86 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.141 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -93.53 125.85 38.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -103.88 99.48 9.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.4 t -121.72 112.64 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 2.5 mptp? 58.66 41.1 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 5.9 t 65.63 37.69 5.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -134.6 125.96 28.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.468 ' HB3' HG11 ' A' ' 154' ' ' VAL . 40.2 mt-10 -92.29 81.73 4.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.28 121.63 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.8 p -126.64 123.44 37.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.115 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.36 104.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.454 ' C ' ' NE2' ' A' ' 186' ' ' GLN . 12.1 t -130.45 149.06 52.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.167 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.422 ' CE2' ' OE1' ' A' ' 186' ' ' GLN . 15.2 m-85 -105.69 108.71 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.35 111.46 20.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.66 0.743 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -7.03 20.02 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -129.19 154.29 80.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 87.6 m -116.7 135.38 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -78.11 136.22 37.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.31 159.47 17.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.416 ' H ' HG22 ' A' ' 197' ' ' ILE . 20.5 m -94.72 -23.64 17.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.0 t -96.48 -75.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.137 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.9 p -67.7 -22.2 65.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 40.3 m80 62.34 50.91 3.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -122.59 145.32 48.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -55.25 119.47 5.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 198' ' ' HIS . 25.4 t -98.81 65.21 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.541 ' O ' ' CG ' ' A' ' 181' ' ' TRP . 4.7 p-90 -124.38 37.29 4.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.47 139.39 20.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.521 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.7 128.23 35.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.886 0.374 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 61.44 45.56 8.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -124.91 99.89 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.454 ' NE2' ' C ' ' A' ' 165' ' ' THR . 38.7 tp60 -70.08 131.81 44.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -114.41 -156.28 11.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.459 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.413 ' CE2' HD12 ' A' ' 202' ' ' ILE . 11.4 m-85 -140.92 132.82 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 110.883 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -132.47 119.73 20.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.55 162.07 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -95.43 -24.37 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.34 -75.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.9 p -71.34 -24.0 62.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.37 51.95 2.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.49 129.99 36.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.83 126.15 40.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 201' ' ' CYS . 29.9 pt -149.86 153.62 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.174 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.3 m80 -67.02 159.94 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -59.2 -35.86 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -76.04 -23.28 55.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.615 ' O ' HD12 ' A' ' 197' ' ' ILE . 66.2 m -87.91 24.5 1.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.413 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.1 tt -87.61 -30.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.82 -19.54 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.537 ' HB2' HG11 ' A' ' 175' ' ' VAL . 11.4 mmtp -89.23 25.02 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.41 117.68 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 25.6 mm -116.17 -47.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.31 141.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -89.55 156.97 18.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 3.5 t -83.48 133.51 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.521 HG23 ' N ' ' A' ' 211' ' ' GLY . 10.0 t -86.91 -47.21 9.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 210' ' ' THR . . . 103.57 154.04 23.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.8 t -123.2 140.41 53.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 110.834 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 179.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -151.73 137.4 17.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.873 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.6 m -129.66 162.46 28.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.4 174.4 39.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.7 m -146.41 162.54 38.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.934 0.397 . . . . 0.0 110.792 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.4 m -103.8 -62.1 1.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.04 141.47 0.63 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -148.17 134.43 19.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -139.58 133.61 30.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -151.7 128.39 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.33 132.98 6.45 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -133.71 165.96 23.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 0.0 111.104 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.7 tt -140.43 151.35 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -79.48 122.56 26.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -66.53 151.13 47.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -165.39 147.38 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.089 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.413 ' HE3' ' CE1' ' A' ' 155' ' ' HIS . 15.3 pttt -150.2 168.23 24.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.6 t -114.51 129.54 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.413 ' CE1' ' HE3' ' A' ' 153' ' ' LYS . 32.0 m170 -109.01 116.56 32.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -82.21 110.43 17.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 160' ' ' HIS . 70.9 t -134.12 126.29 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.607 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.0 mptt 36.41 46.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 66.2 m 63.14 42.35 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 94.9 m-70 -136.99 131.77 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -96.36 79.18 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -69.45 133.84 48.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.3 p -136.7 125.53 24.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.09 113.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 189' ' ' GLN . 15.3 t -133.02 158.41 42.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.172 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.03 100.88 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.437 ' CZ ' ' CB ' ' A' ' 196' ' ' ALA . 84.1 m-85 -75.29 118.96 74.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.606 0.717 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -9.03 25.1 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.656 2.237 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.63 158.01 54.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 110.1 2.48 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.7 2.267 . . . . 0.0 112.334 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.52 HG21 ' CB ' ' A' ' 196' ' ' ALA . 9.8 t -98.14 150.71 21.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 177' ' ' HIS . 2.1 t80 -76.97 107.66 9.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 t -57.25 127.16 30.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.1 p -82.92 25.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.614 HG23 HG21 ' A' ' 197' ' ' ILE . 88.8 t -131.91 -53.63 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -106.85 -17.91 14.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 4.8 m170 72.8 49.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -136.96 140.13 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -46.16 120.4 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.734 HG22 ' CE1' ' A' ' 198' ' ' HIS . 60.0 t -99.78 84.25 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -133.68 -34.49 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -67.32 -159.74 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 25.0 mt 62.5 44.14 7.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.355 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.57 43.4 12.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt 42.58 43.56 3.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -127.37 137.0 52.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -156.65 -140.6 2.99 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.501 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 199' ' ' LYS . 17.8 m-85 -148.83 132.77 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.922 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.591 ' HB2' HG21 ' A' ' 165' ' ' THR . 21.7 tt0 -132.34 127.39 35.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.9 t -69.49 162.06 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -92.31 -18.64 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -103.72 -73.87 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.453 ' C ' ' CG ' ' A' ' 194' ' ' ASN . 27.8 p -72.48 -14.46 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.453 ' CG ' ' C ' ' A' ' 193' ' ' CYS . 1.0 OUTLIER 48.47 53.44 12.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.93 126.14 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 171' ' ' THR . . . -96.38 121.14 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 201' ' ' CYS . 40.2 pt -143.61 163.21 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.734 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.7 m80 -67.87 152.13 46.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 188' ' ' TYR . 47.5 mtpt -57.32 -27.32 62.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -84.7 -25.36 28.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.722 ' O ' HD12 ' A' ' 197' ' ' ILE . 77.4 m -85.13 26.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.7 tt -87.1 -33.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.79 -23.98 31.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -89.24 28.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 201' ' ' CYS . 86.2 t -104.49 119.7 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.088 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 87.5 mt -114.28 -54.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.44 118.0 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -73.59 158.59 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.9 t -86.77 131.05 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t -104.78 -21.54 13.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 139.92 -134.57 6.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.5 m -91.91 129.28 37.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.85 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.079 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -100.69 139.04 36.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.85 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.4 m -160.87 151.04 17.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.82 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.79 -179.92 26.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.551 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.4 t -161.83 123.98 2.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.85 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 t -132.25 159.6 38.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.848 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.18 105.43 0.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.492 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -165.57 151.49 9.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.792 0.33 . . . . 0.0 110.936 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -134.28 171.45 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.18 147.2 30.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.922 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.42 150.5 21.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.07 106.45 5.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.735 0.302 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.8 tt -149.96 138.7 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -103.78 173.73 6.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -137.92 175.9 9.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.36 159.15 42.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.73 118.28 5.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 161' ' ' GLU . 84.6 t -100.57 148.58 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -110.46 138.92 46.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -104.05 102.15 11.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -127.78 108.02 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.11 43.24 21.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 66.04 35.87 6.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CB ' ' CE2' ' A' ' 162' ' ' PHE . 97.7 m-70 -129.27 117.86 21.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.413 ' HB3' HG11 ' A' ' 154' ' ' VAL . 5.7 mp0 -76.75 50.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 160' ' ' HIS . 37.2 m-85 -60.2 105.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -122.16 136.27 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.12 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.56 124.86 3.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.42 HG21 ' HB2' ' A' ' 189' ' ' GLN . 15.2 t -143.2 153.49 42.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -102.65 128.82 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.05 109.33 58.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.707 2.272 . . . . 0.0 112.309 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -144.76 157.51 54.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 127.19 14.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 88.4 m -128.96 138.72 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -75.39 129.73 37.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.0 t -60.7 157.4 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.543 ' H ' HG22 ' A' ' 197' ' ' ILE . 17.9 t -98.63 -29.2 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.445 HG11 ' HB2' ' A' ' 204' ' ' LYS . 99.0 t -85.16 -74.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.1 p -71.09 -23.87 62.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 63.54 53.88 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 179' ' ' PHE . 20.8 mt-10 -134.44 130.86 37.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 178' ' ' GLU . 8.5 p90 -34.73 123.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 198' ' ' HIS . 84.1 t -103.72 87.78 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -172.78 110.91 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 151.37 -132.45 3.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 183' ' ' LEU . 7.7 tt -44.92 -43.93 9.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.06 85.57 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 186' ' ' GLN . 16.5 pttm -76.89 -42.22 40.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 185' ' ' LYS . 35.8 mt-30 -78.88 136.94 37.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -140.95 -136.98 3.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.48 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -154.08 140.55 18.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.42 ' HB2' HG21 ' A' ' 165' ' ' THR . 66.5 tt0 -140.81 109.69 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -58.78 161.42 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -95.13 -19.84 19.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.458 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 20.6 mt-30 -98.84 -74.57 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.425 ' C ' ' CG ' ' A' ' 194' ' ' ASN . 30.7 p -71.3 -12.63 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 192' ' ' GLN . 0.6 OUTLIER 47.16 52.01 12.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.92 122.68 32.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.79 115.31 27.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.09 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 174' ' ' SER . 27.3 pt -140.64 173.91 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.477 ' CE1' HG22 ' A' ' 180' ' ' VAL . 58.8 m80 -63.59 172.61 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -78.1 -15.43 58.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.8 pptp? -106.03 -32.21 8.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 3.4 m -55.43 -16.68 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.59 -26.83 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.85 -31.72 61.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.445 ' HB2' HG11 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -92.67 32.87 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 201' ' ' CYS . 54.5 t -110.69 89.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.8 mt -91.25 -44.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.62 135.19 1.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -79.1 153.74 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.477 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 8.1 t -79.57 113.26 17.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 45.4 p -104.82 39.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -44.86 -40.71 6.94 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.471 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.1 t -54.18 138.85 37.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 110.866 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.121 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 81.7 p -153.24 123.6 7.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.865 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.1 m -139.01 153.3 48.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -134.45 174.21 21.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.1 t -165.2 163.1 20.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.5 p -169.24 143.54 2.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.847 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -149.55 92.35 0.14 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.49 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -118.23 169.13 9.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.904 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -128.08 158.14 38.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -134.56 162.21 32.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.5 161.13 22.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.44 158.51 16.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.332 . . . . 0.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 149' ' ' ILE . 4.2 tp -78.15 121.7 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -68.0 104.03 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -101.24 141.04 34.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.07 173.41 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.096 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -143.96 151.39 39.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.5 t -119.27 133.52 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -106.86 136.53 46.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.832 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -112.34 123.78 51.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.6 t -140.01 107.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.508 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.5 mttm 62.36 47.91 5.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.61 37.92 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.522 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 99.6 m-70 -131.04 113.55 14.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -84.13 76.3 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -71.9 138.79 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 73.3 p -140.72 128.71 22.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.493 ' HB1' HE21 ' A' ' 186' ' ' GLN . . . -44.56 116.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 15.3 t -138.67 142.07 39.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 186' ' ' GLN . 20.7 m-85 -106.88 110.62 22.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 13.3 m-85 -88.13 111.37 42.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.749 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -16.16 37.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.301 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -114.23 154.29 46.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 109.57 2.35 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.661 2.24 . . . . 0.0 112.317 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 57.1 m -113.69 135.01 54.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 7.3 p90 -77.14 115.67 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -44.93 159.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.561 ' H ' HG22 ' A' ' 197' ' ' ILE . 18.2 m -99.29 -26.12 14.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.1 t -88.69 -71.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.8 p -75.23 -23.78 57.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.833 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.5 m80 64.21 51.87 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 179' ' ' PHE . 62.2 mt-10 -133.18 131.53 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 178' ' ' GLU . 27.3 p90 -32.91 113.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.647 HG22 ' CE1' ' A' ' 198' ' ' HIS . 68.1 t -93.74 93.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -174.63 107.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -126.52 -119.7 2.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.542 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.9 tt -120.04 108.51 14.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 44.86 40.48 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -101.63 149.24 24.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 12.2 pt20 -121.4 155.22 35.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -118.67 -137.8 5.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -150.4 129.82 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 110.946 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.457 ' HB2' HG21 ' A' ' 165' ' ' THR . 17.1 tt0 -123.72 131.62 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 11.4 t -76.22 161.81 28.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -93.23 -20.38 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.24 -75.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.6 p -69.92 -15.18 63.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 51.6 52.61 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -90.19 123.39 33.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -98.29 120.99 39.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 174' ' ' SER . 38.2 pt -141.36 171.97 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.647 ' CE1' HG22 ' A' ' 180' ' ' VAL . 49.7 m80 -63.01 -177.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -79.21 -37.15 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -87.32 -37.18 17.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 4.6 m -49.07 -18.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.41 ' HA ' HD11 ' A' ' 197' ' ' ILE . 16.6 tt -54.97 -32.5 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.81 -35.56 64.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.541 ' HB2' HG11 ' A' ' 175' ' ' VAL . 6.9 mmpt? -84.68 35.05 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.29 118.7 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 206' ' ' ILE . 3.8 mp -119.65 -56.86 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -35.02 112.4 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -64.38 150.25 46.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.522 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.8 t -73.07 137.19 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 77.6 p -113.81 -42.57 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 113.92 -41.95 2.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.482 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.0 t -115.46 163.73 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 110.862 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.094 179.894 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 t -154.27 152.27 30.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 0.0 110.854 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.8 p -132.47 154.28 50.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -141.29 -170.99 12.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.471 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.8 t -115.52 165.32 13.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 0.0 110.825 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.3 m -152.1 160.94 43.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -169.6 157.43 29.13 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -123.49 173.64 7.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -155.07 162.56 41.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -145.06 166.39 25.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -111.31 112.96 3.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.454 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.36 42.23 1.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.806 0.336 . . . . 0.0 111.08 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 149' ' ' ILE . 6.9 tt -126.46 126.51 69.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -146.14 151.38 37.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -143.76 131.92 21.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.951 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.43 175.85 9.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.075 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 135.89 47.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.7 141.16 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.094 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -116.16 107.92 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -76.22 113.4 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.78 106.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.495 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.0 mptp? 60.62 42.59 13.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 63.3 m 64.41 37.85 8.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.3 m-70 -131.47 119.02 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -83.07 79.45 9.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -72.76 135.75 45.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 p -140.01 123.32 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -51.14 112.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -141.02 148.54 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -94.3 134.19 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -107.71 105.02 55.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.637 0.732 . . . . 0.0 110.901 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -3.53 12.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -128.92 153.54 80.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.709 2.273 . . . . 0.0 112.333 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.5 m -126.87 136.04 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -83.57 123.03 29.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 3.0 t -54.23 156.39 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 33.9 p -100.79 -17.41 16.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.3 t -97.77 -68.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -80.03 -14.86 58.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.5 m170 57.49 49.09 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 179' ' ' PHE . 70.9 mt-10 -128.29 130.94 48.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.7 p90 -35.46 134.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 198' ' ' HIS . 63.6 t -111.6 79.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -174.42 153.89 2.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 83.36 -71.62 2.97 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.57 -43.4 20.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -113.51 89.34 3.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -74.75 -48.5 25.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -80.98 127.89 33.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -136.15 -157.35 7.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 16.0 m-85 -136.33 140.33 43.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -135.92 115.22 12.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 14.4 t -63.09 138.34 58.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -85.67 20.48 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -132.32 -64.52 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.8 p -86.94 -15.52 38.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 59.48 54.06 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.39 128.06 52.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 129.9 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 33.2 pt -151.03 153.68 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.583 ' CE1' HG22 ' A' ' 180' ' ' VAL . 60.8 m80 -64.57 161.65 17.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.53 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 7.6 mtpm? -64.04 -27.2 68.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -22.56 24.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.2 m -83.98 14.57 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 203' ' ' ASP . 18.1 tt -79.47 -41.87 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.453 ' N ' HG23 ' A' ' 202' ' ' ILE . 64.0 m-20 -73.84 -26.81 60.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -88.07 38.16 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.5 t -111.02 112.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.411 ' O ' ' C ' ' A' ' 207' ' ' ALA . 77.4 mt -106.76 -50.78 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.14 143.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.076 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -97.23 137.57 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.539 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.5 t -65.47 140.52 58.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.6 p -129.11 36.52 4.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.168 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.1 -96.26 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.452 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 60.5 p -56.7 113.68 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.87 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.918 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.3 m -147.6 170.38 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.894 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 t -162.15 144.77 11.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -129.54 153.6 20.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 87.3 p -168.04 136.65 2.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.842 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.7 m -144.33 119.27 9.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -105.76 138.1 14.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.437 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -166.63 134.32 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.28 167.37 9.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -124.54 -58.89 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 163.76 106.67 0.2 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.54 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.06 -8.34 57.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 0.0 111.038 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.7 tp -57.16 131.35 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -102.94 129.9 49.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -86.06 125.14 33.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.9 165.82 26.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -166.37 118.78 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.48 135.82 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -98.94 104.39 16.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -88.87 109.13 19.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.9 t -132.12 136.92 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.606 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 21.6 mmtm 38.96 43.07 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 2.2 m 64.75 41.7 4.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 87.2 m-70 -136.27 142.17 43.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.73 75.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -66.43 105.13 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 p -109.95 121.25 44.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.99 105.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.7 t -127.9 149.9 50.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -107.18 105.08 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.62 114.58 33.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -6.96 19.81 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.751 2.3 . . . . 0.0 112.383 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -140.1 159.5 63.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.599 0.714 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 179' ' ' PHE . 53.7 Cg_endo -69.78 116.5 4.59 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.666 2.244 . . . . 0.0 112.327 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.9 t -114.38 156.87 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.75 146.98 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.9 t -79.53 160.05 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.477 ' H ' HG22 ' A' ' 197' ' ' ILE . 46.6 t -101.84 -30.38 11.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.46 -73.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.2 p -75.02 -25.12 58.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 63.18 50.13 3.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -123.2 135.59 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 170' ' ' PRO . 4.2 t80 -39.63 122.18 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.613 HG22 ' CE1' ' A' ' 198' ' ' HIS . 22.5 t -98.88 83.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -173.88 148.21 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.954 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 98.06 -100.91 2.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.449 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.2 mt -52.57 -55.65 20.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.917 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -98.51 117.11 32.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -108.23 44.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -164.94 144.58 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.53 -176.04 27.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -122.35 135.65 54.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -124.83 121.82 35.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 25.9 t -64.21 163.01 13.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -90.4 -21.82 21.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -103.25 -73.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.5 p -71.36 -12.15 61.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 194' ' ' ASN . 5.1 p-10 43.05 52.87 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -91.24 130.32 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.19 122.4 35.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 174' ' ' SER . 28.6 pt -142.81 147.82 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.613 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.2 m80 -57.69 151.46 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.84 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -57.27 -19.7 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -90.99 -27.41 18.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.458 ' O ' HD12 ' A' ' 197' ' ' ILE . 84.9 m -82.62 20.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.21 -37.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -82.84 -24.22 33.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -85.28 31.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.7 t -101.52 127.0 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.43 -44.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -53.75 125.07 17.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.79 167.29 11.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.468 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 7.8 t -88.31 113.13 23.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.8 p -84.14 34.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.141 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -81.77 -41.65 9.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 43.4 t -57.27 164.09 1.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 110.821 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 179.877 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.2 m -129.09 87.23 2.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.368 . . . . 0.0 110.885 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.9 m -75.94 -58.55 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.813 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.66 164.06 36.74 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.54 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.1 m -129.71 106.29 8.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.0 110.853 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.5 p -153.66 172.55 17.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.86 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 147.06 -171.16 27.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.505 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -150.05 166.73 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -102.1 167.16 10.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.82 162.02 26.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.04 154.39 12.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.557 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -173.39 173.38 3.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.313 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.4 tt -141.02 135.27 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -111.12 150.57 29.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -152.01 150.14 29.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.615 ' CB ' ' HB3' ' A' ' 164' ' ' ALA . . . -79.24 165.28 23.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.451 ' HD2' ' CD2' ' A' ' 155' ' ' HIS . 0.0 OUTLIER -143.94 164.11 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 161' ' ' GLU . 90.4 t -86.27 129.14 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.451 ' CD2' ' HD2' ' A' ' 153' ' ' LYS . 52.6 m-70 -107.33 144.05 34.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -96.29 112.0 23.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 158' ' ' LYS . 97.3 t -140.65 135.53 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mptt 36.31 45.19 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 99.0 m 63.31 46.08 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.1 m-70 -136.3 178.37 7.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.448 ' HB3' HG13 ' A' ' 154' ' ' VAL . 33.7 mt-10 -130.66 50.23 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.538 ' CD2' HG13 ' A' ' 202' ' ' ILE . 23.2 m-85 -51.43 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.46 HG21 ' NH2' ' A' ' 191' ' ' ARG . 7.3 t -117.95 136.67 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.182 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.615 ' HB3' ' CB ' ' A' ' 152' ' ' ALA . . . -43.55 124.16 3.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.418 HG21 ' HB2' ' A' ' 189' ' ' GLN . 13.6 t -145.75 159.89 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -124.94 109.89 13.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -85.26 119.27 72.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.276 . . . . 0.0 112.309 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -147.74 158.28 42.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.614 0.721 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 124.48 11.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.481 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.2 t -117.68 157.47 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -84.78 115.75 22.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.478 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 49.1 t -64.81 126.56 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.54 ' H ' HG22 ' A' ' 197' ' ' ILE . 23.0 t -87.12 26.96 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.625 HG23 HG21 ' A' ' 197' ' ' ILE . 53.5 t -129.76 -55.34 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.89 -16.03 14.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.9 m170 63.59 51.87 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -134.99 132.63 38.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -40.25 109.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.767 HG22 ' CE1' ' A' ' 198' ' ' HIS . 82.6 t -82.51 79.62 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -175.33 115.77 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 174.68 -109.26 0.29 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.7 tp -86.74 -44.51 11.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.98 151.91 28.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -151.5 -179.73 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 65.64 54.36 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.24 -156.03 1.09 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.94 143.87 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.835 0.35 . . . . 0.0 110.926 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.418 ' HB2' HG21 ' A' ' 165' ' ' THR . 46.0 tt0 -143.52 119.71 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 28.2 t -63.46 163.08 11.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.46 ' NH2' HG21 ' A' ' 163' ' ' THR . 21.3 mmt-85 -98.03 -22.79 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -92.28 -68.4 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.99 -25.36 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 63.53 50.15 2.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -89.44 119.39 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.076 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.481 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -92.58 121.04 33.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.625 HG21 HG23 ' A' ' 175' ' ' VAL . 43.1 pt -144.18 174.91 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.767 ' CE1' HG22 ' A' ' 180' ' ' VAL . 52.9 m80 -68.42 178.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.584 ' O ' HG22 ' A' ' 202' ' ' ILE . 37.3 tttm -73.84 -53.88 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 202' ' ' ILE . 10.7 pttm -70.97 -43.7 67.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 18.7 m -43.16 -22.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 199' ' ' LYS . 19.3 tt -50.37 -38.26 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -34.95 71.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.428 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 36.8 mmtt -82.72 36.82 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.55 126.17 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.65 -55.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -37.98 139.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.103 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -90.07 159.36 16.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 5.2 t -79.54 110.18 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.8 t -68.54 -27.87 66.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 69.24 -84.24 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 82.3 p -68.52 140.0 55.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.893 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 179.973 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 t -151.58 137.39 18.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.934 0.397 . . . . 0.0 110.84 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.6 p -170.82 122.45 0.6 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.96 -81.06 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.9 t 67.97 42.22 1.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.875 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -56.28 155.39 6.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.1 157.56 25.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -144.3 109.23 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.749 0.309 . . . . 0.0 110.931 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -154.6 139.98 17.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -170.75 124.64 0.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.08 -112.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.23 160.38 18.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 5.1 tp -74.74 138.06 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.126 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -117.01 127.63 54.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -145.51 119.21 9.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.45 176.09 8.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.6 95.24 4.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.931 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.58 127.97 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -97.73 157.98 15.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.46 ' CE1' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m-70 -125.22 105.49 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 88.7 t -137.83 120.68 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 52.91 39.44 29.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.3 t 65.99 40.01 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -132.01 119.94 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.46 ' OE1' ' CE1' ' A' ' 156' ' ' HIS . 6.6 mm-40 -78.35 70.58 4.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -71.48 97.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.1 t -112.12 134.44 53.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.25 120.32 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.57 HG23 ' CE1' ' A' ' 167' ' ' PHE . 5.1 t -139.29 149.74 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -105.82 117.46 34.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 165' ' ' THR . 18.8 m-85 -91.13 109.73 37.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.728 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -7.56 21.37 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.701 2.267 . . . . 0.0 112.348 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -136.04 160.72 66.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 121.9 8.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.751 2.301 . . . . 0.0 112.326 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.8 m -115.66 150.18 37.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.412 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 32.8 p90 -96.74 111.43 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 12.7 t -47.56 157.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 p -97.56 -22.67 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.763 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.5 t -92.81 -74.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -73.27 -23.62 60.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 63.56 46.27 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.98 148.66 43.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -45.01 130.57 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.559 HG22 ' CE1' ' A' ' 198' ' ' HIS . 69.1 t -108.79 75.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 3.0 p-90 -173.9 150.94 1.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 109.47 -65.02 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.521 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.08 142.44 25.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -57.13 -30.32 64.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.844 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -67.08 143.6 56.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -91.48 176.21 6.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.939 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -112.09 166.75 12.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.52 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.534 ' CZ ' ' HG2' ' A' ' 199' ' ' LYS . 14.5 m-85 -104.0 131.98 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -129.78 118.71 22.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 8.9 t -62.68 161.68 11.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -96.49 -20.71 18.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -97.21 -71.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 21.5 p -74.18 -20.55 60.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 57.83 53.51 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.38 128.7 41.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -94.84 125.79 39.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 201' ' ' CYS . 23.7 pt -152.09 147.27 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.076 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.559 ' CE1' HG22 ' A' ' 180' ' ' VAL . 69.5 m80 -60.01 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.534 ' HG2' ' CZ ' ' A' ' 188' ' ' TYR . 41.7 mttt -58.67 -22.83 58.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -22.85 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.576 ' O ' HD12 ' A' ' 197' ' ' ILE . 79.2 m -86.77 27.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 tt -88.27 -30.39 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -80.58 -25.45 38.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.763 ' HB2' HG11 ' A' ' 175' ' ' VAL . 24.3 mttm -88.77 31.48 0.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.58 110.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' ALA . 46.7 mm -109.27 -54.3 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.38 145.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.131 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -91.92 167.11 12.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.6 t -98.64 124.97 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p -78.2 -45.69 22.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 42.92 -97.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.505 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 73.8 m -78.52 120.77 23.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.378 . . . . 0.0 110.886 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.919 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 93.2 p -174.59 176.66 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.851 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.1 t -154.49 174.91 14.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.71 163.4 14.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 m -149.65 173.55 13.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.378 . . . . 0.0 110.862 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.8 t -134.71 174.33 10.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.15 121.27 2.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.481 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -143.4 176.38 9.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.778 0.323 . . . . 0.0 110.893 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -148.34 160.77 42.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -133.38 124.68 27.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.07 -153.95 15.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -172.63 160.22 4.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 111.08 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.7 tp -63.06 140.64 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -151.68 143.48 23.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.02 150.89 24.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.89 146.33 14.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -159.63 145.68 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 163' ' ' THR . 91.4 t -104.66 108.99 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -74.38 144.73 44.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -110.57 107.12 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.833 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 160' ' ' HIS . 58.2 t -129.65 131.46 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.078 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 14.2 mptt 37.41 45.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 59.1 m 63.47 41.22 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.545 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -133.25 120.88 21.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.6 70.39 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -75.69 103.68 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.525 ' HB ' HG22 ' A' ' 154' ' ' VAL . 3.1 t -119.9 138.94 53.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.52 119.82 2.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.5 t -141.25 141.39 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -97.21 118.85 34.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -90.63 108.84 30.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -5.68 16.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.725 2.284 . . . . 0.0 112.289 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -133.88 153.95 80.15 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 m -108.62 156.35 19.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 172' ' ' PHE . 19.0 p90 -103.74 131.95 50.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.06 155.28 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 m -100.49 -24.29 14.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.23 -72.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 14.3 p -74.43 -21.29 59.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 8.2 m170 63.2 47.67 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -124.52 143.85 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -48.23 128.17 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' A' ' 198' ' ' HIS . 21.3 t -99.93 79.89 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -172.44 109.47 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 149.05 -94.53 0.16 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -61.55 -62.48 1.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 0.0 110.925 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -96.27 79.98 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -47.18 -40.84 16.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.922 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 185' ' ' LYS . 7.6 pt20 -95.74 175.29 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -164.95 -155.87 8.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 199' ' ' LYS . 20.8 m-85 -124.78 135.51 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.46 112.92 9.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.9 t -57.72 159.17 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -96.98 -16.99 20.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -97.85 -68.43 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 32.1 p -76.68 -23.45 53.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.98 53.33 3.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.75 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.51 118.75 31.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 29.8 pt -140.02 158.12 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.407 ' CE1' HG22 ' A' ' 180' ' ' VAL . 68.1 m80 -62.64 161.35 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 188' ' ' TYR . 50.9 tttt -68.75 -11.17 60.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -105.19 -20.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.69 15.66 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 203' ' ' ASP . 17.6 tt -79.27 -40.09 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.425 ' N ' HG23 ' A' ' 202' ' ' ILE . 6.8 p-10 -71.55 -25.52 62.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.407 ' HD2' ' CG ' ' A' ' 203' ' ' ASP . 0.6 OUTLIER -90.54 37.25 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.44 96.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.68 -44.82 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -41.75 154.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.08 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -99.31 159.96 14.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -85.51 145.14 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 211' ' ' GLY . 8.9 t -106.51 -40.81 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 210' ' ' THR . . . 72.2 46.28 35.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.1 t -97.64 128.48 44.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.854 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.1 t -171.71 173.37 4.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.8 m -149.31 173.24 13.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -149.99 178.69 27.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.8 t -150.75 166.97 28.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -132.84 168.56 18.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -101.46 -175.04 28.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.2 166.78 29.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -135.32 165.65 24.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -164.94 152.14 11.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.09 111.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.465 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.5 170.13 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.084 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 149' ' ' ILE . 18.4 tt -109.95 121.88 63.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 151' ' ' GLN . 30.0 tptt -70.85 124.28 23.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 150' ' ' LYS . 17.8 mp0 -35.89 130.74 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.91 128.22 18.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -137.07 153.76 50.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 163' ' ' THR . 68.4 t -99.88 131.69 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -93.87 128.43 40.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -101.69 99.62 9.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 160' ' ' HIS . 90.1 t -117.87 134.67 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.568 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 1.5 mmmp? 33.79 47.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.864 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 64.3 m 64.61 45.08 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.5 m-70 -135.09 118.75 17.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.83 75.56 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -72.34 144.53 48.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.419 HG22 HG22 ' A' ' 154' ' ' VAL . 81.7 p -134.01 127.33 32.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.82 119.17 3.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -143.99 153.26 42.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -116.5 112.77 21.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -87.74 111.18 40.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.668 0.747 . . . . 0.0 110.863 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -6.39 18.45 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.328 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -128.83 152.53 79.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.61 0.719 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.67 2.247 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.0 m -113.9 138.47 50.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -66.93 129.72 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.1 t -72.04 159.26 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 197' ' ' ILE . 29.1 t -98.09 -29.21 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.47 HG11 ' HB2' ' A' ' 204' ' ' LYS . 85.9 t -87.55 -75.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.3 p -72.17 -22.11 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 60.91 45.45 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.35 169.67 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -62.84 122.86 17.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 198' ' ' HIS . 48.4 t -110.24 88.14 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.12 157.86 43.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.967 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 147.89 143.78 3.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.71 -44.62 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 0.0 110.949 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -111.77 51.79 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -127.67 87.16 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.464 ' HG2' ' N ' ' A' ' 187' ' ' GLY . 14.5 tt0 -71.0 146.89 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.464 ' N ' ' HG2' ' A' ' 186' ' ' GLN . . . -127.0 -151.5 7.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.439 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -154.43 134.59 13.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -132.58 127.85 35.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.4 t -71.76 162.02 30.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -88.72 -20.02 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -105.61 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 25.7 p -66.56 -10.61 47.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 42.57 49.92 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.75 28.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -94.94 122.05 37.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.464 HG21 HG23 ' A' ' 175' ' ' VAL . 36.4 pt -145.54 173.75 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.576 ' CE1' HG22 ' A' ' 180' ' ' VAL . 74.2 m80 -66.9 176.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -24.13 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -96.57 -38.11 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.48 -25.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 203' ' ' ASP . 19.2 tt -49.02 -39.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.153 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 202' ' ' ILE . 39.6 m-20 -70.25 -32.72 70.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.47 ' HB2' HG11 ' A' ' 175' ' ' VAL . 27.5 mmmt -86.04 38.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.4 125.51 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 80.7 mt -120.64 -40.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.14 136.09 42.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.443 ' HG3' ' NZ ' ' A' ' 158' ' ' LYS . 7.0 mtpm? -83.1 167.05 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.401 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.3 t -84.6 122.18 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 31.4 p -86.58 -46.53 10.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 80.32 103.46 0.29 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.5 p -58.22 152.37 17.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.863 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.145 179.862 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.1 t -117.23 135.15 54.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.88 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.4 m -124.14 142.04 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.91 118.11 0.85 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.455 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.3 t -163.53 122.99 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.884 0.373 . . . . 0.0 110.869 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 95.4 p -157.67 109.55 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.62 123.26 1.46 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.19 165.48 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.935 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -112.96 90.61 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -133.61 85.37 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.67 55.79 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.503 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -117.38 42.32 2.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.73 0.3 . . . . 0.0 111.059 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.5 tt -123.19 135.88 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -127.24 153.7 45.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -104.16 121.38 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.45 139.55 53.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.54 133.94 17.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.86 124.39 37.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -103.34 105.1 15.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -78.06 111.4 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.698 HG21 HD11 ' A' ' 202' ' ' ILE . 54.7 t -130.99 115.36 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 10.9 mptt 53.16 40.93 32.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 42.0 m 67.04 40.27 2.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 96.1 m-70 -134.79 118.1 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -79.25 80.41 5.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -80.69 107.23 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 77.0 p -111.53 126.8 55.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.83 108.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.6 t -132.8 146.34 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.159 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.36 143.15 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.97 124.96 28.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.615 0.722 . . . . 0.0 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -23.97 29.77 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.654 2.236 . . . . 0.0 112.311 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -127.45 152.47 76.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.52 ' HB3' ' CG ' ' A' ' 181' ' ' TRP . 53.8 Cg_endo -69.71 127.93 15.33 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 180' ' ' VAL . 4.7 t -120.21 149.82 41.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -79.14 128.76 33.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.73 159.63 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.426 ' H ' HG22 ' A' ' 197' ' ' ILE . 25.6 m -95.93 -19.16 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.457 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 90.2 t -100.31 -72.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.5 p -71.62 -22.48 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.457 ' CE1' ' O ' ' A' ' 175' ' ' VAL . 9.9 m80 62.83 44.38 6.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.83 151.27 37.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -52.43 130.61 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 171' ' ' THR . 66.4 t -103.5 67.36 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.52 ' CG ' ' HB3' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -106.85 46.96 0.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -73.88 87.88 0.66 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.3 tt -42.8 -52.96 4.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -99.13 -40.18 8.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 140.95 57.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -105.83 161.64 14.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -123.31 -168.3 13.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.532 ' CE2' ' HG2' ' A' ' 199' ' ' LYS . 26.9 m-85 -128.69 147.55 50.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.0 110.887 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.591 ' OE1' ' HB2' ' A' ' 196' ' ' ALA . 28.6 tp60 -143.7 110.58 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 5.3 t -57.94 157.81 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -96.34 -14.76 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -99.28 -67.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.42 -22.26 54.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 59.78 47.89 9.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.69 133.33 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.591 ' HB2' ' OE1' ' A' ' 189' ' ' GLN . . . -99.55 124.24 44.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 174' ' ' SER . 42.7 pt -145.15 175.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.52 ' NE2' HG22 ' A' ' 180' ' ' VAL . 67.7 m80 -85.99 163.87 17.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.532 ' HG2' ' CE2' ' A' ' 188' ' ' TYR . 34.2 mttm -67.29 -20.22 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -92.51 -27.16 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.638 ' O ' HG23 ' A' ' 205' ' ' VAL . 76.3 m -82.56 11.04 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.698 HD11 HG21 ' A' ' 157' ' ' VAL . 20.1 tt -73.16 -34.98 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.85 -27.08 49.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.433 ' HB2' HG11 ' A' ' 175' ' ' VAL . 20.3 mttm -88.75 32.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 201' ' ' CYS . 76.8 t -111.12 88.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.184 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.1 mp -85.13 -55.74 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.81 116.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -73.86 144.43 45.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.75 134.11 53.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 67.8 p -107.34 -37.96 6.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 137.47 158.05 7.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 74.3 p -57.12 149.14 20.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.099 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.1 p -114.3 120.8 41.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 110.869 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.1 m -92.94 -51.61 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 68.64 137.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.472 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -148.25 128.34 13.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 99.9 p -89.03 112.11 22.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -143.03 56.9 0.56 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.518 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -66.65 137.07 56.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -85.26 157.8 20.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -147.75 165.51 30.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.05 162.79 9.23 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.04 177.57 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.03 -179.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.7 tptm 70.06 41.23 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -117.37 93.09 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.948 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -173.69 152.04 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 106.32 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.8 t -139.2 135.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -97.37 134.42 40.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -100.96 107.62 19.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 85.2 t -131.66 125.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 45.33 36.52 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.8 t 67.92 44.4 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.9 m-70 -134.66 118.31 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.448 ' OE2' ' NH2' ' A' ' 191' ' ' ARG . 21.0 mt-10 -91.92 78.17 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -67.84 150.07 49.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 43.6 p -142.0 117.82 10.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.5 106.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.4 t -133.6 157.65 45.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.141 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -112.75 107.66 16.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.849 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -81.55 112.11 31.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.436 ' HG2' ' CD ' ' A' ' 169' ' ' GLN . 53.5 Cg_endo -69.78 -7.01 19.97 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.313 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.436 ' CD ' ' HG2' ' A' ' 168' ' ' PRO . 19.6 mp0 -125.46 152.71 71.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.608 0.718 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 110.53 2.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 180' ' ' VAL . 1.3 m -109.26 157.42 18.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.157 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -96.48 129.7 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.6 t -69.29 128.63 37.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 197' ' ' ILE . 72.2 m -85.62 19.52 2.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 204' ' ' LYS . 98.2 t -125.07 -57.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.69 -13.91 17.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 4.7 m170 63.93 52.26 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 179' ' ' PHE . 25.9 mt-10 -132.67 136.71 46.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.458 ' C ' ' O ' ' A' ' 178' ' ' GLU . 29.9 m-85 -33.35 137.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.538 HG22 ' NE2' ' A' ' 198' ' ' HIS . 88.0 t -123.39 102.1 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -172.85 174.75 3.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 136.33 133.85 3.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.21 -61.01 2.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.79 0.329 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -85.72 42.41 0.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -131.66 168.44 17.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -148.35 157.09 43.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -135.38 -149.73 5.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.508 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -149.1 137.15 20.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -130.24 120.03 23.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.404 ' HB3' ' N ' ' A' ' 194' ' ' ASN . 4.7 t -66.93 162.02 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.448 ' NH2' ' OE2' ' A' ' 161' ' ' GLU . 18.9 mtm105 -92.93 -24.91 18.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -99.78 -74.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.4 p -72.51 -9.74 58.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.404 ' N ' ' HB3' ' A' ' 190' ' ' CYS . 1.3 p-10 42.99 54.17 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.46 131.96 34.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.105 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -97.7 115.66 28.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 201' ' ' CYS . 12.5 pt -143.11 159.49 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.538 ' NE2' HG22 ' A' ' 180' ' ' VAL . 46.2 m80 -65.23 159.61 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -65.02 -35.09 80.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 201' ' ' CYS . 0.0 OUTLIER -77.96 -26.62 48.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.486 ' O ' HD12 ' A' ' 197' ' ' ILE . 86.0 m -84.21 22.53 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.45 -36.03 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -83.16 -25.27 32.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.717 ' O ' HG13 ' A' ' 175' ' ' VAL . 30.3 mmtm -86.11 31.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.449 HG22 ' CG2' ' A' ' 175' ' ' VAL . 96.7 t -104.94 116.52 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.19 -47.47 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -38.59 137.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.473 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 19.7 ttpt -88.38 156.0 19.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.2 t -91.88 113.39 25.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.2 p -95.21 -46.62 6.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 87.86 98.66 0.91 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.53 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 213' ' ' ALA . 14.3 t -134.54 166.79 22.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 0.0 110.855 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 212' ' ' SER . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.1 p -170.49 136.51 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.842 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.1 t -167.46 159.47 12.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.845 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.82 176.25 45.69 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.4 t -167.11 159.95 13.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.9 t -162.98 157.54 21.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -159.62 150.35 20.65 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.47 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -145.34 120.68 10.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -130.15 137.15 49.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -156.03 153.13 28.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -102.96 -154.83 24.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -130.3 167.51 18.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.741 0.305 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.84 143.38 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -161.13 107.48 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -150.28 163.33 38.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.67 172.07 7.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.099 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.89 172.63 10.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.4 t -137.84 144.44 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -105.31 137.53 42.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -97.49 98.57 10.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 65.3 t -120.15 116.58 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.608 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.9 mptt 43.39 45.94 5.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 65.2 m 62.88 40.05 9.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 91.9 m-70 -135.64 123.67 22.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -87.91 88.95 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -82.51 122.88 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -129.67 123.3 30.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.08 101.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.8 t -126.23 155.42 41.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -112.09 112.99 25.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -84.94 126.48 67.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -11.05 30.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.706 2.271 . . . . 0.0 112.382 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.16 152.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 117.62 5.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.3 t -114.67 136.41 53.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.134 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.24 128.83 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.04 159.64 9.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 197' ' ' ILE . 12.6 m -97.36 -26.45 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.92 -75.15 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 12.7 p -70.55 -20.79 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 5.7 m170 60.87 49.45 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 179' ' ' PHE . 5.9 mm-40 -126.95 133.49 50.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 178' ' ' GLU . 12.1 p90 -36.05 111.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.666 HG22 ' CE1' ' A' ' 198' ' ' HIS . 58.5 t -87.92 86.26 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -175.95 124.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -151.62 -113.03 0.56 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.6 mt -147.12 117.74 7.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 57.5 42.24 24.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -128.75 92.57 3.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -74.17 140.04 44.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -105.44 -150.4 19.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -140.47 137.08 33.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -132.44 118.26 19.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 10.6 t -58.56 162.67 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -94.14 -13.56 26.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -112.36 -62.59 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 194' ' ' ASN . 17.3 p -87.92 4.95 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 193' ' ' CYS . 2.0 p30 34.08 45.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.413 ' HB2' ' SG ' ' A' ' 193' ' ' CYS . . . -72.48 119.41 16.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.096 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -93.31 115.05 27.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.085 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 201' ' ' CYS . 29.9 pt -141.88 158.32 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.666 ' CE1' HG22 ' A' ' 180' ' ' VAL . 72.7 m80 -63.22 161.2 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -65.03 -18.88 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.59 -23.72 16.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.542 ' O ' HD12 ' A' ' 197' ' ' ILE . 81.3 m -83.35 22.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 203' ' ' ASP . 21.1 tt -84.3 -39.57 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.422 ' N ' HG23 ' A' ' 202' ' ' ILE . 3.4 p30 -75.33 -30.74 60.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -84.39 36.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -108.74 108.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 39.7 mm -105.42 -50.2 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -36.49 146.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -92.89 165.12 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.556 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.7 t -95.39 118.16 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.2 t -50.37 -38.54 43.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 51.57 83.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.461 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 1.9 t -70.87 141.32 51.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 110.86 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.064 179.923 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.7 m -134.05 160.3 38.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 0.0 110.818 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.4 m -104.18 173.8 6.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 149.54 156.99 7.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 96.1 p -94.84 160.87 14.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t -174.27 145.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.51 -62.99 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.464 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 62.48 42.43 8.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -107.36 41.82 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -94.4 145.01 25.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.56 134.22 2.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -167.56 169.9 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.3 tt -152.16 143.44 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 150' ' ' LYS . 3.3 mppt? -98.45 40.56 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -41.94 150.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.18 159.07 16.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.473 ' HD2' ' CE1' ' A' ' 155' ' ' HIS . 0.0 OUTLIER -134.72 151.32 50.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.524 HG11 ' HB3' ' A' ' 161' ' ' GLU . 90.8 t -105.39 131.02 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.473 ' CE1' ' HD2' ' A' ' 153' ' ' LYS . 64.0 m-70 -78.17 113.53 16.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -94.08 106.41 18.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 160' ' ' HIS . 87.5 t -124.83 126.67 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . 28.7 mmmt 34.76 39.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 t 74.98 43.92 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.554 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 92.1 m-70 -137.76 115.4 11.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.524 ' HB3' HG11 ' A' ' 154' ' ' VAL . 38.1 mt-10 -80.77 74.25 7.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 33.1 m-85 -70.3 128.75 37.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 80.9 p -136.01 126.43 26.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -43.3 115.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.8 t -134.45 154.14 51.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.17 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -105.36 103.7 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -77.9 111.91 21.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.64 19.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.644 2.229 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -140.48 156.68 69.37 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.712 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 109.0 2.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.676 2.25 . . . . 0.0 112.355 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.559 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.8 t -99.16 157.91 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.113 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 1.4 p90 -87.6 129.01 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 40.0 t -79.37 119.01 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.1 t -82.31 26.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 204' ' ' LYS . 57.9 t -128.27 -59.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -101.81 -13.37 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.4 m170 62.16 53.37 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.95 131.13 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -40.91 114.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.1 t -84.76 92.58 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -174.02 153.05 2.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 89.28 -60.7 3.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.527 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.91 159.74 18.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.907 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 186' ' ' GLN . 12.3 m-20 58.81 37.35 24.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.469 ' HG2' ' N ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -34.06 -33.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 184' ' ' ASN . 23.7 mt-30 -93.68 112.84 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -115.32 -142.78 7.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.464 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.573 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 14.8 m-85 -150.54 134.99 17.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -132.3 117.99 18.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 41.7 t -63.36 163.72 10.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -99.71 -27.06 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.4 ' HB2' ' SG ' ' A' ' 209' ' ' CYS . 36.6 mm-40 -87.98 -68.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.3 p -81.49 -24.64 36.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 190' ' ' CYS . 4.0 m-80 62.71 51.06 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.23 125.69 34.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.059 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.559 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -94.09 130.24 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 201' ' ' CYS . 28.4 pt -154.16 170.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -71.37 159.86 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.573 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 2.2 ttpm? -66.33 -29.19 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 -27.21 24.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.553 ' O ' HD12 ' A' ' 197' ' ' ILE . 72.3 m -81.69 21.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.8 tt -79.55 -39.22 20.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.405 ' N ' HG23 ' A' ' 202' ' ' ILE . 34.3 m-20 -77.73 -28.4 50.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.619 ' O ' HG13 ' A' ' 175' ' ' VAL . 13.5 mmmm -84.64 32.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 201' ' ' CYS . 62.3 t -107.48 114.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 207' ' ' ALA . 5.4 mp -103.09 -54.74 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -33.68 122.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -82.84 158.36 22.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 1.8 t -88.06 137.5 32.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 t -119.53 -31.52 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.2 99.64 2.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 6.2 t -166.38 161.11 16.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.859 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.078 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.6 t -171.49 169.82 6.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.859 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.2 m -170.94 172.89 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.17 -174.79 38.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 t -171.42 152.92 3.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.393 . . . . 0.0 110.824 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.4 t -165.13 171.35 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.57 142.7 3.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.527 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -152.75 148.15 26.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 57.5 mtt85 -149.76 140.07 22.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -79.38 86.84 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -103.8 70.88 0.27 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.466 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.8 178.3 4.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 111.081 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.57 146.37 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -175.16 133.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -171.47 141.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.04 159.61 41.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.137 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.08 174.67 12.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.755 HG22 HG22 ' A' ' 163' ' ' THR . 64.1 t -105.06 132.49 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -88.25 141.98 28.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -96.95 110.75 23.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 160' ' ' HIS . 93.0 t -134.68 126.46 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . 22.7 mmtt 37.2 38.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 3.4 t 70.23 42.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.1 m-70 -132.9 128.6 36.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.751 ' HB3' HG11 ' A' ' 154' ' ' VAL . 11.7 mt-10 -92.65 74.78 5.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.899 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 38.4 m-85 -65.12 140.49 58.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.755 HG22 HG22 ' A' ' 154' ' ' VAL . 26.4 p -139.76 121.87 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.162 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.09 114.48 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.5 HG23 ' CZ ' ' A' ' 167' ' ' PHE . 14.4 t -142.46 149.0 38.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -110.43 125.12 52.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.5 ' CZ ' HG23 ' A' ' 165' ' ' THR . 18.1 m-85 -100.92 106.65 45.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -5.1 15.37 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.694 2.263 . . . . 0.0 112.36 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -126.93 158.92 67.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 116.26 4.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.634 2.222 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 88.9 m -121.16 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.23 138.32 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.92 159.24 30.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 197' ' ' ILE . 3.6 m -105.82 -26.85 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.552 HG23 HG21 ' A' ' 197' ' ' ILE . 75.2 t -80.24 -62.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.9 p -86.79 -27.0 23.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 10.6 m80 72.84 40.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 179' ' ' PHE . 37.9 mt-10 -125.27 128.89 48.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 178' ' ' GLU . 1.5 p90 -36.61 119.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 198' ' ' HIS . 47.1 t -95.78 68.86 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.556 ' CG ' ' O ' ' A' ' 181' ' ' TRP . 4.1 p-90 -134.62 35.75 3.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 183' ' ' LEU . . . -98.15 178.17 31.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.509 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 182' ' ' GLY . 5.6 tp -36.2 -53.32 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.331 . . . . 0.0 110.934 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -90.13 76.43 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.929 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.492 ' H ' ' CD ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -74.06 -37.21 64.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.453 ' N ' ' HG2' ' A' ' 185' ' ' LYS . 28.7 tt0 -41.02 110.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.33 -153.47 8.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.483 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.452 ' HB3' ' CD1' ' A' ' 162' ' ' PHE . 42.0 m-85 -134.55 137.74 44.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -123.84 124.77 43.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 52.2 t -73.15 143.3 47.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -89.97 18.41 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.855 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -128.54 -61.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 26.5 p -91.85 -16.21 27.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 60.4 48.12 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.33 124.22 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.96 128.86 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.552 HG21 HG23 ' A' ' 175' ' ' VAL . 43.9 pt -145.39 173.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.759 ' CE1' HG22 ' A' ' 180' ' ' VAL . 46.4 m80 -67.73 175.42 2.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -75.35 -31.88 60.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -91.1 -41.36 11.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.7 m -43.77 -25.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.7 tt -45.8 -36.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.53 -37.45 65.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.484 ' O ' HG13 ' A' ' 175' ' ' VAL . 9.7 mmmm -82.57 40.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.27 116.18 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.11 -41.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -42.29 154.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -107.76 138.82 43.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -72.5 140.37 48.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 t -102.03 -30.75 11.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.08 110.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 94.5 p -132.85 143.99 49.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.3 t -154.86 149.15 26.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.935 0.398 . . . . 0.0 110.844 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.9 m -159.15 175.16 13.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.881 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -153.57 -173.39 22.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 54.9 p -156.75 172.13 19.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 110.821 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.1 t -167.61 161.6 13.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -152.61 -179.82 28.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.462 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -160.4 162.74 33.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 110.887 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.32 149.18 29.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.0 mtt-85 -128.69 169.03 14.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.49 64.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -46.84 174.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.728 0.299 . . . . 0.0 111.087 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.0 tt -121.17 150.34 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -128.43 106.46 9.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -107.81 145.01 34.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.77 171.32 16.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -163.47 149.9 11.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -127.47 124.7 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -84.45 116.52 23.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.832 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.47 112.64 24.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.94 125.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm 47.98 36.42 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 11.0 t 72.51 39.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 96.7 m-70 -132.29 122.45 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -90.7 76.55 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.512 ' CD2' HG13 ' A' ' 202' ' ' ILE . 42.7 m-85 -75.03 107.69 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.9 p -113.26 130.94 56.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.5 101.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 189' ' ' GLN . 14.9 t -121.67 152.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -113.0 114.54 27.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -88.48 128.47 52.83 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.674 0.749 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.92 154.51 67.64 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.535 0.683 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.474 ' HB3' ' CB ' ' A' ' 181' ' ' TRP . 53.7 Cg_endo -69.77 115.94 4.33 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.4 t -105.62 153.41 21.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.36 116.28 28.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.3 t -44.9 160.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.425 ' H ' HG22 ' A' ' 197' ' ' ILE . 1.6 m -103.99 -34.29 8.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 204' ' ' LYS . 80.6 t -76.61 -68.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 15.4 p -80.29 -24.51 39.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.416 ' NE2' ' O ' ' A' ' 174' ' ' SER . 39.2 m80 64.27 47.94 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 180' ' ' VAL . 15.4 mm-40 -120.61 152.02 38.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -50.68 116.52 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 198' ' ' HIS . 81.2 t -103.93 73.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.474 ' CB ' ' HB3' ' A' ' 170' ' ' PRO . 1.2 t90 -176.46 162.82 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 183' ' ' LEU . . . 123.94 54.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 183' ' ' LEU . 6.8 mp 35.33 40.94 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.944 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -102.03 -61.32 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -175.09 158.02 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -78.38 161.48 27.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -108.69 -153.52 16.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 199' ' ' LYS . 12.4 m-85 -127.28 150.14 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.92 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.431 ' HB2' HG21 ' A' ' 165' ' ' THR . 33.5 tt0 -138.52 119.46 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 42.5 t -74.43 132.27 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -83.3 24.24 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.4 ' HB2' ' SG ' ' A' ' 209' ' ' CYS . 6.5 mm100 -131.37 -55.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -98.53 -24.81 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.8 t30 73.73 45.34 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.77 120.85 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.89 121.06 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 174' ' ' SER . 46.0 pt -143.97 171.35 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.576 ' CE1' HG22 ' A' ' 180' ' ' VAL . 58.2 m80 -65.16 175.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 188' ' ' TYR . 24.0 mtpt -77.39 -28.66 52.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 202' ' ' ILE . 18.9 pttm -93.46 -38.8 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.27 -20.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' A' ' 162' ' ' PHE . 19.2 tt -51.54 -26.03 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.48 -32.95 36.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.63 ' HB2' HG11 ' A' ' 175' ' ' VAL . 1.3 mmmp? -83.4 33.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 82.2 t -112.82 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.11 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 89.8 mt -120.65 -38.09 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -47.72 138.39 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -84.6 140.67 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.543 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 6.5 t -71.48 141.01 50.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 62.5 p -110.01 -43.4 3.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 96.14 53.56 1.47 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.486 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -91.86 149.5 21.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.89 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.105 179.929 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.8 m 62.13 43.21 8.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.9 m -104.76 123.3 47.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.821 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -143.95 -171.82 14.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.8 p -152.39 154.27 35.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.5 t -83.17 175.63 9.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.61 174.74 17.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -123.11 133.11 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 144.25 45.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -111.48 177.89 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -143.66 -166.96 11.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.1 172.85 7.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.01 144.61 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -95.16 148.87 21.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -102.56 156.52 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.49 138.26 26.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -160.34 148.89 16.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.494 HG11 ' HG3' ' A' ' 161' ' ' GLU . 84.6 t -82.44 133.99 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -95.38 125.61 40.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.814 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -90.2 114.64 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.83 127.8 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 11.6 mmtp 39.85 43.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 87.1 m 63.57 44.96 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 89.6 m-70 -137.23 131.74 32.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.494 ' HG3' HG11 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -97.77 77.17 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 188' ' ' TYR . 39.0 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 42.4 p -140.85 123.33 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.47 109.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.1 t -134.42 150.29 50.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.59 115.55 30.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 41.0 m-85 -91.44 107.49 22.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.61 0.719 . . . . 0.0 110.86 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.461 ' HG2' ' NE2' ' A' ' 169' ' ' GLN . 54.2 Cg_endo -69.74 -6.37 18.42 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.311 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.461 ' NE2' ' HG2' ' A' ' 168' ' ' PRO . 14.7 mp0 -129.38 153.65 80.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 53.7 Cg_endo -69.86 109.5 2.35 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.653 2.235 . . . . 0.0 112.331 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 172' ' ' PHE . 21.8 m -104.58 157.33 17.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.438 ' N ' HG22 ' A' ' 171' ' ' THR . 37.7 p90 -92.86 112.89 25.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.853 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.5 t -61.86 127.82 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.0 t -83.75 19.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.588 HG23 HG21 ' A' ' 197' ' ' ILE . 90.0 t -127.38 -59.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.0 p -98.95 -16.17 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.2 m170 62.47 49.43 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -125.85 139.62 53.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -40.14 132.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.989 HG22 ' NE2' ' A' ' 198' ' ' HIS . 75.2 t -119.8 91.06 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -146.05 174.5 11.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.69 148.55 21.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.46 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.72 -45.38 92.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -81.21 -176.62 6.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.404 ' HA ' ' NZ ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER 58.96 47.89 11.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.947 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -40.19 160.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -117.28 -169.64 15.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.464 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 11.4 m-85 -138.31 130.06 28.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -121.99 119.52 31.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' ASN . 34.8 t -65.6 162.66 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -94.83 -24.22 17.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 194' ' ' ASN . 15.7 mt-30 -94.52 -75.09 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 31.6 p -72.67 -22.17 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 192' ' ' GLN . 7.6 m-80 59.22 52.99 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -92.12 130.02 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -95.69 120.97 36.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.588 HG21 HG23 ' A' ' 175' ' ' VAL . 23.1 pt -145.47 165.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.989 ' NE2' HG22 ' A' ' 180' ' ' VAL . 53.2 m80 -73.96 154.55 39.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 188' ' ' TYR . 45.0 mtmt -57.74 -36.47 72.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -74.72 -30.35 61.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.557 ' O ' HD12 ' A' ' 197' ' ' ILE . 57.1 m -83.99 28.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 203' ' ' ASP . 20.8 tt -85.72 -38.96 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.4 ' N ' HG23 ' A' ' 202' ' ' ILE . 5.2 m-20 -80.35 -23.35 40.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.524 ' HB2' HG11 ' A' ' 175' ' ' VAL . 26.1 mmtm -84.3 29.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.9 t -104.16 121.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.43 -47.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.18 125.72 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.05 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -75.53 153.39 37.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.538 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.9 t -78.98 126.19 30.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.4 t -116.6 38.25 3.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -89.62 65.99 2.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.556 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.4 26.14 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 110.845 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.085 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.5 m -152.8 156.26 38.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.9 m -159.35 168.78 25.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.839 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 175.04 176.08 43.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.528 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 92.8 p -161.09 134.98 6.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.831 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.4 t -146.98 140.29 25.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.39 -173.56 13.35 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -148.44 163.69 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.347 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -136.01 130.83 34.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -148.4 144.35 27.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.18 102.59 0.21 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.476 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.23 163.6 14.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.6 tt -148.61 154.02 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.115 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -143.53 142.14 31.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -136.09 157.82 45.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -109.15 -175.65 2.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.414 ' HE2' ' NE2' ' A' ' 155' ' ' HIS . 0.0 OUTLIER -137.88 166.99 22.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 161' ' ' GLU . 62.5 t -115.58 110.5 32.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.13 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.414 ' NE2' ' HE2' ' A' ' 153' ' ' LYS . 82.8 m-70 -70.69 159.2 34.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.67 110.13 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 160' ' ' HIS . 85.2 t -137.94 130.33 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 17.6 mmtm 36.95 45.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.1 m 64.56 46.13 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.565 ' CE1' ' HB2' ' A' ' 209' ' ' CYS . 97.1 m-70 -136.99 128.76 28.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.403 ' HB3' ' CG1' ' A' ' 154' ' ' VAL . 56.7 mt-10 -87.27 76.6 9.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -78.03 126.46 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.655 HG21 ' CZ ' ' A' ' 191' ' ' ARG . 6.1 t -147.16 135.52 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.159 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -42.71 115.29 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.785 HG21 ' HB2' ' A' ' 189' ' ' GLN . 10.2 t -135.43 158.57 44.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.03 118.13 33.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.455 ' CZ ' HG23 ' A' ' 165' ' ' THR . 24.9 m-85 -94.63 127.66 42.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.2 32.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.718 2.279 . . . . 0.0 112.375 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -127.11 158.84 67.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.58 0.705 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 109.19 2.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.718 2.279 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.633 HG21 ' HB1' ' A' ' 196' ' ' ALA . 12.9 t -96.95 157.74 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -97.22 140.36 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.473 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 48.7 t -80.09 124.49 28.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 t -86.17 22.11 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.6 t -121.87 -48.32 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.65 -11.36 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 17.5 m170 63.2 52.24 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 179' ' ' PHE . 13.6 mm-40 -131.85 136.02 47.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 178' ' ' GLU . 5.5 m-85 -36.97 126.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.591 HG22 ' CE1' ' A' ' 198' ' ' HIS . 46.4 t -111.48 80.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -174.37 156.22 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 79.37 -58.96 4.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.12 166.45 10.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.921 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.8 p30 39.54 42.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.85 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -49.57 175.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 65.85 54.24 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.05 -161.86 2.63 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.465 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.591 ' CE2' ' HG3' ' A' ' 199' ' ' LYS . 11.8 m-85 -126.47 131.14 51.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 110.895 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.785 ' HB2' HG21 ' A' ' 165' ' ' THR . 45.2 tt0 -126.75 124.38 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 49.3 t -77.13 130.12 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.655 ' CZ ' HG21 ' A' ' 163' ' ' THR . 0.2 OUTLIER -81.2 19.08 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -124.95 -61.55 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.4 p -93.11 -24.56 18.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 73.54 46.64 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.8 121.55 38.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 171' ' ' THR . . . -95.85 123.06 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 201' ' ' CYS . 41.8 pt -141.97 167.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.591 ' CE1' HG22 ' A' ' 180' ' ' VAL . 44.8 m80 -70.73 151.13 45.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.87 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.591 ' HG3' ' CE2' ' A' ' 188' ' ' TYR . 23.8 tttt -57.94 -34.98 70.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -80.95 -26.07 36.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.559 ' O ' HD12 ' A' ' 197' ' ' ILE . 87.2 m -83.04 27.45 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 203' ' ' ASP . 19.5 tt -86.06 -39.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 202' ' ' ILE . 8.1 t70 -74.17 -29.82 61.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 36.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.09 128.9 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 207' ' ' ALA . 88.4 mt -126.08 -52.94 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -34.84 116.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.094 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 160.41 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 9.1 t -87.81 144.53 26.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 211' ' ' GLY . 10.2 t -93.45 -40.18 10.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 210' ' ' THR . . . 74.69 109.27 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.469 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 1.1 t -111.49 25.85 11.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.898 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.104 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.7 p -167.3 133.16 2.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.4 t -174.52 161.96 3.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.06 98.43 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.7 t -66.02 100.78 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.878 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 t -112.58 109.46 19.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.63 159.94 23.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.502 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -150.15 118.34 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -98.86 162.85 12.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -141.72 141.93 33.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -132.18 154.44 21.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -123.24 165.13 17.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.331 . . . . 0.0 111.074 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.4 tt -163.96 131.2 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.36 169.52 13.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -169.19 174.12 6.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.72 167.92 20.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -154.0 137.95 16.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.4 t -109.28 122.34 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -84.72 116.3 23.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.77 100.05 12.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.21 107.79 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 16.6 mmtm 62.63 41.3 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.9 m 63.94 39.16 8.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.897 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 97.4 m-70 -132.54 124.92 29.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -92.74 77.84 4.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.01 121.19 21.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 62.5 p -123.91 127.27 47.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.157 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.446 ' HB1' ' NE2' ' A' ' 186' ' ' GLN . . . -43.9 115.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.459 ' CG2' ' CZ ' ' A' ' 167' ' ' PHE . 10.1 t -134.63 143.29 47.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -99.89 108.09 20.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.459 ' CZ ' ' CG2' ' A' ' 165' ' ' THR . 45.6 m-85 -81.19 127.41 74.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.661 0.743 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -26.69 27.46 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.244 . . . . 0.0 112.373 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -129.94 153.38 80.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.42 ' HB3' ' CB ' ' A' ' 181' ' ' TRP . 53.7 Cg_endo -69.76 110.15 2.48 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.2 t -97.73 153.64 18.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 1.3 p90 -81.7 118.77 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.5 t -54.04 160.49 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.1 t -103.16 -29.05 11.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.57 -66.82 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 16.7 p -81.19 -22.31 38.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 5.4 m170 63.48 45.17 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 179' ' ' PHE . 54.3 mt-10 -127.42 133.79 49.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 178' ' ' GLU . 3.8 p90 -35.38 105.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 198' ' ' HIS . 83.9 t -75.35 81.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.42 ' CB ' ' HB3' ' A' ' 170' ' ' PRO . 3.4 t-105 -176.2 140.31 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 174.42 -99.49 0.14 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -67.42 -176.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.919 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.41 ' O ' ' CG ' ' A' ' 185' ' ' LYS . 1.7 m120 -85.57 88.79 7.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.881 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 184' ' ' ASN . 48.5 mttt -161.21 176.9 10.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.446 ' NE2' ' HB1' ' A' ' 164' ' ' ALA . 10.2 pt20 -123.8 162.43 23.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -101.63 -153.02 25.54 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.567 ' CE2' ' HA ' ' A' ' 199' ' ' LYS . 23.1 m-85 -133.41 143.12 48.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -139.61 132.67 29.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 19.7 t -73.83 162.71 28.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -90.82 -20.08 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.83 -70.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 15.4 p -72.07 -16.24 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 50.3 48.21 22.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -82.25 118.76 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.31 121.55 33.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 202' ' ' ILE . 40.0 pt -145.74 175.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.449 ' CE1' HG22 ' A' ' 180' ' ' VAL . 64.9 m80 -70.97 175.24 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.668 ' O ' HG22 ' A' ' 202' ' ' ILE . 5.9 mtpm? -70.51 -43.67 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 201' ' ' CYS . 2.4 pptp? -80.15 -36.08 35.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 1.8 m -51.02 -22.5 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 199' ' ' LYS . 16.6 tt -52.79 -38.33 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.6 -32.73 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -83.27 37.16 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.8 t -114.23 115.35 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 95.9 mt -110.65 -43.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -43.64 163.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 209' ' ' CYS . 3.8 ttmp? -110.92 162.85 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 208' ' ' LYS . 4.2 t -86.8 109.42 19.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.9 t -91.12 30.52 1.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 83.5 -48.31 4.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 28.1 t -161.22 147.6 14.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.857 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.074 179.903 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.9 p -134.38 -42.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.794 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.7 t 64.86 43.78 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.02 127.79 22.19 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.535 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.9 m -139.85 108.91 6.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 110.874 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 m -130.4 151.82 50.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -53.94 169.6 1.22 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -126.62 -66.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.326 . . . . 0.0 110.931 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -141.32 122.66 14.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.856 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -79.93 -46.9 15.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.35 122.26 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -127.22 163.67 23.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.742 0.306 . . . . 0.0 111.124 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.6 tt -110.68 141.98 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.36 151.22 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -93.24 122.01 35.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.62 156.82 25.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -170.17 148.49 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.59 132.6 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -88.12 99.65 12.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -74.57 118.11 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.8 t -139.8 122.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 13.4 mptt 42.04 44.9 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.939 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 4.2 m 63.31 42.47 6.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 158' ' ' LYS . 95.4 m-70 -137.16 119.15 15.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -84.32 79.35 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -73.62 139.14 45.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 81.6 p -141.5 125.86 17.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -46.2 106.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.1 t -125.1 160.97 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.159 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -112.56 115.79 29.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.455 ' O ' ' NE1' ' A' ' 181' ' ' TRP . 21.0 m-85 -89.56 110.64 40.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.628 0.728 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -15.09 36.69 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 0.0 112.355 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -129.97 160.91 62.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.923 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.32 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 m -102.09 147.36 26.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -89.58 109.43 20.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.87 159.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 p -99.36 -28.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.6 -73.48 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.7 p -75.31 -22.64 57.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 63.13 44.42 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.54 142.79 49.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -42.67 123.07 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.608 HG22 ' CE1' ' A' ' 198' ' ' HIS . 92.8 t -100.03 80.17 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.455 ' NE1' ' O ' ' A' ' 167' ' ' PHE . 0.4 OUTLIER -176.38 139.17 0.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.32 -97.44 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.455 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.8 mt -71.23 178.65 3.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.86 45.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -110.28 174.19 5.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -132.9 164.99 25.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -119.71 -125.29 3.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.52 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.443 ' CZ ' ' HD2' ' A' ' 199' ' ' LYS . 23.3 m-85 -149.17 146.22 27.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -145.62 114.75 7.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.76 161.11 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -96.12 -20.47 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -96.81 -70.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.943 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.9 p -72.55 -20.63 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 56.67 51.58 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.24 126.23 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -92.48 131.71 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 29.7 pt -151.39 151.51 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.608 ' CE1' HG22 ' A' ' 180' ' ' VAL . 73.0 m80 -61.03 157.66 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 188' ' ' TYR . 0.2 OUTLIER -63.28 -14.31 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -98.51 -23.03 15.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.652 ' O ' HG23 ' A' ' 205' ' ' VAL . 88.0 m -83.0 16.56 2.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 188' ' ' TYR . 19.9 tt -81.13 -38.98 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 202' ' ' ILE . 0.7 OUTLIER -75.12 -28.79 60.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 201' ' ' CYS . 1.6 mptt -87.68 32.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 201' ' ' CYS . 55.0 t -110.01 111.48 36.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.167 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 207' ' ' ALA . 97.5 mt -111.23 -46.89 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 206' ' ' ILE . . . -37.39 155.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -101.37 164.0 11.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.463 ' HB2' ' CE1' ' A' ' 160' ' ' HIS . 4.6 t -91.39 138.62 31.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 210' ' ' THR . 15.0 t -123.95 38.09 4.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -115.18 96.15 0.74 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.524 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 23.9 p -92.37 143.77 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.857 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.095 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_